
<html lang="en"     class="pb-page"  data-request-id="05bc87c4-7fdc-4490-8fe4-57513b17a79e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b01726;issue:issue:10.1021/jmcmar.2019.62.issue-4;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors" /></meta><meta name="dc.Creator" content="Patrick  Sarver" /></meta><meta name="dc.Creator" content="Michael  Acker" /></meta><meta name="dc.Creator" content="Jeffrey T.  Bagdanoff" /></meta><meta name="dc.Creator" content="Zhouliang  Chen" /></meta><meta name="dc.Creator" content="Ying-Nan  Chen" /></meta><meta name="dc.Creator" content="Homan  Chan" /></meta><meta name="dc.Creator" content="Brant  Firestone" /></meta><meta name="dc.Creator" content="Michelle  Fodor" /></meta><meta name="dc.Creator" content="Jorge  Fortanet" /></meta><meta name="dc.Creator" content="Huaixiang  Hao" /></meta><meta name="dc.Creator" content="Murphy  Hentemann" /></meta><meta name="dc.Creator" content="Mitsunori  Kato" /></meta><meta name="dc.Creator" content="Robert  Koenig" /></meta><meta name="dc.Creator" content="Laura R.  LaBonte" /></meta><meta name="dc.Creator" content="Gang  Liu" /></meta><meta name="dc.Creator" content="Shumei  Liu" /></meta><meta name="dc.Creator" content="Chen  Liu" /></meta><meta name="dc.Creator" content="Eric  McNeill" /></meta><meta name="dc.Creator" content="Morvarid  Mohseni" /></meta><meta name="dc.Creator" content="Martin  Sendzik" /></meta><meta name="dc.Creator" content="Travis  Stams" /></meta><meta name="dc.Creator" content="Stan  Spence" /></meta><meta name="dc.Creator" content="Victoriano  Tamez" /></meta><meta name="dc.Creator" content="Ritesh  Tichkule" /></meta><meta name="dc.Creator" content="Christopher  Towler" /></meta><meta name="dc.Creator" content="Hongyun  Wang" /></meta><meta name="dc.Creator" content="Ping  Wang" /></meta><meta name="dc.Creator" content="Sarah L.  Williams" /></meta><meta name="dc.Creator" content="Bing  Yu" /></meta><meta name="dc.Creator" content="Matthew J.  LaMarche" /></meta><meta name="dc.Description" content="Protein tyrosine phosphatase SHP2 is an oncoprotein associated with cancer as well as a potential immune modulator because of its role in the programmed cell death PD-L1/PD-1 pathway. In the preced..." /></meta><meta name="Description" content="Protein tyrosine phosphatase SHP2 is an oncoprotein associated with cancer as well as a potential immune modulator because of its role in the programmed cell death PD-L1/PD-1 pathway. In the preced..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 28, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01726" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01726" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01726" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01726" /></link>
        
    
    

<title>6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01726" /></meta><meta property="og:title" content="6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0012.jpeg" /></meta><meta property="og:description" content="Protein tyrosine phosphatase SHP2 is an oncoprotein associated with cancer as well as a potential immune modulator because of its role in the programmed cell death PD-L1/PD-1 pathway. In the preceding manuscript, we described the optimization of a fused, bicyclic screening hit for potency, selectivity, and physicochemical properties in order to further expand the chemical diversity of allosteric SHP2 inhibitors. In this manuscript, we describe the further expansion of our approach, morphing the fused, bicyclic system into a novel monocyclic pyrimidinone scaffold through our understanding of SAR and use of structure-based design. These studies led to the identification of SHP394 (1), an orally efficacious inhibitor of SHP2, with high lipophilic efficiency, improved potency, and enhanced pharmacokinetic properties. We also report other pyrimidinone analogues with favorable pharmacokinetic and potency profiles. Overall, this work improves upon our previously described allosteric inhibitors and exemplifies and extends the range of permissible chemical templates that inhibit SHP2 via the allosteric mechanism." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Protein tyrosine phosphatase SHP2 is an oncoprotein associated with cancer as well as a potential immune modulator because of its role in the programmed cell death PD-L1/PD-1 pathway. In the preceding manuscript, we described the optimization of a fused, bicyclic screening hit for potency, selectivity, and physicochemical properties in order to further expand the chemical diversity of allosteric SHP2 inhibitors. In this manuscript, we describe the further expansion of our approach, morphing the fused, bicyclic system into a novel monocyclic pyrimidinone scaffold through our understanding of SAR and use of structure-based design. These studies led to the identification of SHP394 (1), an orally efficacious inhibitor of SHP2, with high lipophilic efficiency, improved potency, and enhanced pharmacokinetic properties. We also report other pyrimidinone analogues with favorable pharmacokinetic and potency profiles. Overall, this work improves upon our previously described allosteric inhibitors and exemplifies and extends the range of permissible chemical templates that inhibit SHP2 via the allosteric mechanism." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0012.jpeg" /></meta><meta name="twitter:title" content="6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01726"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01726">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01726&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01726&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01726&amp;href=/doi/10.1021/acs.jmedchem.8b01726" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1793-1802</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01725" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01766" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.9b00436"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Patrick Sarver</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick Sarver</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Sarver">Patrick Sarver</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Acker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Acker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Acker">Michael Acker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeffrey T. Bagdanoff</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffrey T. Bagdanoff</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+T.++Bagdanoff">Jeffrey T. Bagdanoff</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhouliang Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhouliang Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhouliang++Chen">Zhouliang Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ying-Nan Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying-Nan Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying-Nan++Chen">Ying-Nan Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Homan Chan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Homan Chan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Homan++Chan">Homan Chan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brant Firestone</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brant Firestone</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brant++Firestone">Brant Firestone</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michelle Fodor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michelle Fodor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology & Therapeutics, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Fodor">Michelle Fodor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jorge Fortanet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jorge Fortanet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jorge++Fortanet">Jorge Fortanet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Huaixiang Hao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Huaixiang Hao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Huaixiang++Hao">Huaixiang Hao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Murphy Hentemann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Murphy Hentemann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Murphy++Hentemann">Murphy Hentemann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mitsunori Kato</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mitsunori Kato</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mitsunori++Kato">Mitsunori Kato</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Koenig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Koenig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Koenig">Robert Koenig</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura R. LaBonte</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura R. LaBonte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura+R.++LaBonte">Laura R. LaBonte</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gang Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gang Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gang++Liu">Gang Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shumei Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shumei Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shumei++Liu">Shumei Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chen Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chen Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chen++Liu">Chen Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric McNeill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric McNeill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric++McNeill">Eric McNeill</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Morvarid Mohseni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Morvarid Mohseni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Morvarid++Mohseni">Morvarid Mohseni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Sendzik</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Sendzik</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Sendzik">Martin Sendzik</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Travis Stams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Travis Stams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology & Therapeutics, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Travis++Stams">Travis Stams</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stan Spence</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stan Spence</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stan++Spence">Stan Spence</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Victoriano Tamez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Victoriano Tamez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Victoriano++Tamez">Victoriano Tamez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ritesh Tichkule</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ritesh Tichkule</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ritesh++Tichkule">Ritesh Tichkule</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher Towler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher Towler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Towler">Christopher Towler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hongyun Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongyun Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongyun++Wang">Hongyun Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ping Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ping Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ping++Wang">Ping Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sarah L. Williams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah L. Williams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+L.++Williams">Sarah L. Williams</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bing Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bing Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bing++Yu">Bing Yu</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Matthew J. LaMarche</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew J. LaMarche</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#137e7267677b76643d7f727e7261707b76537d7c657261677a603d707c7e"><span class="__cf_email__" data-cfemail="4d202c393925283a63212c202c3f2e25280d23223b2c3f39243e632e2220">[email protected]</span></a>. Phone: 617-871-7729.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+J.++LaMarche">Matthew J. LaMarche</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2932-4159" title="Orcid link">http://orcid.org/0000-0003-2932-4159</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01726&amp;href=/doi/10.1021%2Facs.jmedchem.8b01726" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1793–1802</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 28, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 November 2018</li><li><span class="item_label"><b>Published</b> online</span>28 January 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 February 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01726" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01726</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ec-1612971054143.svg" alt="ACS Editors’ Choice" /></img><span>ACS Editors’ Choice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01726"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">8863</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01726" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Sarver&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Acker&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;T. Bagdanoff&quot;},{&quot;first_name&quot;:&quot;Zhouliang&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Ying-Nan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Homan&quot;,&quot;last_name&quot;:&quot;Chan&quot;},{&quot;first_name&quot;:&quot;Brant&quot;,&quot;last_name&quot;:&quot;Firestone&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Fodor&quot;},{&quot;first_name&quot;:&quot;Jorge&quot;,&quot;last_name&quot;:&quot;Fortanet&quot;},{&quot;first_name&quot;:&quot;Huaixiang&quot;,&quot;last_name&quot;:&quot;Hao&quot;},{&quot;first_name&quot;:&quot;Murphy&quot;,&quot;last_name&quot;:&quot;Hentemann&quot;},{&quot;first_name&quot;:&quot;Mitsunori&quot;,&quot;last_name&quot;:&quot;Kato&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Koenig&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;R. LaBonte&quot;},{&quot;first_name&quot;:&quot;Gang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Shumei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Chen&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;McNeill&quot;},{&quot;first_name&quot;:&quot;Morvarid&quot;,&quot;last_name&quot;:&quot;Mohseni&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Sendzik&quot;},{&quot;first_name&quot;:&quot;Travis&quot;,&quot;last_name&quot;:&quot;Stams&quot;},{&quot;first_name&quot;:&quot;Stan&quot;,&quot;last_name&quot;:&quot;Spence&quot;},{&quot;first_name&quot;:&quot;Victoriano&quot;,&quot;last_name&quot;:&quot;Tamez&quot;},{&quot;first_name&quot;:&quot;Ritesh&quot;,&quot;last_name&quot;:&quot;Tichkule&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Towler&quot;},{&quot;first_name&quot;:&quot;Hongyun&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Ping&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;L. Williams&quot;},{&quot;first_name&quot;:&quot;Bing&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;J. LaMarche&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;1793-1802&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01726&quot;},&quot;abstract&quot;:&quot;Protein tyrosine phosphatase SHP2 is an oncoprotein associated with cancer as well as a potential immune modulator because of its role in the programmed cell death PD-L1/PD-1 pathway. In the preceding manuscript, we described the optimization of a fused, bicyclic screening hit for potency, selectivity, and physicochemical properties in order to further expand the chemical diversity of allosteric SHP2 inhibitors. In this manuscript, we describe the further expansion of our approach, morphing the fused, bicyclic system into a novel monocyclic pyrimidinone scaffold through our understanding of SAR and use of structure-based design. These studies led to the identification of SHP394 (1), an orally efficacious inhibitor of SHP2, with high lipophilic efficiency, improved potency, and enhanced pharmacokinetic properties. We also report other pyrimidinone analogues with favorable pharmacokinetic and potency profiles. Overall, this work improves upon our previously described allosteric inhibitors and exemplifies and ex&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01726&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01726" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01726&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01726" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01726&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01726" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01726&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01726&amp;href=/doi/10.1021/acs.jmedchem.8b01726" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01726" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01726" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01726%26sid%3Dliteratum%253Aachs%26pmid%3D30688459%26genre%3Darticle%26aulast%3DSarver%26date%3D2019%26atitle%3D6-Amino-3-methylpyrimidinones%2Bas%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BEfficacious%2BSHP2%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D4%26spage%3D1793%26epage%3D1802%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/4" title="Go to Volume 62, Issue 4"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/jmcmar.2019.62.issue-4/20190228/jmcmar.2019.62.issue-4.largecover.jpg" alt="Go to Volume 62, Issue 4"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Protein tyrosine phosphatase SHP2 is an oncoprotein associated with cancer as well as a potential immune modulator because of its role in the programmed cell death PD-L1/PD-1 pathway. In the preceding manuscript, we described the optimization of a fused, bicyclic screening hit for potency, selectivity, and physicochemical properties in order to further expand the chemical diversity of allosteric SHP2 inhibitors. In this manuscript, we describe the further expansion of our approach, morphing the fused, bicyclic system into a novel monocyclic pyrimidinone scaffold through our understanding of SAR and use of structure-based design. These studies led to the identification of SHP394 (<b>1</b>), an orally efficacious inhibitor of SHP2, with high lipophilic efficiency, improved potency, and enhanced pharmacokinetic properties. We also report other pyrimidinone analogues with favorable pharmacokinetic and potency profiles. Overall, this work improves upon our previously described allosteric inhibitors and exemplifies and extends the range of permissible chemical templates that inhibit SHP2 via the allosteric mechanism.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mutations in the <i>Ptpn11</i> gene, which encodes the nonreceptor protein tyrosine phosphatase (PTP) SHP2, are associated with several human diseases. Hyperactivating mutations of SHP2 has been observed in Noonan syndrome (50%),<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> juvenile myelomonocytic leukemia (JMML, 35%), myelodysplastic syndrome (10%), B-cell acute lymphoblastic leukemia (7%), acute myeloid leukemia (4%),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and a number of solid tumors.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although its precise role is not fully understood, SHP2 functions in the cytoplasm downstream of various receptor tyrosine kinases and is involved in oncogenic cell-signaling cascades including RAS-ERK, PI3K-AKT, and JAK-STAT.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> SHP2 may also play a role in the PD-L1/PD-1 pathway, suggesting possible applications of SHP2 inhibition in immuno-oncology.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Given the demonstrated importance of SHP2 to human diseases, small molecule inhibition of SHP2 has attracted significant attention in the scientific community.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Over the last two decades, a number of small molecule active site inhibitors have been described, but have not progressed to the clinic.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Because of the challenges inherent to targeting the active site of phosphatases,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> for example, the inherent polarity and difficulty in achieving selectivity across the phosphatome, the general concept of allosteric phosphatase inhibition is gaining momentum.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Previously, we reported a screening method that led to the identification of a new site for allosteric SHP2 inhibition.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Initial medicinal chemistry efforts identified a moderately potent, selective, and orally bioavailable inhibitor, SHP099 (<b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> By concurrently binding to the interface of N-terminal SH2, C-terminal SH2, and PTP domains, <b>2</b> stabilizes an inactive conformation in which the active site is inaccessible to substrates. This binding modality resembles the published inactive apo structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> in which the N-terminal SH2 domain blocks the active site, resulting in autoinhibition of PTP activity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Design of pyrimidinones <b>4</b> from pyrazine (<b>2</b>) and pyrazolo-pyrimidinone (<b>3</b>). (B) Overlay of X-ray of <b>2</b>-SHP2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>) and <b>3</b>-SHP2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a>) in the allosteric binding pocket of SHP2. (C) Amine region overlay: X-ray of <b>2</b>-SHP2 and <b>3</b>-SHP2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During the course of the discovery and characterization of <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), we sought to investigate other chemical matter which would provide structural and property diversification. Part of this effort to generate new chemotypes focused on alternative screening strategies. We<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and others<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> employed oncogenic mutants of SHP2. We also engineered inhibitor-resistant mutants to identify an additional allosteric site for SHP2 inhibition,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and then demonstrated that dual allosteric inhibition of SHP2 was possible. In the preceding paper,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> multiple, unique, fused bicyclic screening hits were optimized for potency, selectivity, and structural diversity. These studies identified potent and selective inhibitors that are structurally distinct from <b>2</b>. Additionally, this work further explored the allosteric pocket, identifying important elements of the pharmacophore such as the thioether functionality, and the conformationally restricted spirocyclic amine motif.</div><div class="NLM_p last">Despite the successful optimization for potency and selectivity of this fused bicyclic template, it remained difficult to identify pyrazolo-pyrimidinones, or related fused systems, which coupled these properties with acceptable oral exposure and ADME properties. In order to further broaden our approach to SHP2 allosteric inhibition and access more desirable ADME and property space, we employed a scaffold-morphing strategy using pyrazolo-pyrimidinones as a starting point. This exploited our working knowledge of the SAR, a compendium of HTS data, and structure-based design. In this, the second of two papers, we report the discovery of 6-amino-3-methylpyrimidinones as potent, selective, and orally efficacious SHP2 inhibitors with favorable physicochemical and ADME properties.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67684" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67684" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As in our previous studies, we utilized a well-precedented, fluorescence-based phosphatase biochemical assay measuring dephosphorylation of 6,8-difluoro-4-methylumbelliferyl phosphate (0.5 μM 2P-IRS-1, DIFMUP assay<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>). We also evaluated modulation of p-ERK and DUSP6 as downstream markers of MAPK pathway activity and antiproliferation activity in EGFR-amplified human esophageal squamous cell carcinoma cell line KYSE520 and in Detroit-562, a pharyngeal carcinoma cell line. Early investigations of the pyrazolo-pyrimidinone scaffold (see the preceding paper) for SHP2 inhibition led to the identification of <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), a 5,6-fused system bearing the same aryl and aminopiperidine present in <b>2</b>. Comparison of the X-ray binding poses of <b>3</b> and aminopyrazine <b>2</b> (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>, respectively; overlay in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B) indicated significant overlap of the six-membered pyrimidinone ring and aminopyrazine. Several interactions of <b>3</b> with the protein are quite similar to those previously described for <b>2</b>:<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> the pyrimidinone carbonyl of <b>3</b> makes a crucial hydrogen bond with R111, positioning the residue for π–cation stacking interaction with the dichlorophenyl motif; the dichlorophenyl occupies a hydrophobic area of the pharmacophore (e.g., L254, Q257, and P491); the pyrazole forms a hydrogen bond with E250; the primary amine makes contact with the backbone carbonyl of F113. Given the challenges in identifying compounds from pyrazolo-pyrimidinones with an acceptable balance of potency, hERG selectivity, and oral exposure (see the preceding paper), we redirected our efforts toward monocyclic central ring systems in an effort to ease multiparameter optimization. Thus, breaking the 5–6 ring fusion by removal of the pyrazole ring in <b>3</b> and joining dichlorophenyl directly to pyrimidinone resulted in <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). Compound <b>4</b> is equipotent to <b>2</b> and <b>3</b> in the biochemical assay (IC<sub>50</sub> = 0.105 μM). Importantly, as reduced lipophilicity is strongly correlated with improved in vivo properties,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> the monocyclic pyrimidinone has lower lipophilicity (clog <i>P</i> = 1.9) and increased lipophilic efficiency (5.1).</div><div class="NLM_p">The fused bicycle of <b>3</b> is also reminiscent of another screening hit, azabenzimidazole <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A), a weak inhibitor of SHP2 (IC<sub>50</sub> = 46 μM) that also interacts with R111 via pyridine N, thereby preorganizing the dichlorophenyl ring into the hydrophobic cleft and toward a π–cation interaction with R111 in a similar fashion to <b>2</b> and <b>3</b>. Notably, <b>5</b> and <b>3</b> both join dihalo-arene with the central ring by the same number of atoms, yet with different functional groups: a thioether versus a pyrazole ring, respectively. With the removal of the pyrazole ring in <b>4</b>, we hypothesized that the thioether linker from <b>5</b> would successfully replace and mimic the pyrazole and also balance the substantially increased polarity of the central pyrimidinone ring. In addition, our SAR understanding of the allosteric binding pocket allowed us to also consider amine extension. In previous studies (see the preceding paper), homologation of the amine displaced structural water allowing for binding interactions directly to the protein (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C and vide infra). We thus incorporated the thioether linker and amine extension into our monocyclic pyrimidinone design, which resulted in <b>6</b>. We evaluated <b>6</b> in the biochemical and cellular assays and found improved biochemical potency (IC<sub>50</sub> = 0.012 μM) relative to aminopyrazine, pyrazolo-pyrimidinone, and aminopyrimidinone starting points (<b>2</b>: IC<sub>50</sub> = 0.071 μM; <b>3</b>: IC<sub>50</sub> = 0.064 μM; <b>4</b>: IC<sub>50</sub> = 0.105 μM, respectively), as well as improved cellular potency (<b>6</b>: p-ERK IC<sub>50</sub> = 0.049 μM, antiproliferation IC<sub>50</sub> = 0.273 μM). Compound <b>6</b> was also evaluated for solubility in aqueous buffer (0.25 mM at pH 6.8), permeability (Caco-2: 2.5 × 10<sup>–6</sup> cm/s),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and hERG activity (IC<sub>50</sub> = 6 μM). Taken together, these results indicated that the pyrimidinone template was an attractive starting point for further optimization (e.g., potency, permeability, and hERG selectivity). We were further encouraged by the presence of the 4-pyrimidinone moiety in a range of marketed and developmental drugs.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Thioether-azabenzimidazole HTS hit <b>5</b> and thioether-pyrimidinones <b>6</b> and <b>7</b>. (B) X-ray of <b>7</b> and SHP2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD7">6MD7</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our optimization was facilitated by X-ray crystallography of a less potent analog (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A: <b>7</b>, IC<sub>50</sub> = 0.181 μM) bound to SHP2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD7">6MD7</a>) in a conformation resembling the bound aminopyrazines and pyrazolopyrimidinones (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). As anticipated, the central pyrimidinone ring of <b>7</b> occupies a position nearly identical to that of the 5,6-fused pyrimidinone in <b>3</b> and the aminopyrazine in <b>2</b>. Further comparison of the binding pose of <b>7</b> and <b>2</b> indicated that the aminopyrazine of <b>2</b>, which was previously shown to engage in hydrogen bonding with backbone carbonyl of E250 and substantially improve potency, could likely be reintroduced at the 6-position of the pyrimidinone (vide infra). The crystal structure of <b>7</b>-SHP2 also revealed that pyrimidinone oxygen facilitates a π–cation interaction with R111 and trifluoromethyl-pyridine, through a hydrogen bond interaction. This resembles a similar π–cation interaction preorganized by the pyrazine nitrogen of <b>2</b>, despite a distance of one bond length between the pyrimidinone oxygen and pyrazine nitrogen. In addition, the extended amine in <b>7</b> displaced structural water found in the X-ray of <b>2</b>-SHP2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>), making direct interactions with several residues (e.g., T253, S109, and E110). Importantly, <b>7</b> was selective over the hERG channel (IC<sub>50</sub> > 30 μM), indicating that increasing the polarity of the central scaffold could result in higher hERG selectivity. The overlay of <b>7</b> and other scaffolds (i.e., <b>2</b>, <b>3</b>: not shown) also showed excellent overlap of the aryl and amine regions, suggesting that previously developed SAR could be transferrable from the aminopyrazines and pyrazolopyrimidinones to the monocyclic pyrimidinones. This enabled the application of a range of previously investigated fragments in our continued efforts to optimize this novel template.</div><div class="NLM_p">Given the polar core present in the aminopyrimidinones, we hypothesized that reoptimization of the aryl thioether and spirocyclic amine could yield significant improvements in balancing potency, permeability, and oral exposure. First, we utilized a spiro[4.5]-furanyl-amine moiety (e.g., <b>8</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) which had proven to improve potency and permeability, and reduce the p<i>K</i><sub>a</sub> of the basic amine in other scaffolds (see the preceding paper). Compound <b>8</b> exhibited 4- to 10-fold improvement compared to <b>6</b> in the cellular assays (p-ERK IC<sub>50</sub> = 0.005 μM, antiproliferation IC<sub>50</sub> = 0.069 μM) and acceptable oral exposure (dose normalized to 1 mg/kg PO, 0.95 μM·h) and bioavailability (38% <i>F</i>) in rat.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Optimization of the Pyrimidinone Scaffold for Improved Potency, hERG Selectivity, and Oral Exposure</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0006.gif" alt="" id="GRAPHIC-d7e807-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0007.gif" alt="" id="gr6" /></img><div></div></div><div class="NLM_p">In addition, <b>8</b> was membrane permeable (Caco-2 Papp A-B = 6.8 × 10<sup>–6</sup> cm/s), moderately stable in rat liver microsomes (Cl<sub>int</sub> = 39.3, μL/min/mg, <i>T</i><sub>1/2</sub> = 37 min), and had no CYP inhibition (IC<sub>50</sub> = > 50 μM for CYP3A4, CYP2C9, and CYP2D6). Compound <b>8</b> was next evaluated in vivo at 10, 30, and 100 mg/kg in mice bearing subcutaneously implanted KYSE520 xenografts. Free concentration of <b>8</b> (92% mouse plasma protein bound) correlated well with the MAPK pathway pharmacodynamic markers p-ERK and DUSP6. Maximal PD effects were observed at 100 mg/kg and as early as 3 h post-dose (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PK-PD of <b>8</b> in KYSE520 tumor-implanted immunocompromised mice at 10, 30, and 100 mg/kg. (A) p-ERK modulation in the KYSE520 model. (B) DUSP6 modulation in the KYSE520 model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although robust p-ERK modulation was observed in vivo, significant hERG inhibition (<b>6</b>, <b>8</b>: IC<sub>50</sub> = 4.0–6.0 μM) still plagued the series despite varying the amine p<i>K</i><sub>a</sub>, presumably due to the lipophilic arene present. Redesign of the aryl group to include pyridyl N in proximity to K492, while satisfying the hydrophobic demands of the pocket formed by L254, Q257, and P491, resulted in the more polar 2-methyl-3-chloropyridyl analog, <b>9</b>. Compound <b>9</b> retained cellular potency (antiproliferative IC<sub>50</sub> = 0.220 μM), had excellent aqueous solubility (0.88 mM in pH 6.8 buffer), and no accompanying hERG inhibition (IC<sub>50</sub> > 30 μM). Gratifyingly, pharmacokinetic analysis in rats showed an improvement in rodent oral exposure (dose-normalized to 1 mg/kg PO, 2.01 μM·h) and bioavailability (56% <i>F</i>) compared to <b>8</b>, <b>10</b>, and other tested pyrimidinones. Attempts to further improve <b>9</b> by introducing additional lipophilic functional groups in the aryl region generally resulted in no potency improvement, but increased hERG inhibition, as exemplified by <b>10</b>. Further evolution of the aryl motif included transposition of the pyridyl nitrogen meta to the thioether, and introduction of an ortho-trifluoromethyl group resulting in <b>1</b>. Compound <b>1</b> was approximately equipotent to <b>9</b> and <b>10</b> in biochemical and cellular assays, selective over the hERG ion channel, and displayed high lipophilic efficiency (6.6).</div><div class="NLM_p">Though the unique nature of each of these heterocycles sometimes required various synthetic approaches, many of the analogues were prepared following the synthetic route outlined for <b>1</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Beginning with the corresponding pyrimidine-dione (<b>11</b>), the spirocyclic amine <b>12</b><a onclick="showRef(event, 'ref17 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref22">(17,22)</a> was coupled using BOP;<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> other well-precedented methods, including the synthesis of the corresponding 2-chloro-4-pyrimidones with POCl<sub>3</sub> and more modern coupling reagents failed to provide for a number of modified core analogues in acceptable yields. The coupled product was then reacted with di-<i>tert</i>-butyl dicarbonate to afford the corresponding Boc-protected amine (<b>13</b>), which substantially improved the handling of these otherwise water soluble compounds. Selective iodination at the 2-position of the pyrimidinone ring afforded 5-iodopyrimidinone <b>14</b>, which was converted to the corresponding biaryl thioether through a copper-catalyzed Ullman reaction with <b>15</b>. A final Boc deprotection with TFA followed by HPLC purification afforded the desired product (<b>1</b>) in approximately 10% overall yield. This synthetic route was amenable to scale-up and was successfully utilized to produce <b>1</b> on a multigram scale.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-Methylamino Pyrimidinone <b>1</b>: (a) Amine, BOP, DBU, DMF, RT, 3 Days, 59% Yield (b) Boc<sub>2</sub>O, DIPEA, DMF, RT, 1 h, (c) NIS, DMF, RT, 10 min, 39% Yield (2 Steps) (d) ArSH, CuI, TMEDA, K<sub>3</sub>PO<sub>4</sub>, 1,4-Dioxane, 100 °C, 1.5 h, and (e) TFA, DCM, 3 h, 51% Yield (2 Steps)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because of the encouraging initial results with peripheral fragment optimization, and the promising designs enabled by our crystal structures, we sought to further explore the minimum pharmacophore requirements around the central pyrimidinone ring. Our central ring studies began by maintaining the spiro[4.5]-amine and trifluoromethyl-pyridine in order to maintain potency and minimize hERG activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Removal of the 6-position NH<sub>2</sub> resulted in a loss in potency (<b>16</b>: p-ERK IC<sub>50</sub> = 0.096 μM), and removal of 3-Me further eroded cellular potency (<b>17</b>: p-ERK IC<sub>50</sub> > 1 μM) which was reminiscent of <b>7</b>. Removal of nitrogen at the 1-position of the <i>N</i>-methylpyrimidinone resulted in pyridone <b>18</b> and aminopyridone <b>19</b>, which substantially decreased the biochemical activity. The 1-position N likely affects the R111 H-bond interaction via inductive effects on the 4-position carbonyl, and also allows for piperidine conformations preferred for binding. Taken together, the 6-amino, 3-methyl pyrimidinone, present in <b>1</b>, was optimal.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Systematic Removal of Functional Groups From the Core To Define the Minimum Pharmacophore</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0008.gif" alt="" id="GRAPHIC-d7e1017-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0009.gif" alt="" id="gr7" /></img><div></div></div><div class="NLM_p">Our efforts to further optimize <b>1</b> via the spirocyclic amine region similarly began with efforts to improve permeability and potency by matching lipophilic fragments to the polar pyrimidinone core. Holding the trifluoromethyl-pyridine fragment constant, we prepared <b>20</b>, which bears a γ-methylamino spiro[4.5]-amine lacking the cyclic ether common to <b>1</b> and <b>8–10</b>. This compound showed similar gains in cellular potency to those observed for <b>8</b> while crucially maintaining selectivity against hERG (IC<sub>50</sub> > 30 μM). Disappointingly, rat pharmacokinetic data indicated that this compound had very poor oral exposure (6 mg/kg PO, 0.03 μM·h) and bioavailability (1% <i>F</i>). In vitro microsomal clearance (Cl<sub>int</sub> = 3.4 μL/min/mg, <i>T</i><sub>1/2</sub> = 6.6 h in rat liver microsomes) and permeability (Caco-2 Papp A-B < 0.5 × 10<sup>–6</sup> cm/s) data suggested these inadequate pharmacokinetic properties resulted from poor permeability and absorption, which we attributed to the more basic and less sterically encumbered primary amine in <b>20</b>. In order to improve the properties of <b>20</b>, we introduced a fluorine β to the amine (e.g., <b>21</b>), thus reducing the p<i>K</i><sub>a</sub> of the amine via an inductive effect.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Although <b>21</b> showed promising potency (less than two-fold reduction in antiproliferation potency compared to <b>20</b>), the synthetic challenge of a molecule bearing three contiguous stereocenters adjacent to a spirocyclic center on a cyclopentyl ring reduced the attractiveness of this analogue when compared to other analogues (e.g., <b>1</b>, <b>9</b>). The increased lipophilicity of <b>21</b> (clog <i>P</i> = 2.3) compared to <b>1</b> and <b>9</b> (clog <i>P</i> = 1.2, 1.5, respectively) further reduced the desire to pursue this synthetically challenging target (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Select Spirocyclic Amine SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0010.gif" alt="" id="GRAPHIC-d7e1110-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0011.gif" alt="" id="gr8" /></img><div></div></div><div class="NLM_p">Given the acceptable in vitro potency and hERG selectivity of pyrimidinone <b>1</b>, we next investigated its selectivity, physicochemical, and pharmacokinetic properties. Initial evaluation against a standard kinase and safety pharmacology panel (consisting of ion channels, kinases, and GPCRs) showed no evidence of off-target activity, suggesting that the pyrimidinone series possessed the same overall selectivity observed for aminopyrazines. The overall polarity of <b>1</b> enabled excellent aqueous solubility (0.98 mM in pH 6.8 buffer), but low permeability (Papp(A-B) 1.02 × 10<sup>–6</sup> cm/s), and apparent efflux (B-A/A-B = 15) in Caco-2 cells. The metabolic stability of <b>1</b> in both rat and mouse liver microsomes indicated low clearance (Cl<sub>int</sub> = 7.9–11.1 μL/min/mg; <i>T</i><sub>1/2</sub> > 2 h) for both species. Subsequent pharmacokinetic studies of <b>1</b> in rat confirmed low clearance (Cl<sub>int</sub> = 21 μL/min/mg; <i>T</i><sub>1/2</sub> = 10.9 h), moderate oral exposure (dose-normalized to 1 mg/kg PO, 0.45 μM·h), and oral bioavailability (29% <i>F</i>). We speculate that low membrane permeability and efflux contributed to this moderate oral exposure.</div><div class="NLM_p">With the acceptable disposition of <b>1</b> in rat, and the previous demonstration of p-ERK and DUSP6 modulation in the KYSE520 model by <b>8</b>, we next sought to broaden our characterization of the series across cancer cell lineages. We evaluated <b>1</b> in the Detroit-562 pharyngeal carcinoma cell line in vitro (antiproliferative IC<sub>50</sub> = 1.38 μM), and compared it to other inhibitors (<b>8</b>: IC<sub>50</sub> = 0.35 μM; <b>2</b> (SHP099): IC<sub>50</sub> = 6.47 μM; SHP389:<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> IC<sub>50</sub> = 4.13 μM). Although absolute IC<sub>50</sub> was perturbed as compared to the KYSE520 cells, possibly due to the differences in cell lines and p-ERK assays, the rank order of compound potency across the two models remained constant. We also evaluated <b>1</b> in the Detroit-562 mouse model, with tumors subcutaneously implanted into immunocompromised mice (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Single rising doses of 20, 40, and 80 mg/kg dosed twice daily, led to dose-dependent exposure and reduction in expression of pharmacodynamic marker DUSP6 mRNA (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). An efficacy study employing 20, 40, and 80 mg/kg BID dosing of <b>1</b> demonstrated a clear dose-dependent reduction in tumor volume (TV). Approximate tumor stasis was observed by 21 days at the well-tolerated dose of 40 mg/kg twice daily (11% T/C), and tumor regression was achieved at 80 mg/kg twice daily (34% regression) after dosing for 14 days, with a mean reduction on mouse host bodyweight (−2.2% from first dose).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PK/PD and efficacy of <b>1</b> in the pharyngeal carcinoma Detroit-562 xenograft model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24245" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24245" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The development of potent, selective, and orally efficacious SHP2 inhibitors presents an important challenge due to the increasingly appreciated biological significance of this oncogenic PTP in cancer, stromal, and immune cells. Following our discovery of an allosteric pocket that enables stabilization of an autoinhibited conformation, we have pursued several classes of SHP2 inhibitors and clinical investigation is underway.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In this manuscript, we apply SAR across aminopyrazine (e.g., <b>2</b>), 5,6-fused bicyclic (e.g., <b>3</b>), and 6,5-fused bicyclic (e.g., <b>5</b>) chemical templates in conjunction with X-ray crystallographic data to originate a monocyclic pyrimidinone scaffold with high lipophilic efficiency. The minimum pharmacophore requirements of the central scaffold were determined, and the potency and ADME properties of the pyrimidinones were further improved. These studies culminated in the identification of <b>1</b>, which showed correlative and dose-dependent PK, PD, and efficacy when dosed orally to immunocompromised mice bearing subcutaneously implanted Detroit-562 tumor cells. Further perturbation of the aryl thioether and spiro[4.5]-amine moieties resulted in the synthesis of a number of related analogues with similar antiproliferation potency to <b>1</b>. Notably, <b>8</b> improved upon the potency, and <b>9</b> improved the oral exposure and hERG selectivity as compared to <b>1</b>. Aminopyrimidinones <b>1</b>, <b>8</b>, <b>9</b>, and the additional analogues described here provide compelling potent, selective, and orally bioavailable alternatives to previously disclosed SHP2 inhibitors for future investigation of the multifaceted roles of SHP2 in signal transduction and human disease.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound Synthesis and Characterization</h3><div class="NLM_p last">Compound purity was assessed by HPLC to confirm >95% purity. All solvents employed were commercially available anhydrous grade, and reagents used as received unless otherwise noted. Purification of intermediates and final products was carried out on a normal phase using an ISCO CombiFlash system and prepacked SiO<sub>2</sub> cartridges eluted with optimized gradients of either ethyl acetate/heptane mixture or methanol/dichloromethane as described. Preparative high-pressure liquid chromatography (HPLC) was performed using a Waters 2525 pump with a 2487 dual wavelength detector and a 2767 sample manager. Columns were Waters C18 OBD 5 μm, either 50 × 100 mm Xbridge or 30 × 100 mm Sunfire. NMR spectra were recorded on Bruker AV400 (Avance 400 MHz) or AV600 (Avance 600 MHz) instruments. Analytical LC-MS was conducted using an Agilent 1100 series with UV detection at 214 and 254 nm and an electrospray mode (ESI) coupled with a Waters ZQ single quad mass detector. One of two methods was used: method (A) 5–95% acetonitrile/H<sub>2</sub>O with 5 mM ammonium formate with a 2 min run and 3 μL injection through an inertsil C8 3 cm × 5 mm × 3 μm; method (B) 20–95% acetonitrile/H<sub>2</sub>O with 10 mM ammonium formate with a 2 min run and 3 μL injection through an inertsil C8 3 cm × 5 mm × 3 μm. Purity of all tested compounds was determined by LC/ESI-MS, and data are recorded using an Agilent 6220 mass spectrometer with an electrospray ionization source and Agilent 1200 liquid chromatography. The mass accuracy of the system has been found to be <5 ppm. HPLC separation was performed at 75 mL/min flow rate with the indicated gradient within 3.5 min with an initial hold of 10 s. 10 mM ammonia hydroxide or 0.1 M TFA was used as the modifier additive in the aqueous phase.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Preparation of 6-Amino-2-((3<i>S</i>,4<i>S</i>)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-methyl-5-((2-(trifluoromethyl)pyridin-3-yl)thio)pyrimidin-4(3<i>H</i>)-one (<b>1</b>)</h3><div class="NLM_p">A mixture of 6-amino-3-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (1 g, 7.09 mmol), (3<i>S</i>,4<i>S</i>)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine (1.81 g, 7.44 mmol), BOP (6.27 g, 14.17 mmol), and DBU (7.48 mL, 49.6 mmol) in DMF (15 mL) was stirred for 60 h at RT. The resulting mixture was purified by HPLC (gradient elution 2–12% MeCN in water, 5 mM NH<sub>4</sub>OH modifier) to give 6-amino-2-((3<i>S</i>,4<i>S</i>)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-methylpyrimidin-4(3<i>H</i>)-one (2.08 g, 7.09 mmol). MS: <i>m</i>/<i>z</i> 294.3 (M + H)<sup>+</sup>.</div><div class="NLM_p">A mixture 6-amino-2-((3<i>S</i>,4<i>S</i>)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-methylpyrimidin-4(3<i>H</i>)-one (2.08 g, 7.09 mmol), Boc<sub>2</sub>O (1.55 g, 7.09 mmol), and DIPEA (2.5 mL, 14.18 mmol) in DMF (14 mL) was stirred for 1 h at RT. The resulting mixture was poured into a separation funnel containing sat. aq NH<sub>4</sub>Cl (75 mL), and it was extracted with DCM (3 × 15 mL). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and the volatiles were removed under reduced pressure to give <i>tert</i>-butyl((3<i>S</i>,4<i>S</i>)-8-(4-amino-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)carbamate (2.79 g, 7.09 mmol). MS: <i>m</i>/<i>z</i> 394.4 (M + H)<sup>+</sup>. This compound was used in the next step without further purification.</div><div class="NLM_p">A mixture of <i>tert</i>-butyl((3<i>S</i>,4<i>S</i>)-8-(4-amino-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)carbamate (2.79 g, 7.09 mmol) and NIS (1.76 g, 7.80 mmol) in DMF (14 mL) was stirred for 1 h at RT. The resulting mixture was poured into a separation funnel containing sat. aq Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (25 mL), sat. aq NH<sub>4</sub>Cl (25 mL), and water (25 mL) and was extracted with DCM (3 × 20 mL). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, the volatiles were removed under reduced pressure, and the residue was purified by silica chromatography (0–5% gradient of MeOH/DCM) to give <i>tert</i>-butyl((3<i>S</i>,4<i>S</i>)-8-(4-amino-5-iodo-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)carbamate (1.51 g, 2.91 mmol). MS: <i>m</i>/<i>z</i> 520.1 (M + H)<sup>+</sup>.</div><div class="NLM_p last">A mixture of <i>tert</i>-butyl((3<i>S</i>,4<i>S</i>)-8-(4-amino-5-iodo-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)carbamate (42 mg, 0.081 mmol), 2-(trifluoromethyl)pyridine-3-thiol (22 mg, 0.121 mmol), CuI (3.1 mg, 0.016 mmol), TMEDA (5 μL, 0.032 mmol), and K<sub>3</sub>PO<sub>4</sub> (51 mg, 0.243 mmol) in dioxane (0.5 mL) was stirred for 90 min at 100 °C. After cooling to RT, the reaction mixture was poured into a separation funnel containing aq K<sub>2</sub>CO<sub>3</sub> (2 M, 2 mL) and extracted with DCM (3 × 5 mL). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and the volatiles were removed under reduced pressure. The residue was dissolved in DCM (5 mL) and TFA (1 mL) was added. After stirring for 20 min at RT, the volatiles were removed under reduced pressure and the residue was purified by HPLC (gradient elution 15–40% MeCN in water, 5 mM NH<sub>4</sub>OH modifier) to give 6-amino-2-((3<i>S</i>,4<i>S</i>)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-methyl-5-((2-(trifluoromethyl)pyridin-3-yl)thio)pyrimidin-4(3<i>H</i>)-one (<b>1</b>) as a white solid (20.0 mg, 0.043 mmol). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ ppm 8.24–8.41 (m, 1H), 7.51 (d, <i>J</i> = 7.58 Hz, 1H), 7.41 (dd, <i>J</i> = 8.34, 4.55 Hz, 1H), 4.22 (dd, <i>J</i> = 6.32, 5.05 Hz, 1H), 3.84 (d, <i>J</i> = 8.84 Hz, 1H), 3.69 (d, <i>J</i> = 8.59 Hz, 1H), 3.47–3.61 (m, 2H), 3.36–3.47 (m, 3H), 3.04–3.26 (m, 2H), 3.03 (d, <i>J</i> = 5.05 Hz, 1H), 1.79–2.02 (m, 2H), 1.60–1.78 (m, 2H), 1.13–1.28 (m, 3H). <sup>19</sup>F NMR (376 MHz, methanol-<i>d</i><sub>4</sub>): δ ppm −66.36. HRMS: calcd for C<sub>20</sub>H<sub>26</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup>, 4711790; found, 471.1809.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Protein Expression and Purification</h3><div class="NLM_p">The gene encoding human SHP2 from residues Met1–Leu525 was inserted into a pET30 vector. A coding sequence for a 6× histidine tag followed by a TEV protease consensus sequence was added 5′ to the SHP2 gene sequence. The construct was transformed into BL21 Star (DE3) cells and grown at 37 °C in Terrific Broth containing 100 μg/mL kanamycin. At an OD<sub>600</sub> of 4.0, the SHP2 expression was induced using 1 mM IPTG. Cells were harvested following overnight growth at 18 °C.</div><div class="NLM_p last">Cell pellets were resuspended in lysis buffer containing 50 mM Tris-HCl, pH 8.5, 25 mM imidazole, 500 mM NaCl, 2.5 mM MgCl<sub>2</sub>, 1 mM TCEP, 1 μg/mL DNase1, and complete EDTA-free protease inhibitor and lysed using a microfluidizer, followed by ultracentrifugation. The supernatant was loaded onto a HisTrap HP chelating column in 50 mM Tris-HCl, 25 mM imidazole, 500 mM NaCl, 1 mM TCEP, and protein was eluted with the addition of 250 mM imidazole. The N-terminal histidine tag was removed by incubating overnight using TEV protease at 4 °C. The protein was subsequently diluted to 50 mM NaCl with 20 mM Tris-HCl, pH 8.5, and 1 mM TCEP, and then applied to a HiTrap Q FastFlow column equilibrated with 20 mM Tris, pH 8.5, 50 mM NaCl, and 1 mM TCEP. The protein was eluted with a 10 column volume gradient from 50 to 500 mM NaCl. Fractions containing SHP2 were pooled and concentrated and then loaded onto a HiLoad Superdex200 PG 16/100 column, exchanging the protein into the crystallization buffer, 20 mM Tris-HCl, pH 8.5, 150 mM NaCl, and 3 mM TCEP. The protein was concentrated to 15 mg/mL for use in crystallization. Crystallization, DSF, and high-throughput screening assays used the 1–525 construct of SHP2, whereas biochemical assays used the 2–593 construct.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biochemical Assay</h3><div class="NLM_p">SHP2 is allosterically activated through binding of bis-tyrosyl-phosphorylated peptides to its Src homology 2 (SH2) domains. The latter activation step leads to the release of the autoinhibitory interface of SHP2, which in turn renders the SHP2 PTP active and available for substrate recognition and reaction catalysis. The catalytic activity of SHP2 was monitored using the surrogate substrate DiFMUP in a prompt fluorescence assay format. More specifically, the phosphatase reactions were performed at room temperature in a 384-well black polystyrene plate with a flat bottom, low flange, and nonbinding surface (Corning, cat. no. 3575) using a final reaction volume of 25 μL and the following assay buffer conditions: 60 mM HEPES, pH 7.2, 75 mM NaCl, 75 mM KCl, 1 mM EDTA, 0.05% P-20, and 5 mM DTT.</div><div class="NLM_p last">The inhibition of SHP2 from the tested compounds (concentrations varying from 0.003 to 100 μM) was monitored using an assay in which 0.5 nM of SHP2 was incubated with 0.5 μM of peptide IRS1_pY1172(dPEG8)pY1222(sequence H2N-LN(pY)IDLDLV-(dPEG8)LST(pY)ASINFQK-amide). After 30–60 min incubation at 25 °C, the surrogate substrate DiFMUP (Invitrogen, cat. no. D6567, 200 μM) was added to the reaction and incubated at 25 °C for 30 min (200 μM for residue 2–593, 100 μM for residue 1–525 construct). The reaction was then quenched by the addition of 5 μL of a 160 μM solution of bpV(Phen) (Enzo Life Sciences cat. no. ALX-270-204). The fluorescence signal was monitored using a microplate reader (Envision, PerkinElmer) using excitation and emission wavelengths of 340 and 450 nm, respectively. The inhibitor dose–response curves were analyzed using normalized IC<sub>50</sub> regression curve fitting with control-based normalization.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cellular Assay</h3><div class="NLM_p last">p-ERK cellular assay using the AlphaScreen SureFire Phospho-ERK1/2 Kit (PerkinElmer) was performed as follows: KYSE520 cells (30 000 cells/well) were grown in 96-well plate culture overnight and treated with SHP2 inhibitors at concentrations of 20, 6.6, 2.2, 0.74, 0.24, 0.08, and 0.027 μM for 2 h at 37 °C. Incubations were terminated by the addition of 30 μL of lysis buffer (PerkinElmer) supplied with the SureFire phospho-extracellular signal-regulated kinase (p-ERK) assay kit (PerkinElmer). Samples were processed according to the manufacturer’s directions. The fluorescence signal from p-ERK was measured in duplicate using a 2101 multilabel reader (PerkinElmer Envision). The percentage of inhibition was normalized by the total ERK signal and compared with the DMSO vehicle control.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cell Proliferation Assay</h3><div class="NLM_p last">Cells (1500 cells/well) were plated onto 96-well plates in 100 μL medium (RPMI-1640 containing 10% FBS, Lonza). Compounds with various concentrations (1.25, 2.5, 5, 10, and 20 μM) were added 24 h after cell plating. At day 5, 50 μL of Celltiter-Glo reagent (Promega) was added, and the luminescent signal was determined according to the supplier’s instruction (Promega).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Crystallization and Structure Determination</h3><div class="NLM_p">Sitting drop vapor diffusion method was used for crystallization, with the crystallization well containing 17% PEG 3350 and 200 mM ammonium phosphate and a drop with a 1:1 volume of SHP2 protein and crystallization solution. Crystals were formed within 5 days and subsequently soaked in the crystallization solution with 2.5 mM of 2. This was followed by cryoprotection using the crystallization solution with the addition of 20% glycerol and 1 mM compound <b>7</b>, followed by flash-freezing directly into liquid nitrogen.</div><div class="NLM_p last">Diffraction data for the SHP2/compound <b>2</b> and SHP2/compound <b>3</b> complexes are reported elsewhere,<a onclick="showRef(event, 'ref12 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref17">(12,17)</a> and those for the SHP2/compound <b>7</b> complex (PDB accession <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD7">6MD7</a>) were collected on a Dectris Pilatus 6M detector at beamline 17ID (IMCA-CAT) at the Advanced Photon Source at Argonne National Laboratories. The data were measured from a single crystal maintained at 100 K at a wavelength of 1 Å, and the reflections were indexed, integrated, and scaled using XDS.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The spacegroup of the complex was <i>P</i>21 with two molecules in the asymmetric unit. The structure was determined with Fourier methods, using the SHP2 apo structure<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (PDB accession <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>) with all waters removed. Structure determination was achieved through iterative rounds of positional and simulated annealing refinement using BUSTER,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> with model building using COOT.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Individual B-factors were refined using an overall anisotropic B-factor refinement along with bulk solvent correction. The solvent, phosphate ions, and inhibitor were built into the density in later rounds of the refinement. Data collection and refinement statistics are shown in Table S1 of the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01726/suppl_file/jm8b01726_si_001.csv" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Pharmacokinetics</h3><div class="NLM_p">All animal-related procedures were conducted under a Novartis IACUC approved protocol in compliance with Animal Welfare Act regulations and the Guide for the Care and Use of Laboratory Animals. Male C57BL/6 mice were obtained from Harlan Laboratories. Following IV administration (via the tail vein) at 1 mg/kg, approximately 50 μL of whole blood was collected via tail transection at 0.083, 0.5, 1, 2, 4, and 7 h post-dose and transferred to an Eppendorf microcentrifuge tube containing EDTA. Oral administration (at 5 mg/kg) and collection procedures were similar to IV, except with whole blood collection at 0.25, 0.5, 1, 2, 4, and 7 h. The blood was centrifuged at 5000 rpm, and plasma was transferred to a matrix 96-well plate, capped, and stored frozen (−20 °C) for parent compound analysis. Samples were precipitated and diluted with acetonitrile containing the internal standard and prepared for LC/MS/MS. An aliquot (20 μL) of each sample was injected into an API4000 LC/MS/MS system for analysis, and transitions of 352.05 amu (Q1) and 267.10 amu (Q3) were monitored. All pharmacokinetic (PK) parameters were derived from concentration–time data by noncompartmental analyses. All PK parameters were calculated with the computer program WinNonlin (Version 6.4) purchased from Certara Company (St. Louis, MO). For the intravenous dose, the concentration of the unchanged compound at time 0 was calculated based on a log-linear regression of first two data points to back-extrapolate <i>C</i>(0). The area under the concentration–time curve (AUClast) was calculated using the linear trapezoidal rule.</div><div class="NLM_p">The bioavailability was estimated as the following equation<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_m001.gif" alt="" id="_i18" /></img></span></div><div class="NLM_p last">Results are expressed as mean. No further statistical analysis was performed.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Tumor Xenograft Experiments</h3><div class="NLM_p last">All animal studies were carried out according to the Novartis Guide for the Care and Use of Laboratory Animals. Six-week old female athymic NU/NU mice (Charles River Labs, MA) were inoculated subcutaneously with either KYSE520 esophageal carcinoma cells (ATCC) at a concentration of 2 × 10<sup>6</sup> or Detroit-562 pharyngeal carcinoma cells (ATTC) at a concentration of 5 × 10<sup>5</sup>, in a suspension containing 50% phenol red-free matrigel (BD Biosciences) in Hank’s balanced salt solution. For all PK/PD studies, mice were administered a single dose of vehicle control (0.5% methylcellulose, 0.1% Tween 80), <b>1</b> or <b>8</b>, by oral gavage once tumors reached roughly 300 mm<sup>3</sup>. Mice were subsequently euthanized at predetermined time points following a single dose of the compound at which point plasma and xenograft fragments were harvested for determination of 1 or 8 plasma concentrations and PD modulation. Phospho-ERK PD assessment was carried on lysed frozen tumor tissue fragments following the protocol provided by the Mesoscale Discovery assay whole cell lysis kits (Catalog#: total ERK1/2: K151DXD, phospho-ERK1/2: K151DWD). Protein concentration was assessed by BCA (Pierce, Catalog # 23225), and 2.5 mg for total-ERK or 20 mg for phospho-ERK was loaded onto mesoscale plates. Samples were analyzed by a Mesoscale plate reader. Data were analyzed and the fold change in phospho-ERK1/2 levels were calculated by normalizing to total ERK concentrations and the ratio of phospho-ERK/total-ERK in the vehicle-treated group. DUSP6 PD assessment was carried out by quantitative real-time PCR. Frozen tumor fragments were processed to extract mRNA (Qiagen #74106). RNA quantification was performed using Nanodrop 8000. One-step qPCR (Qiagen, #204645) was performed on the 7900 HT Fast Real-Time PCR system (Thermo Fisher Scientific) using a human DUSP6 primer set (Hs00737962, Life Technologies) multiplexed with a housekeeping gene control primer, HPO (#4326314E, Life Technologies). Data were analyzed and normalized to the expression of a housekeeping gene, human ribosomal protein lateral stalk subunit P0, HPO, in order to calculate the fold change in mRNA expression with and without compound treatment. For in vivo efficacy studies, subcutaneously implanted Detroit-562 tumor xenografts were measured in the two dimension length and width (<i>l</i> and <i>w</i>, respectively) with digital calipers once to twice weekly from the start of dosing. TV was calculated using a modified ellipsoid formula, where TV (mm<sup>3</sup>) = [((<i>l</i> × <i>w</i><sub>2</sub>) × 3.14159)/6], where <i>l</i> is the longest axis of the tumor and <i>w</i> is perpendicular to <i>l</i>. Detroit-562 tumor-bearing mice were randomized into treatment groups based on TV mean of 300 mm<sup>3</sup> and were dosed by oral gavage twice daily.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01726" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01726" class="ext-link">10.1021/acs.jmedchem.8b01726</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01726/suppl_file/jm8b01726_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">X-ray data table and additional synthetic procedures (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01726/suppl_file/jm8b01726_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01726/suppl_file/jm8b01726_si_001.csv">jm8b01726_si_001.csv (1.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01726/suppl_file/jm8b01726_si_002.pdf">jm8b01726_si_002.pdf (325.09 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD7">6MD7</a> for SHP2 in complex with compound <b>7</b>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01726" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew J. LaMarche</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2932-4159" title="Orcid link">http://orcid.org/0000-0003-2932-4159</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#076a6673736f6270296b666a6675646f62476968716675736e742964686a"><span class="__cf_email__" data-cfemail="e68b8792928e8391c88a878b8794858e83a68889908794928f95c885898b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Sarver</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Acker</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey T. Bagdanoff</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhouliang Chen</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying-Nan Chen</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Homan Chan</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brant Firestone</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Fodor</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology & Therapeutics, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jorge Fortanet</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huaixiang Hao</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murphy Hentemann</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mitsunori Kato</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Koenig</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura R. LaBonte</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetic
Sciences, Novartis Institutes for Biomedical Research, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gang Liu</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shumei Liu</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chen Liu</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric McNeill</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Morvarid Mohseni</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Sendzik</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Travis Stams</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology & Therapeutics, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stan Spence</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victoriano Tamez</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ritesh Tichkule</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Towler</span> - <span class="hlFld-Affiliation affiliation">Chemical and
Pharmaceutical Profiling, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongyun Wang</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ping Wang</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah L. Williams</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing Yu</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , and , Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Use of IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. The authors thank Yue Pan, Dan Palacios, Joe Wzorek, and Jonathan Hempel for editing suggestions, and the entire SHP2 team.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">PTP</td><td class="NLM_def"><p class="first last">protein tyrosine phosphatase</p></td></tr><tr><td class="NLM_term">RAS</td><td class="NLM_def"><p class="first last">rat sarcoma protein</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription proteins</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last">tris(2-carboxyethyl)phosphine</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehler, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Burgt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ion, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalidas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patton, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Mutations in <i>Ptpn11</i>, Encoding the Protein Tyrosine Phosphatase SHP-2, Cause Noonan syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">468</span>, <span class="refDoi"> DOI: 10.1038/ng772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-468&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+van+der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=M.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+Ptpn11%2C+Encoding+the+Protein+Tyrosine+Phosphatase+SHP-2%2C+Cause+Noonan+syndrome&doi=10.1038%2Fng772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0lhR1lW6oGwWew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DM.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520Ptpn11%252C%2520Encoding%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%252C%2520Cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D468%26doi%3D10.1038%2Fng772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemeyer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hählen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/ng1156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+H%C3%A4hlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+mutations+in+PTPN11+in+juvenile+myelomonocytic+leukemia%2C+myelodysplastic+syndromes+and+acute+myeloid+leukemia&doi=10.1038%2Fng1156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0lhR1lW6oGwWew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DH%25C3%25A4hlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520mutations%2520in%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%252C%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150%26doi%3D10.1038%2Fng1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mulero-Navarro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevilla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riess, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaniel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baccarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavé, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strullu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalcin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhandapany, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yongchao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahieg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flex, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemischka, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11 -Associated Juvenile Myelomonocytic Leukemia</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">515</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.celrep.2015.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=26456833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=504-515&author=S.+Mulero-Navarroauthor=A.+Sevillaauthor=A.+C.+Romanauthor=D.-F.+Leeauthor=S.+L.+D%E2%80%99Souzaauthor=S.+Pardoauthor=I.+Riessauthor=J.+Suauthor=N.+Cohenauthor=C.+Schanielauthor=N.+A.+Rodriguezauthor=A.+Baccariniauthor=B.+D.+Brownauthor=H.+Cav%C3%A9author=A.+Cayeauthor=M.+Strulluauthor=S.+Yalcinauthor=C.+Y.+Parkauthor=P.+S.+Dhandapanyauthor=G.+Yongchaoauthor=L.+Edelmannauthor=S.+Bahiegauthor=P.+Raynalauthor=E.+Flexauthor=M.+Tartagliaauthor=K.+A.+Mooreauthor=I.+R.+Lemischkaauthor=B.+D.+Gelb&title=Myeloid+Dysregulation+in+a+Human+Induced+Pluripotent+Stem+Cell+Model+of+PTPN11+-Associated+Juvenile+Myelomonocytic+Leukemia&doi=10.1016%2Fj.celrep.2015.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia</span></div><div class="casAuthors">Mulero-Navarro, Sonia; Sevilla, Ana; Roman, Angel C.; Lee, Dung-Fang; D'Souza, Sunita L.; Pardo, Sherly; Riess, Ilan; Su, Jie; Cohen, Ninette; Schaniel, Christoph; Rodriguez, Nelson A.; Baccarini, Alessia; Brown, Brian D.; Cave, Helene; Caye, Aurelie; Strullu, Marion; Yalcin, Safak; Park, Christopher Y.; Dhandapany, Perundurai S.; Yongchao, Ge; Edelmann, Lisa; Bahieg, Sawsan; Raynal, Patrick; Flex, Elisabetta; Tartaglia, Marco; Moore, Kateri A.; Lemischka, Ihor R.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">504-515</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Somatic PTPN11 mutations cause juvenile myelomonocytic leukemia (JMML).  Germline PTPN11 defects cause Noonan syndrome (NS), and specific inherited mutations cause NS/JMML.  Here, we report that hematopoietic cells differentiated from human induced pluripotent stem cells (hiPSCs) harboring NS/JMML-causing PTPN11 mutations recapitulated JMML features.  HiPSC-derived NS/JMML myeloid cells exhibited increased signaling through STAT5 and upregulation of miR-223 and miR-15a.  Similarly, miR-223 and miR-15a were upregulated in 11/19 JMML bone marrow mononuclear cells harboring PTPN11 mutations, but not those without PTPN11 defects.  Reducing miR-223's function in NS/JMML hiPSCs normalized myelogenesis.  MicroRNA target gene expression levels were reduced in hiPSC-derived myeloid cells as well as in JMML cells with PTPN11 mutations.  Thus, studying an inherited human cancer syndrome with hiPSCs illuminated early oncogenesis prior to the accumulation of secondary genomic alterations, enabling us to discover microRNA dysregulation, establishing a genotype-phenotype assocn. for JMML and providing therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY4KSRRWwnr7Vg90H21EOLACvtfcHk0ljIdNs-Wd0unQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjM&md5=a572b0d257818fc6510cdf2f81297834</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DMulero-Navarro%26aufirst%3DS.%26aulast%3DSevilla%26aufirst%3DA.%26aulast%3DRoman%26aufirst%3DA.%2BC.%26aulast%3DLee%26aufirst%3DD.-F.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DS.%2BL.%26aulast%3DPardo%26aufirst%3DS.%26aulast%3DRiess%26aufirst%3DI.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DN.%26aulast%3DSchaniel%26aufirst%3DC.%26aulast%3DRodriguez%26aufirst%3DN.%2BA.%26aulast%3DBaccarini%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DB.%2BD.%26aulast%3DCav%25C3%25A9%26aufirst%3DH.%26aulast%3DCaye%26aufirst%3DA.%26aulast%3DStrullu%26aufirst%3DM.%26aulast%3DYalcin%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DC.%2BY.%26aulast%3DDhandapany%26aufirst%3DP.%2BS.%26aulast%3DYongchao%26aufirst%3DG.%26aulast%3DEdelmann%26aufirst%3DL.%26aulast%3DBahieg%26aufirst%3DS.%26aulast%3DRaynal%26aufirst%3DP.%26aulast%3DFlex%26aufirst%3DE.%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DK.%2BA.%26aulast%3DLemischka%26aufirst%3DI.%2BR.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMyeloid%2520Dysregulation%2520in%2520a%2520Human%2520Induced%2520Pluripotent%2520Stem%2520Cell%2520Model%2520of%2520PTPN11%2520-Associated%2520Juvenile%2520Myelomonocytic%2520Leukemia%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D13%26spage%3D504%26epage%3D515%26doi%3D10.1016%2Fj.celrep.2015.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bentires-Alj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paez, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilhack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maris, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugarbaker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Activating Mutations of the Noonan Syndrome-AssociatedSHP2/PTPN11Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">8816</span>– <span class="NLM_lpage">8820</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-04-1923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1158%2F0008-5472.can-04-1923" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-8820&author=M.+Bentires-Aljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbakerauthor=W.+G.+Richardsauthor=J.+Duauthor=L.+Girardauthor=J.+D.+Minnaauthor=M.+L.+Lohauthor=D.+E.+Fisherauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=M.+Meyersonauthor=W.+R.+Sellersauthor=B.+G.+Neel&title=Activating+Mutations+of+the+Noonan+Syndrome-AssociatedSHP2%2FPTPN11Gene+in+Human+Solid+Tumors+and+Adult+Acute+Myelogenous+Leukemia&doi=10.1158%2F0008-5472.can-04-1923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DActivating%2520Mutations%2520of%2520the%2520Noonan%2520Syndrome-AssociatedSHP2%252FPTPN11Gene%2520in%2520Human%2520Solid%2520Tumors%2520and%2520Adult%2520Acute%2520Myelogenous%2520Leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D8820%26doi%3D10.1158%2F0008-5472.can-04-1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaitzidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+tyrosine+phosphatase+Shp2+%28PTPN11%29+in+cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0ljIdNs-Wd0unQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520tyrosine%2520phosphatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yomogita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatakeyama, M.</span></span> <span> </span><span class="NLM_article-title">Isolation of a Distinct Class of Gain-of-Function SHP-2 mutants with Oncogenic RAS-like Transforming Activity From Solid Tumors</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3508</span>– <span class="NLM_lpage">3515</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1211019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+Distinct+Class+of+Gain-of-Function+SHP-2+mutants+with+Oncogenic+RAS-like+Transforming+Activity+From+Solid+Tumors&doi=10.1038%2Fsj.onc.1211019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0ljGmCBbpXFlbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520Distinct%2520Class%2520of%2520Gain-of-Function%2520SHP-2%2520mutants%2520with%2520Oncogenic%2520RAS-like%2520Transforming%2520Activity%2520From%2520Solid%2520Tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515%26doi%3D10.1038%2Fsj.onc.1211019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, L.</span></span> <span> </span><span class="NLM_article-title">The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/s0968-0004(03)00091-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fs0968-0004%2803%2900091-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%98Shp%E2%80%99ing+news%3A+SH2+domain-containing+tyrosine+phosphatases+in+cell+signaling&doi=10.1016%2Fs0968-0004%2803%2900091-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fs0968-0004%2803%2900091-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0968-0004%252803%252900091-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2598Shp%25E2%2580%2599ing%2520news%253A%2520SH2%2520domain-containing%2520tyrosine%2520phosphatases%2520in%2520cell%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293%26doi%3D10.1016%2Fs0968-0004%2803%2900091-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, G. S.</span></span> <span> </span><span class="NLM_article-title">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">867</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-07-028829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1182%2Fblood-2006-07-028829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=17053061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+first+identified+proto-oncogene+that+encodes+a+tyrosine+phosphatase&doi=10.1182%2Fblood-2006-07-028829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span></div><div class="casAuthors">Chan, Rebecca J.; Feng, Gen-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-867</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Elucidation of the mol. mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes.  One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homol. 2 (SH2) domains (Shp2).  This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis.  More recently, somatic missense PTPN11 gain-of-function mutations were detected in leukemias and rarely in solid tumors, and were found to induce aberrant hyperactivation of the Ras-Erk pathway.  This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the mol. mechanisms underlying cell transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqsuOora-d37Vg90H21EOLACvtfcHk0ljGmCBbpXFlbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D&md5=8c5760a6ac385635f9794acbf5b64a03</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-028829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-028829%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520first%2520identified%2520proto-oncogene%2520that%2520encodes%2520a%2520tyrosine%2520phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867%26doi%3D10.1182%2Fblood-2006-07-028829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tiganis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, A. M.</span></span> <span> </span><span class="NLM_article-title">Protein tyrosine phosphatase function: the substrate perspective</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1042/bj20061548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1042%2Fbj20061548" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2007&pages=1-15&author=T.+Tiganisauthor=A.+M.+Bennett&title=Protein+tyrosine+phosphatase+function%3A+the+substrate+perspective&doi=10.1042%2Fbj20061548"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1042%2Fbj20061548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20061548%26sid%3Dliteratum%253Aachs%26aulast%3DTiganis%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DA.%2BM.%26atitle%3DProtein%2520tyrosine%2520phosphatase%2520function%253A%2520the%2520substrate%2520perspective%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D402%26spage%3D1%26epage%3D15%26doi%3D10.1042%2Fbj20061548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jie, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildener-Leapman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R. L.</span></span> <span> </span><span class="NLM_article-title">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-14-1215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1158%2F0008-5472.can-14-1215" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=508-518&author=J.+Liauthor=H.-B.+Jieauthor=Y.+Leiauthor=N.+Gildener-Leapmanauthor=S.+Trivediauthor=T.+Greenauthor=L.+P.+Kaneauthor=R.+L.+Ferris&title=PD-1%2FSHP-2+Inhibits+Tc1%2FTh1+Phenotypic+Responses+and+the+Activation+of+T+Cells+in+the+Tumor+Microenvironment&doi=10.1158%2F0008-5472.can-14-1215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-14-1215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-14-1215%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJie%26aufirst%3DH.-B.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DGildener-Leapman%26aufirst%3DN.%26aulast%3DTrivedi%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DT.%26aulast%3DKane%26aufirst%3DL.%2BP.%26aulast%3DFerris%26aufirst%3DR.%2BL.%26atitle%3DPD-1%252FSHP-2%2520Inhibits%2520Tc1%252FTh1%2520Phenotypic%2520Responses%2520and%2520the%2520Activation%2520of%2520T%2520Cells%2520in%2520the%2520Tumor%2520Microenvironment%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D75%26spage%3D508%26epage%3D518%26doi%3D10.1158%2F0008-5472.can-14-1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasmal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vale, R. D.</span></span> <span> </span><span class="NLM_article-title">T Cell Costimulatory Receptor CD28 is a Primary Target for PD-1-Mediated Inhibition</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1428</span>– <span class="NLM_lpage">1433</span>, <span class="refDoi"> DOI: 10.1126/science.aafl29210.1126/science.aaf1292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1126%2Fscience.aafl29210.1126%2Fscience.aaf1292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=28280247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVWhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2017&pages=1428-1433&author=E.+Huiauthor=J.+Cheungauthor=J.+Zhuauthor=X.+Suauthor=M.+J.+Taylorauthor=H.+A.+Wallweberauthor=D.+K.+Sasmalauthor=J.+Huangauthor=J.+M.+Kimauthor=I.+Mellmanauthor=R.+D.+Vale&title=T+Cell+Costimulatory+Receptor+CD28+is+a+Primary+Target+for+PD-1-Mediated+Inhibition&doi=10.1126%2Fscience.aafl29210.1126%2Fscience.aaf1292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition</span></div><div class="casAuthors">Hui, Enfu; Cheung, Jeanne; Zhu, Jing; Su, Xiaolei; Taylor, Marcus J.; Wallweber, Heidi A.; Sasmal, Dibyendu K.; Huang, Jun; Kim, Jeong M.; Mellman, Ira; Vale, Ronald D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6332</span>),
    <span class="NLM_cas:pages">1428-1433</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">PD-1-targeted therapies have been a breakthrough for treating certain tumors and can rejuvenate T cells to unleash the anticancer immune response (see the Perspective by Clouthier and Ohashi).  It is widely believed that PD-1 suppresses signaling through the T cell receptor (TCR).  However, Hui et al. find instead that the TCR costimulatory receptor, CD28, is the primary target of PD-1 signaling.  Independently, Kamphorst et al. show that CD28 is required for PD-1 therapies to kill cancer cells efficiently and eliminate chronic viral infections in mice.  Lung cancer patients that responded to PD-1 therapy had more CD28+ T cells, which suggests that CD28 may predict treatment response.  Science, ibid p. 1428, p. 1423; see also p. 1373.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM_s4cf1lkxrVg90H21EOLACvtfcHk0lhWNbOAiwXjrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVWhu7g%253D&md5=69750b99b68316ee035a0b7eeddfb9fa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.aafl29210.1126%2Fscience.aaf1292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aafl29210.1126%252Fscience.aaf1292%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DE.%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DSasmal%26aufirst%3DD.%2BK.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DVale%26aufirst%3DR.%2BD.%26atitle%3DT%2520Cell%2520Costimulatory%2520Receptor%2520CD28%2520is%2520a%2520Primary%2520Target%2520for%2520PD-1-Mediated%2520Inhibition%26jtitle%3DScience%26date%3D2017%26volume%3D355%26spage%3D1428%26epage%3D1433%26doi%3D10.1126%2Fscience.aafl29210.1126%2Fscience.aaf1292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overduin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatase SHP2 for Therapeutic Intervention</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1423</span>– <span class="NLM_lpage">1437</span>, <span class="refDoi"> DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+Protein+Tyrosine+Phosphatase+SHP2+for+Therapeutic+Intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0lhWNbOAiwXjrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520for%2520Therapeutic%2520Intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, M. L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1124/mol.106.025536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1124%2Fmol.106.025536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=16717135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=562-570&author=L.+Chenauthor=S.-S.+Sungauthor=M.+L.+R.+Yipauthor=H.+R.+Lawrenceauthor=Y.+Renauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Discovery+of+a+Novel+Shp2+Protein+Tyrosine+Phosphatase+Inhibitor&doi=10.1124%2Fmol.106.025536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor</span></div><div class="casAuthors">Chen, Liwei; Sung, Shen-Shu; Yip, M. L. Richard; Lawrence, Harshani R.; Ren, Yuan; Guida, Wayne C.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">562-570</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Shp2 is a non-receptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene.  It is involved in growth factor-induced activation of mitogen-activated protein (MAP) kinases Erk1 and Erk2 (Erk1/2) and has been implicated in the pathogenicity of the oncogenic bacterium Helicobacter pylori.  Moreover, gain-of-function Shp2 mutations have been found in childhood leukemias and Noonan syndrome.  Thus, small mol. Shp2 PTP inhibitors are much needed reagents for evaluation of Shp2 as a therapeutic target and for chem. biol. studies of Shp2 function.  By screening the National Cancer Institute (NCI) Diversity Set chem. library, we identified 8-hydroxy-7-(6-sulfonaphthalen-2-yl)diazenyl-quinoline-5-sulfonic acid (NSC-87877) as a potent Shp2 PTP inhibitor.  Mol. modeling and site-directed mutagenesis studies suggested that NSC-87877 binds to the catalytic cleft of Shp2 PTP.  NSC-87877 cross-inhibited Shp1 in vitro, but it was selective for Shp2 over other PTPs (PTP1B, HePTP, DEP1, CD45, and LAR).  It is noteworthy that NSC-87877 inhibited epidermal growth factor (EGF)-induced activation of Shp2 PTP, Ras, and Erk1/2 in cell cultures but did not block EGF-induced Gab1 tyrosine phosphorylation or Gab1-Shp2 assocn.  Furthermore, NSC-87877 inhibited Erk1/2 activation by a Gab1-Shp2 chimera but did not affect the Shp2-independent Erk1/2 activation by phorbol 12-myristate 13-acetate.  These results identified NSC-87877 as the first PTP inhibitor capable of inhibiting Shp2 PTP in cell cultures without a detectable off-target effect.  Our study also provides the first pharmacol. evidence that Shp2 mediates EGF-induced Erk1/2 MAP kinase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4XVGUjw3W7Vg90H21EOLACvtfcHk0lhWNbOAiwXjrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D&md5=a2ce03150ecbe6937876bb292ced30dc</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025536%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSung%26aufirst%3DS.-S.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Shp2%2520Protein%2520Tyrosine%2520Phosphatase%2520Inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D562%26epage%3D570%26doi%3D10.1124%2Fmol.106.025536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">17626</span>, <span class="refDoi"> DOI: 10.1038/srep17626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fsrep17626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=26626996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=17626&author=C.+Chenauthor=M.+Caoauthor=S.+Zhuauthor=C.+Wangauthor=F.+Liangauthor=L.+Yanauthor=D.+Luo&title=Discovery+of+a+Novel+Inhibitor+of+the+Protein+Tyrosine+Phosphatase+Shp2&doi=10.1038%2Fsrep17626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2</span></div><div class="casAuthors">Chen, Chuan; Cao, Mengmeng; Zhu, Siyu; Wang, Cuicui; Liang, Fan; Yan, Leilei; Luo, Duqiang</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17626</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Shp2 is a ubiquitously expressed protein tyrosine phosphatase (PTP) related to adult acute myelogenous leukemia and human solid tumors.  In this report, we describe identification of a potent Shp2 inhibitor, Fumosorinone (Fumos) from entomogenous fungi, which shows selective inhibition of Shp2 over other tested PTPs.  Using a surface plasmon resonance anal., we further confirmed the phys. interaction between Shp2 and Fumos.  Fumos inhibits Shp2-dependent activation of the Ras/ERK signal pathway downstream of EGFR, and interrupts EGF-induced Gab1-Shp2 assocn.  As expected, Fumos shows little effects on the Shp2-independent ERK1/2 activation induced by PMA or oncogenic Ras.  Furthermore, Fumos down-regulates Src activation, inhibits phosphorylation of Paxillin and prevents tumor cell invasion.  These results suggest that Fumos can inhibit Shp2-dependent cell signaling in human cells and has a potential for treatment of Shp2-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoswqt5Y98UCrVg90H21EOLACvtfcHk0ljBAuMT3MKfNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bN&md5=ae7d1a3adf914820e57a2862ade65cf7</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fsrep17626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep17626%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Inhibitor%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520Shp2%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D17626%26doi%3D10.1038%2Fsrep17626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, D.</span></span> <span> </span><span class="NLM_article-title">Identification of demethylincisterol A 3 as a selective inhibitor of protein tyrosine phosphatase Shp2</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>795</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2016.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.ejphar.2016.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=27939989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyitrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=795&publication_year=2017&pages=124-133&author=C.+Chenauthor=F.+Liangauthor=B.+Chenauthor=Z.+Sunauthor=T.+Xueauthor=R.+Yangauthor=D.+Luo&title=Identification+of+demethylincisterol+A+3+as+a+selective+inhibitor+of+protein+tyrosine+phosphatase+Shp2&doi=10.1016%2Fj.ejphar.2016.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of demethylincisterol A3 as a selective inhibitor of protein tyrosine phosphatase Shp2</span></div><div class="casAuthors">Chen, Chuan; Liang, Fan; Chen, Bo; Sun, Zhongyi; Xue, Tongdan; Yang, Runlei; Luo, Duqiang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">795</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124-133</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Shp2 is a classical non-receptor protein tyrosine phosphatase (PTP) involved in many human diseases such as Noonan syndrome and tumors, and identified as a potential therapeutic target.  In order to find a potent and selective Shp2 inhibitor, we screened a diverse collection of the secondary metabolites from endophyte fungi using an in vitro enzyme assay, and finally identified a potent Shp2 inhibitor, HLP46 (demethylincisterol A3) from Pestalotiopsis sp.  HLP46 was reported to have anti-tumor and anti-inflammation activity previously.  We provide the first evidence that HLP46 is an inhibitor of the Shp2.  HLP46 shows high selective inhibition of Shp2 over Shp1, PTP1B, Lyp, STEP, PTPRA and Cdc25b.  Enzymic kinetic analyses showed that HLP46 is a non-competitive inhibitor of Shp2.  HLP46 interrupts Gab1-Shp2 assocn. and blocked Shp2-dependent activation of the Ras/ERK signal pathway induced by EGF.  Furthermore, HLP46 decreased Src activation and inhibit tumor cell migration and invasion.  As expected, HLP46 has no effect on the Shp2-independent activation of ERK induced by PMA or on the activation of the PI3K/Akt pathway.  We testified therapeutic efficacy targeting both Shp2 and PI3K in MCF7 cells.  HLP46 does not show any synergistic inhibition with PI3K inhibitor in suppressing cell growth.  Collectively, these results suggest that HLP46 is a selective Shp2 inhibitor and could inhibit Shp2-dependent cell signaling in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof4M-8QCExP7Vg90H21EOLACvtfcHk0ljBAuMT3MKfNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyitrjM&md5=433ef816f666648e69bd672b8c75554a</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520demethylincisterol%2520A%25203%2520as%2520a%2520selective%2520inhibitor%2520of%2520protein%2520tyrosine%2520phosphatase%2520Shp2%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D795%26spage%3D124%26epage%3D133%26doi%3D10.1016%2Fj.ejphar.2016.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Grosskopf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radetzki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibitors of the Protein Tyrosine Phosphatase SHP2 Block Cellular Motility and Growth of Cancer Cells in vitro and in vivo</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1002%2Fcmdc.201500015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=25877780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFers7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=815-826&author=S.+Grosskopfauthor=C.+Eckertauthor=C.+Arkonaauthor=S.+Radetzkiauthor=K.+B%C3%B6hmauthor=U.+Heinemannauthor=G.+Wolberauthor=J.-P.+von+Kriesauthor=W.+Birchmeierauthor=J.+Rademann&title=Selective+Inhibitors+of+the+Protein+Tyrosine+Phosphatase+SHP2+Block+Cellular+Motility+and+Growth+of+Cancer+Cells+in+vitro+and+in+vivo&doi=10.1002%2Fcmdc.201500015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibitors of the Protein Tyrosine Phosphatase SHP2 Block Cellular Motility and Growth of Cancer Cells in vitro and in vivo</span></div><div class="casAuthors">Grosskopf, Stefanie; Eckert, Chris; Arkona, Christoph; Radetzki, Silke; Boehm, Kerstin; Heinemann, Udo; Wolber, Gerhard; von Kries, Jens-Peter; Birchmeier, Walter; Rademann, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">815-826</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective inhibitors of the protein tyrosine phosphatase SHP2 (src homol. region 2 domain phosphatase; PTPN11), an enzyme that is deregulated in numerous human tumors, were generated through a combination of chem. synthesis and structure-based rational design.  Seventy pyridazolon-4-ylidenehydrazinyl benzenesulfonates were prepd. and evaluated in enzyme assays.  The binding modes of active inhibitors were simulated in silico using a newly generated crystal structure of SHP2.  The most powerful compd. I inhibited SHP2 with an IC50 value of 71±15 nM in the enzyme assay and was 29- and 45-fold more active toward SHP2 than against related SHP1 and PTP1B.  In cell culture expts. compd. I was found to block hepatocyte growth factor (HGF)-stimulated epithelial-mesenchymal transition of human pancreatic adenocarcinoma (HPAF) cells, as indicated by a decrease in the min. neighbor distances of cells.  Moreover, I inhibited cell colony formation in the nonsmall-cell lung cancer cell line LXFA 526 L in soft agar.  Finally, I was obsd. to inhibit tumor growth in a murine xenograft model.  Therefore, the novel specific compd. I strengthens the hypothesis that SHP2 is a relevant protein target for the inhibition of mobility and invasiveness of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovDT-98edFurVg90H21EOLACvtfcHk0ljBAuMT3MKfNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFers7g%253D&md5=72fa2915b67c514076144b3005441b17</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500015%26sid%3Dliteratum%253Aachs%26aulast%3DGrosskopf%26aufirst%3DS.%26aulast%3DEckert%26aufirst%3DC.%26aulast%3DArkona%26aufirst%3DC.%26aulast%3DRadetzki%26aufirst%3DS.%26aulast%3DB%25C3%25B6hm%26aufirst%3DK.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DWolber%26aufirst%3DG.%26aulast%3Dvon%2BKries%26aufirst%3DJ.-P.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DRademann%26aufirst%3DJ.%26atitle%3DSelective%2520Inhibitors%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520Block%2520Cellular%2520Motility%2520and%2520Growth%2520of%2520Cancer%2520Cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D815%26epage%3D826%26doi%3D10.1002%2Fcmdc.201500015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bialy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Protein Tyrosine Phosphatases: Next Generation Drugs?</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3813</span>– <span class="NLM_lpage">3839</span>, <span class="refDoi"> DOI: 10.1002/anie.200461517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1002%2Fanie.200461517" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=3813-3839&author=L.+Bialyauthor=H.+Waldmann&title=Inhibitors+of+Protein+Tyrosine+Phosphatases%3A+Next+Generation+Drugs%3F&doi=10.1002%2Fanie.200461517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2Fanie.200461517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200461517%26sid%3Dliteratum%253Aachs%26aulast%3DBialy%26aufirst%3DL.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DInhibitors%2520of%2520Protein%2520Tyrosine%2520Phosphatases%253A%2520Next%2520Generation%2520Drugs%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D3813%26epage%3D3839%26doi%3D10.1002%2Fanie.200461517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Targeting protein tyrosine phosphatases for anticancer drug discovery</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1862</span>, <span class="refDoi"> DOI: 10.2174/138161210791209027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.2174%2F138161210791209027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=20337577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1ClsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1843-1862&author=L.+M.+Scottauthor=H.+R.+Lawrenceauthor=N.+J.+Sebtiauthor=J.+Lawrenceauthor=J.+Wu&title=Targeting+protein+tyrosine+phosphatases+for+anticancer+drug+discovery&doi=10.2174%2F138161210791209027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatases for anticancer drug discovery</span></div><div class="casAuthors">Scott, Latanya M.; Lawrence, Harshani R.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1843-1862</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases (PTPs) are a diverse family of enzymes encoded by 107 genes in the human genome.  Together with protein tyrosine kinases (PTKs), PTPs regulate various cellular activities essential for the initiation and maintenance of malignant phenotypes.  While PTK inhibitors are now used routinely for cancer treatment, the PTP inhibitor development field is still in the discovery phase.  In this article, the suitability of targeting PTPs for novel anticancer drug discovery is discussed.  Examples are presented for PTPs that have been targeted for anticancer drug discovery as well as potential new PTP targets for novel anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHuBrNeSP0n7Vg90H21EOLACvtfcHk0lhsgfovCEw09A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1ClsLY%253D&md5=17813d1fba0225fd5e54692b1159bc4a</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.2174%2F138161210791209027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210791209027%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BM.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DSebti%26aufirst%3DN.%2BJ.%26aulast%3DLawrence%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTargeting%2520protein%2520tyrosine%2520phosphatases%2520for%2520anticancer%2520drug%2520discovery%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D1843%26epage%3D1862%26doi%3D10.2174%2F138161210791209027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmartin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faitg, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seefeld, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minthorn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinnamon, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heerding, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span> <span> </span><span class="NLM_article-title">Allosteric WIP1 Phosphatase Inhibition Through Flap-Subdomain Interaction</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fnchembio.1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=24390428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=181-187&author=A.+G.+Gilmartinauthor=T.+H.+Faitgauthor=M.+Richterauthor=A.+Groyauthor=M.+A.+Seefeldauthor=M.+G.+Darcyauthor=X.+Pengauthor=K.+Federowiczauthor=J.+Yangauthor=S.-Y.+Zhangauthor=E.+Minthornauthor=J.-P.+Jaworskiauthor=M.+Schaberauthor=S.+Martensauthor=D.+E.+McNultyauthor=R.+H.+Sinnamonauthor=H.+Zhangauthor=R.+B.+Kirkpatrickauthor=N.+Nevinsauthor=G.+Cuiauthor=B.+Pietrakauthor=E.+Diazauthor=A.+Jonesauthor=M.+Brandtauthor=B.+Schwartzauthor=D.+A.+Heerdingauthor=R.+Kumar&title=Allosteric+WIP1+Phosphatase+Inhibition+Through+Flap-Subdomain+Interaction&doi=10.1038%2Fnchembio.1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction</span></div><div class="casAuthors">Gilmartin, Aidan G.; Faitg, Thomas H.; Richter, Mark; Groy, Arthur; Seefeld, Mark A.; Darcy, Michael G.; Peng, Xin; Federowicz, Kelly; Yang, Jingsong; Zhang, Shu-Yun; Minthorn, Elisabeth; Jaworski, Jon-Paul; Schaber, Michael; Martens, Stan; McNulty, Dean E.; Sinnamon, Robert H.; Zhang, Hong; Kirkpatrick, Robert B.; Nevins, Neysa; Cui, Guanglei; Pietrak, Beth; Diaz, Elsie; Jones, Amber; Brandt, Martin; Schwartz, Benjamin; Heerding, Dirk A.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-187</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although therapeutic interventions of signal-transduction cascades with targeted kinase inhibitors are a well-established strategy, drug-discovery efforts to identify targeted phosphatase inhibitors have proven challenging.  Herein we report a series of allosteric, small-mol. inhibitors of wild-type p53-induced phosphatase (Wip1), an oncogenic phosphatase common to multiple cancers.  Compd. binding to Wip1 is dependent on a 'flap' subdomain located near the Wip1 catalytic site that renders Wip1 structurally divergent from other members of the protein phosphatase 2C (PP2C) family and that thereby confers selectivity for Wip1 over other phosphatases.  Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of Wip1 substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53.  Oral administration of Wip1 inhibitors in mice results in expected pharmacodynamic effects and causes inhibition of lymphoma xenograft growth.  To our knowledge, GSK2830371 is the first orally active, allosteric inhibitor of Wip1 phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jXZXKTKTL7Vg90H21EOLACvtfcHk0lhsgfovCEw09A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D&md5=47524caa70df233fb152a2d683417e7d</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1427%26sid%3Dliteratum%253Aachs%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DFaitg%26aufirst%3DT.%2BH.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DSeefeld%26aufirst%3DM.%2BA.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFederowicz%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DS.-Y.%26aulast%3DMinthorn%26aufirst%3DE.%26aulast%3DJaworski%26aufirst%3DJ.-P.%26aulast%3DSchaber%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DSinnamon%26aufirst%3DR.%2BH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DAllosteric%2520WIP1%2520Phosphatase%2520Inhibition%2520Through%2520Flap-Subdomain%2520Interaction%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D181%26epage%3D187%26doi%3D10.1038%2Fnchembio.1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. C.</span></span> <span> </span><span class="NLM_article-title">Rational Design of Allosteric-Inhibition Sites in Classical Protein Tyrosine Phosphatases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2828</span>– <span class="NLM_lpage">2838</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.bmc.2015.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=25828055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVWhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2828-2838&author=C.+M.+Chioauthor=X.+Yuauthor=A.+C.+Bishop&title=Rational+Design+of+Allosteric-Inhibition+Sites+in+Classical+Protein+Tyrosine+Phosphatases&doi=10.1016%2Fj.bmc.2015.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases</span></div><div class="casAuthors">Chio, Cynthia M.; Yu, Xiaoling; Bishop, Anthony C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2828-2838</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs), which catalyze the dephosphorylation of phosphotyrosine in protein substrates, are crit. regulators of metazoan cell signaling and have emerged as potential drug targets for a range of human diseases.  Strategies for chem. targeting the function of individual PTPs selectively could serve to elucidate the signaling roles of these enzymes and would potentially expedite validation of the therapeutic promise of PTP inhibitors.  Here we report a novel strategy for the design of non-natural allosteric-inhibition sites in PTPs; these sites, which can be introduced into target PTPs through protein engineering, serve to sensitize target PTPs to potent and selective inhibition by a biarsenical small mol.  Building on the recent discovery of a naturally occurring cryptic allosteric site in wild-type Src-homol.-2 domain contg. PTP (Shp2) that can be targeted by biarsenical compds., we hypothesized that Shp2's unusual sensitivity to biarsenicals could be strengthened through rational design and that the Shp2-specific site could serve as a blueprint for the introduction of non-natural inhibitor sensitivity in other PTPs.  Indeed, we show here that the strategic introduction of a cysteine residue at a position removed from the Shp2 active site can serve to increase the potency and selectivity of the interaction between Shp2's allosteric site and the biarsenical inhibitor.  Moreover, we find that 'Shp2-like' allosteric sites can be installed de novo in PTP enzymes that do not possess naturally occurring sensitivity to biarsenical compds.  Using primary-sequence alignments to guide our enzyme engineering, we have successfully introduced allosteric-inhibition sites in four classical PTPs-PTP1B, PTPH-1, FAP-1, and HePTP-from four different PTP subfamilies, suggesting that our sensitization approach can likely be applied widely across the classical PTP family to generate biarsenical-responsive PTPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwDXbkv2RdC7Vg90H21EOLACvtfcHk0lhsgfovCEw09A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVWhs7s%253D&md5=14a48e70c722a586a2e3ccb3fa9006ae</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DC.%2BM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DBishop%26aufirst%3DA.%2BC.%26atitle%3DRational%2520Design%2520of%2520Allosteric-Inhibition%2520Sites%2520in%2520Classical%2520Protein%2520Tyrosine%2520Phosphatases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2828%26epage%3D2838%26doi%3D10.1016%2Fj.bmc.2015.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beumer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simard, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grütter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span> <span> </span><span class="NLM_article-title">Selective Detection of Allosteric Phosphatase Inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">6838</span>– <span class="NLM_lpage">6841</span>, <span class="refDoi"> DOI: 10.1021/ja4030484</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4030484" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlWhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=6838-6841&author=R.+Schneiderauthor=C.+Beumerauthor=J.+R.+Simardauthor=C.+Gr%C3%BCtterauthor=D.+Rauh&title=Selective+Detection+of+Allosteric+Phosphatase+Inhibitors&doi=10.1021%2Fja4030484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Detection of Allosteric Phosphatase Inhibitors</span></div><div class="casAuthors">Schneider, Ralf; Beumer, Claudia; Simard, Jeffrey R.; Gruetter, Christian; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6838-6841</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Normal cellular function, such as signal transduction, is largely controlled by the reversible phosphorylation of cellular proteins catalyzed by two major classes of enzymes, kinases and phosphatases.  A misbalance in this complex and dynamic interplay leads to a variety of severe diseases, such as cancer, inflammation, or autoimmune diseases.  This makes kinases as well as phosphatases equally attractive targets for therapeutic manipulation by small mols.  While the development of kinase inhibitors has resulted in several blockbuster drugs, such as imatinib, with remarkable success in the clinic and sales of many billions of U.S. dollars per yr, not a single phosphatase inhibitor has yet been approved for clin. use.  Similar to the kinase world, substrate-competitive phosphatase inhibitors have been developed but were not suitable for further development into clin. candidates due to their charge and limited selectivity.  Research efforts, therefore, have shifted to the exploitation of allosteric sites that can regulate phosphatase activity and may enable the discovery of novel modulators of phosphatase activity with much improved pharmacol. properties.  However, assay systems, which enable the straightforward discovery of these inhibitor types, are missing.  Here, we present a novel binding assay capable of detecting ligands of an allosteric pocket of the protein tyrosine phosphatase 1B.  This assay is suitable for high-throughput screening and selectively detects ligands which bind to this unique site with a clear discrimination from substrate-competitive ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMMpcm8RfGWrVg90H21EOLACvtfcHk0lggutyBaM97HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlWhtbk%253D&md5=49a980ad7f749718803f1afe1d8d1a04</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Fja4030484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4030484%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DBeumer%26aufirst%3DC.%26aulast%3DSimard%26aufirst%3DJ.%2BR.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DC.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DSelective%2520Detection%2520of%2520Allosteric%2520Phosphatase%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D6838%26epage%3D6841%26doi%3D10.1021%2Fja4030484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonakos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slisz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span> <span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-152&author=Y.-N.+P.+Chenauthor=M.+J.+LaMarcheauthor=H.+M.+Chanauthor=P.+Fekkesauthor=J.+Garcia-Fortanetauthor=M.+G.+Ackerauthor=B.+Antonakosauthor=C.+H.-T.+Chenauthor=Z.+Chenauthor=V.+G.+Cookeauthor=J.+R.+Dobsonauthor=Z.+Dengauthor=F.+Feiauthor=B.+Firestoneauthor=M.+Fodorauthor=C.+Fridrichauthor=H.+Gaoauthor=D.+Grunenfelderauthor=H.-X.+Haoauthor=J.+Jacobauthor=S.+Hoauthor=K.+Hsiaoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=J.+Larrowauthor=L.+R.+La+Bonteauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=E.+Priceauthor=C.+Quinnauthor=S.+Shakyaauthor=M.+D.+Shultzauthor=J.+Sliszauthor=K.+Venkatesanauthor=P.+Wangauthor=M.+Warmuthauthor=S.+Williamsauthor=G.+Yangauthor=J.+Yuanauthor=J.-H.+Zhangauthor=P.+Zhuauthor=T.+Ramseyauthor=N.+J.+Keenauthor=W.+R.+Sellersauthor=T.+Stamsauthor=P.+D.+Fortin&title=Allosteric+inhibition+of+SHP2+phosphatase+inhibits+cancers+driven+by+receptor+tyrosine+kinases&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 μM), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0lggutyBaM97HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.-N.%2BP.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DH.%2BM.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarcia-Fortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DAntonakos%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCooke%26aufirst%3DV.%2BG.%26aulast%3DDobson%26aufirst%3DJ.%2BR.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DF.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DH.-X.%26aulast%3DJacob%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DQuinn%26aufirst%3DC.%26aulast%3DShakya%26aufirst%3DS.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DVenkatesan%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%2520phosphatase%2520inhibits%2520cancers%2520driven%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D152%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">0046ortanet, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7773</span>– <span class="NLM_lpage">7782</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00680</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00680" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7773-7782&author=J.+G.+0046ortanetauthor=C.+H.-T.+Chenauthor=Y.-N.+P.+Chenauthor=Z.+Chenauthor=Z.+Dengauthor=B.+Firestoneauthor=P.+Fekkesauthor=M.+Fodorauthor=P.+D.+Fortinauthor=C.+Fridrichauthor=D.+Grunenfelderauthor=S.+Hoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=N.+Keenauthor=L.+R.+LaBonteauthor=J.+Larrowauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=F.+Lombardoauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=T.+Ramseyauthor=W.+R.+Sellersauthor=M.+D.+Shultzauthor=T.+Stamsauthor=C.+Towlerauthor=P.+Wangauthor=S.+L.+Williamsauthor=J.-H.+Zhangauthor=M.+J.+LaMarche&title=Allosteric+Inhibition+of+SHP2%3A+Identification+of+a+Potent%2C+Selective%2C+and+Orally+Efficacious+Phosphatase+Inhibitor&doi=10.1021%2Facs.jmedchem.6b00680"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26aulast%3D0046ortanet%26aufirst%3DJ.%2BG.%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26aulast%3DChen%26aufirst%3DY.-N.%2BP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLaBonte%26aufirst%3DL.%2BR.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DAllosteric%2520Inhibition%2520of%2520SHP2%253A%2520Identification%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520Phosphatase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7773%26epage%3D7782%26doi%3D10.1021%2Facs.jmedchem.6b00680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Tyrosine Phosphatase SHP-2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1016/s0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fs0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+Structure+of+the+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2Fs0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0lgK9dFM3eN6GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fs0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450%26doi%3D10.1016%2Fs0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Revealing Mechanisms for SH2 Domain Mediated Regulation of the Protein Tyrosine Phosphatase SHP-2</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/s0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fs0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+Mechanisms+for+SH2+Domain+Mediated+Regulation+of+the+Protein+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2Fs0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0lgK9dFM3eN6GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fs0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520Mechanisms%2520for%2520SH2%2520Domain%2520Mediated%2520Regulation%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254%26doi%3D10.1016%2Fs0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durzynska, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2269</span>– <span class="NLM_lpage">2277</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.5b01287</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVagtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2269-2277&author=J.+R.+LaRochelleauthor=M.+Fodorauthor=X.+Xuauthor=I.+Durzynskaauthor=L.+Fanauthor=T.+Stamsauthor=H.+M.+Chanauthor=M.+J.+LaMarcheauthor=R.+Chopraauthor=P.+Wangauthor=P.+D.+Fortinauthor=M.+G.+Ackerauthor=S.+C.+Blacklow&title=Structural+and+Functional+Consequences+of+Three+Cancer-Associated+Mutations+of+the+Oncogenic+Phosphatase+SHP2&doi=10.1021%2Facs.biochem.5b01287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2</span></div><div class="casAuthors">LaRochelle, Jonathan R.; Fodor, Michelle; Xu, Xiang; Durzynska, Izabela; Fan, Lixin; Stams, Travis; Chan, Ho Man; LaMarche, Matthew J.; Chopra, Rajiv; Wang, Ping; Fortin, Pascal D.; Acker, Michael G.; Blacklow, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2269-2277</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The proto-oncogene PTPN11 encodes a cytoplasmic protein tyrosine phosphatase, SHP2, which is required for normal development and sustained activation of the Ras-MAPK signaling pathway.  Germline mutations in SHP2 cause developmental disorders, and somatic mutations have been identified in childhood and adult cancers and drive leukemia in mice.  Despite our knowledge of the PTPN11 variations assocd. with pathol., the structural and functional consequences of many disease-assocd. mutants remain poorly understood.  Here, we combine X-ray crystallog., small-angle X-ray scattering, and biochem. to elucidate structural and mechanistic features of three cancer-assocd. SHP2 variants harboring single point mutations within the N-SH2:PTP interdomain autoinhibitory interface.  Our findings directly compare the impact of each mutation on autoinhibition of the phosphatase and advance the development of structure-guided and mutation-specific SHP2 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdIaFVGm5lArVg90H21EOLACvtfcHk0ljkMUHh40ku4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVagtLw%253D&md5=720b3dd9b18edde2c443d488cfb90dfc</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01287%26sid%3Dliteratum%253Aachs%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DDurzynska%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DH.%2BM.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26atitle%3DStructural%2520and%2520Functional%2520Consequences%2520of%2520Three%2520Cancer-Associated%2520Mutations%2520of%2520the%2520Oncogenic%2520Phosphatase%2520SHP2%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D2269%26epage%3D2277%26doi%3D10.1021%2Facs.biochem.5b01287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellegast, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemulapalli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmaier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span> <span> </span><span class="NLM_article-title">Identification of an Allosteric Benzothiazolopyrimidone Inhibitor of the Oncogenic Protein Tyrosine Phosphatase SHP2</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">6479</span>– <span class="NLM_lpage">6485</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.bmc.2017.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=29089257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A280%3ADC%252BC1M7mtlOksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=6479-6485&author=J.+R.+LaRochelleauthor=M.+Fodorauthor=J.+M.+Ellegastauthor=X.+Liuauthor=V.+Vemulapalliauthor=M.+Mohseniauthor=T.+Stamsauthor=S.+J.+Buhrlageauthor=K.+Stegmaierauthor=M.+J.+LaMarcheauthor=M.+G.+Ackerauthor=S.+C.+Blacklow&title=Identification+of+an+Allosteric+Benzothiazolopyrimidone+Inhibitor+of+the+Oncogenic+Protein+Tyrosine+Phosphatase+SHP2&doi=10.1016%2Fj.bmc.2017.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2</span></div><div class="casAuthors">LaRochelle Jonathan R; Liu Xiaoxi; Vemulapalli Vidyasiri; Buhrlage Sara J; Fodor Michelle; Stams Travis; Ellegast Jana M; Mohseni Morvarid; Acker Michael G; Stegmaier Kimberly; LaMarche Matthew J; Blacklow Stephen C</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6479-6485</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The PTPN11 oncogene encodes the cytoplasmic protein tyrosine phosphatase SHP2, which, through its role in multiple signaling pathways, promotes the progression of hematological malignancies and other cancers.  Here, we employ high-throughput screening to discover a lead chemical scaffold, the benzothiazolopyrimidones, that allosterically inhibits this oncogenic phosphatase by simultaneously engaging the C-SH2 and PTP domains.  We improved our lead to generate an analogue that better suppresses SHP2 activity in vitro.  Suppression of Erk phopsphorylation by the lead compound is also consistent with SHP2 inhibition in AML cells.  Our findings provide an alternative starting point for therapeutic intervention and will catalyze investigations into the relationship between SHP2 conformational regulation, activity, and disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQovWlxLHSQ4MRAV4D_Ins_fW6udTcc2eYRyNE4AHoVk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7mtlOksA%253D%253D&md5=4425bb1a20f079aa02986fb0b8a082e7</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DEllegast%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVemulapalli%26aufirst%3DV.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DStegmaier%26aufirst%3DK.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26atitle%3DIdentification%2520of%2520an%2520Allosteric%2520Benzothiazolopyrimidone%2520Inhibitor%2520of%2520the%2520Oncogenic%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D6479%26epage%3D6485%26doi%3D10.1016%2Fj.bmc.2017.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span> <span> </span><span class="NLM_article-title">Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10205</span>– <span class="NLM_lpage">10219</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01520</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01520" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCks7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10205-10219&author=J.+Xieauthor=X.+Siauthor=S.+Guauthor=M.+Wangauthor=J.+Shenauthor=H.+Liauthor=J.+Shenauthor=D.+Liauthor=Y.+Fangauthor=C.+Liuauthor=J.+Zhu&title=Allosteric+Inhibitors+of+SHP2+with+Therapeutic+Potential+for+Cancer+Treatment&doi=10.1021%2Facs.jmedchem.7b01520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment</span></div><div class="casAuthors">Xie, Jingjing; Si, Xiaojia; Gu, Shoulai; Wang, Mingliang; Shen, Jian; Li, Haoyan; Li, Dan; Fang, Yanjia; Liu, Cong; Zhu, Jidong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10205-10219</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2, a cytoplasmic protein tyrosine phosphatase encoded by the PTPN11 gene, is involved in multiple cell signaling processes including Ras/MAPK and Hippo/YAP pathways.  SHP2 has been shown to contribute to the progression of a no. of cancer types including leukemia, gastric, and breast cancers.  It also regulates T-cell activation by interacting with inhibitory immune checkpoint receptors such as the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA).  Thus, SHP2 inhibitors have drawn great attention by both inhibiting tumor cell proliferation and activating T cell immune responses toward cancer cells.  In this study, the authors report the identification of an allosteric SHP2 inhibitor I that locks SHP2 in a closed conformation by binding to the interface of the N-terminal SH2, C-terminal SH2, and phosphatase domains.  Compd. I suppresses MAPK signaling pathway and YAP transcriptional activity and shows antitumor activity in vivo.  The results indicate that allosteric inhibition of SHP2 could be a feasible approach for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWHA25LKpH7Vg90H21EOLACvtfcHk0ljkMUHh40ku4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCks7%252FM&md5=4aaabafae3250476b7bf3687d83cffd3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01520%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DSi%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DAllosteric%2520Inhibitors%2520of%2520SHP2%2520with%2520Therapeutic%2520Potential%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10205%26epage%3D10219%26doi%3D10.1021%2Facs.jmedchem.7b01520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argintaru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Dual Allosteric Inhibition of SHP2 Phosphatase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00980</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00980" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=647-656&author=M.+Fodorauthor=E.+Priceauthor=P.+Wangauthor=H.+Luauthor=A.+Argintaruauthor=Z.+Chenauthor=M.+Glickauthor=H.-X.+Haoauthor=M.+Katoauthor=R.+Koenigauthor=J.+R.+LaRochelleauthor=G.+Liuauthor=E.+McNeillauthor=D.+Majumdarauthor=G.+A.+Nishiguchiauthor=L.+B.+Perezauthor=G.+Parisauthor=C.+M.+Quinnauthor=T.+Ramseyauthor=M.+Sendzikauthor=M.+D.+Shultzauthor=S.+L.+Williamsauthor=T.+Stamsauthor=S.+C.+Blacklowauthor=M.+G.+Ackerauthor=M.+J.+LaMarche&title=Dual+Allosteric+Inhibition+of+SHP2+Phosphatase&doi=10.1021%2Facschembio.7b00980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dual allosteric inhibition of SHP2 phosphatase</span></div><div class="casAuthors">Fodor, Michelle; Price, Edmund; Wang, Ping; Lu, Hengyu; Argintaru, Andreea; Chen, Zhouliang; Glick, Meir; Hao, Huai-Xiang; Kato, Mitsunori; Koenig, Robert; La Rochelle, Jonathan R.; Liu, Gang; McNeill, Eric; Majumdar, Dyuti; Nishiguchi, Gisele A.; Perez, Lawrence B.; Paris, Gregory; Quinn, Christopher M.; Ramsey, Timothy; Sendzik, Martin; Shultz, Michael David; Williams, Sarah L.; Stams, Travis; Blacklow, Stephen C.; Acker, Michael G.; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">647-656</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a cytoplasmic protein tyrosine phosphatase encoded by the PTPN11 gene and is involved in cell proliferation, differentiation, and survival.  Recently, we reported an allosteric mechanism of inhibition that stabilizes the auto-inhibited conformation of SHP2.  SHP099 (1) was identified and characterized as a moderately potent, orally bioavailable, allosteric small mol. inhibitor, which binds to a tunnel-like pocket formed by the confluence of three domains of SHP2.  In this report, we describe further screening strategies that enabled the identification of a second, distinct small mol. allosteric site.  SHP244 (2) was identified as a weak inhibitor of SHP2 with modest thermal stabilization of the enzyme.  X-ray crystallog. revealed that 2 binds and stabilizes the inactive, closed conformation of SHP2, at a distinct, previously unexplored binding site-a cleft formed at the interface of the N-terminal SH2 and PTP domains.  Derivatization of 2 using structure-based design resulted in an increase in SHP2 thermal stabilization, biochem. inhibition, and subsequent MAPK pathway modulation.  Downregulation of DUSP6 mRNA, a downstream MAPK pathway marker, was obsd. in KYSE-520 cancer cells.  Remarkably, simultaneous occupation of both allosteric sites by 1 and 2 was possible, as characterized by cooperative biochem. inhibition expts. and X-ray crystallog.  Combining an allosteric site 1 inhibitor with an allosteric site 2 inhibitor led to enhanced pharmacol. pathway inhibition in cells.  This work illustrates a rare example of dual allosteric targeted protein inhibition, demonstrates screening methodol. and tactics to identify allosteric inhibitors, and enables further interrogation of SHP2 in cancer and related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdw7pTS6sOLVg90H21EOLACvtfcHk0lh7wc36KQrVWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D&md5=8e4de4c353b9fc196c81e1cb51e367df</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00980%26sid%3Dliteratum%253Aachs%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DArgintaru%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGlick%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DH.-X.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DR.%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMcNeill%26aufirst%3DE.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26aulast%3DParis%26aufirst%3DG.%26aulast%3DQuinn%26aufirst%3DC.%2BM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DDual%2520Allosteric%2520Inhibition%2520of%2520SHP2%2520Phosphatase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D647%26epage%3D656%26doi%3D10.1021%2Facschembio.7b00980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Acker, M.</span>; <span class="NLM_string-name">Chen, Y. N.</span>; <span class="NLM_string-name">Chan, H.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Firestone, B.</span>; <span class="NLM_string-name">Fodor, M.</span>; <span class="NLM_string-name">Garcia-Fortanet, J.</span>; <span class="NLM_string-name">Hentemann, M.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">Koenig, R.</span>; <span class="NLM_string-name">LaBonte, L. R.</span>; <span class="NLM_string-name">Liu, S.</span>; <span class="NLM_string-name">Mohseni, M.</span>; <span class="NLM_string-name">Ntaganda, R.</span>; <span class="NLM_string-name">Sarver, P.</span>; <span class="NLM_string-name">Smith, T.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Stams, T.</span>; <span class="NLM_string-name">Spence, S.</span>; <span class="NLM_string-name">Towler, C.</span>; <span class="NLM_string-name">Wang, H.</span>; <span class="NLM_string-name">Wang, P.</span>; <span class="NLM_string-name">Williams, S. L.</span>; <span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of Fused-Bicyclic Allosteric SHP2 Inhibitors</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>.<span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01725</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01725" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+T.+Bagdanoff&author=Z.+Chen&author=M.+Acker&author=Y.+N.+Chen&author=H.+Chan&author=M.+Dore&author=B.+Firestone&author=M.+Fodor&author=J.+Garcia-Fortanet&author=M.+Hentemann&author=M.+Kato&author=R.+Koenig&author=L.+R.+LaBonte&author=S.+Liu&author=M.+Mohseni&author=R.+Ntaganda&author=P.+Sarver&author=T.+Smith&author=M.+Sendzik&author=T.+Stams&author=S.+Spence&author=C.+Towler&author=H.+Wang&author=P.+Wang&author=S.+L.+Williams&author=M.+J.+LaMarche&title=Optimization+of+Fused-Bicyclic+Allosteric+SHP2+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01725"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01725%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26atitle%3DOptimization%2520of%2520Fused-Bicyclic%2520Allosteric%2520SHP2%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.8b01725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gee, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalgat, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upson, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaubert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugland, R. P.</span></span> <span> </span><span class="NLM_article-title">Fluorogenic Substrates Based on Fluorinated Umbelliferones for Continuous Assays of Phosphatases and β-Galactosidases</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1006/abio.1999.4202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1006%2Fabio.1999.4202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1999&pages=41-48&author=K.+R.+Geeauthor=W.-C.+Sunauthor=M.+K.+Bhalgatauthor=R.+H.+Upsonauthor=D.+H.+Klaubertauthor=K.+A.+Lathamauthor=R.+P.+Haugland&title=Fluorogenic+Substrates+Based+on+Fluorinated+Umbelliferones+for+Continuous+Assays+of+Phosphatases+and+%CE%B2-Galactosidases&doi=10.1006%2Fabio.1999.4202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4202%26sid%3Dliteratum%253Aachs%26aulast%3DGee%26aufirst%3DK.%2BR.%26aulast%3DSun%26aufirst%3DW.-C.%26aulast%3DBhalgat%26aufirst%3DM.%2BK.%26aulast%3DUpson%26aufirst%3DR.%2BH.%26aulast%3DKlaubert%26aufirst%3DD.%2BH.%26aulast%3DLatham%26aufirst%3DK.%2BA.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26atitle%3DFluorogenic%2520Substrates%2520Based%2520on%2520Fluorinated%2520Umbelliferones%2520for%2520Continuous%2520Assays%2520of%2520Phosphatases%2520and%2520%25CE%25B2-Galactosidases%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D273%26spage%3D41%26epage%3D48%26doi%3D10.1006%2Fabio.1999.4202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wenlock, M.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1250</span>– <span class="NLM_lpage">1256</span>, <span class="refDoi"> DOI: 10.1021/jm021053p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021053p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1250-1256&author=M.%0AC.+Wenlockauthor=R.+P.+Austinauthor=P.+Bartonauthor=A.+M.+Davisauthor=P.+D.+Leeson&title=A+Comparison+of+Physiochemical+Property+Profiles+of+Development+and+Marketed+Oral+Drugs&doi=10.1021%2Fjm021053p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span></div><div class="casAuthors">Wenlock, Mark C.; Austin, Rupert P.; Barton, Patrick; Davis, Andrew M.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The process of drug discovery applies rigorous selection pressures.  Marketed oral drugs will generally possess favorable physiochem. properties with respect to absorption, metab., distribution, and clearance.  This paper describes a study in which the distributions of physiochem. properties of oral drugs in different phases of clin. development are compared to those already marketed.  The aim is to identify the trends in physiochem. properties that favor a drug's successful passage through clin. development and on to the market.  Two libraries were created, one of current development oral drugs and one of marketed oral drugs.  Statistical anal. of the two showed that the mean mol. wt. of orally administered drugs in development decreases on passing through each of the different clin. phases and gradually converges toward the mean mol. wt. of marketed oral drugs.  It is also clear that the most lipophilic compds. are being discontinued from development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0PksUFJq0bVg90H21EOLACvtfcHk0ljfX9irbgB2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D&md5=b9809c803a61ec99a1b4171e97952452</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm021053p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021053p%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DA%2520Comparison%2520of%2520Physiochemical%2520Property%2520Profiles%2520of%2520Development%2520and%2520Marketed%2520Oral%2520Drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1250%26epage%3D1256%26doi%3D10.1021%2Fjm021053p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry</span>. <i>Nat. Rev. Drug. Disc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-Like+Concepts+on+Decision-Making+in+Medicinal+Chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljfX9irbgB2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-Like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Disc.%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Setting Expectations in Molecular Optimizations: Strengths and Limitations of Commonly Used Composite Parameters</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5980</span>– <span class="NLM_lpage">5991</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.bmcl.2013.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=24018190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5980-5991&author=M.+D.+Shultz&title=Setting+Expectations+in+Molecular+Optimizations%3A+Strengths+and+Limitations+of+Commonly+Used+Composite+Parameters&doi=10.1016%2Fj.bmcl.2013.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5980-5991</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Over the past 15 years there have been extensive efforts to understand and reduce the high attrition rates of drug candidates with an increased focus on physicochem. properties.  The fruits of this labor have been the generation of numerous efficiency indexes, metric-based rules and visualization tools to help guide medicinal chemists in the design of new compds. with more favorable properties.  This deluge of information may have had the unintended consequence of further obfuscating mol. optimizations by the inability of these scoring functions, rules and guides to reach a consensus on when a particular transformation is identified as beneficial.  In this manuscript, several composite parameters, or efficiency indexes, are examd. utilizing theor. and exptl. matched mol. pair analyses in order to understand the basis for how each will perform under varying scenarios of mol. optimizations.  In contrast to empirically derived composite parameters based on heavy atom count, lipophilic efficiency (LipE) sets consistent expectations regardless of mol. wt. or relative potency and can be used to generate consistent expectations for any matched mol. pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJeTISXSJyLbVg90H21EOLACvtfcHk0ljfX9irbgB2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI&md5=3b766e26254f482b75b8973888c13aec</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DSetting%2520Expectations%2520in%2520Molecular%2520Optimizations%253A%2520Strengths%2520and%2520Limitations%2520of%2520Commonly%2520Used%2520Composite%2520Parameters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5980%26epage%3D5991%26doi%3D10.1016%2Fj.bmcl.2013.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavelin, S.</span></span> <span> </span><span class="NLM_article-title">Caco-2 and Emerging Alternatives for Prediction of Intestinal Drug Transport: A General Overview</span>. <i>Methods Princ. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1002/3527601473.ch4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1002%2F3527601473.ch4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=72-89&author=P.+Arturssonauthor=S.+Tavelin&title=Caco-2+and+Emerging+Alternatives+for+Prediction+of+Intestinal+Drug+Transport%3A+A+General+Overview&doi=10.1002%2F3527601473.ch4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2F3527601473.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F3527601473.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DTavelin%26aufirst%3DS.%26atitle%3DCaco-2%2520and%2520Emerging%2520Alternatives%2520for%2520Prediction%2520of%2520Intestinal%2520Drug%2520Transport%253A%2520A%2520General%2520Overview%26jtitle%3DMethods%2520Princ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D18%26spage%3D72%26epage%3D89%26doi%3D10.1002%2F3527601473.ch4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Paz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvieto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescatore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5843</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1021/jm800245z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+Raltegravir%2C+a+Potent%2C+Selective+Orally+Bioavailable+HIV-Integrase+Inhibitor+for+the+Treatment+of+HIV-AIDS+Infection&doi=10.1021%2Fjm800245z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection</span></div><div class="casAuthors">Summa, Vincenzo; Petrocchi, Alessia; Bonelli, Fabio; Crescenzi, Benedetta; Donghi, Monica; Ferrara, Marco; Fiore, Fabrizio; Gardelli, Cristina; Gonzalez Paz, Odalys; Hazuda, Daria J.; Jones, Philip; Kinzel, Olaf; Laufer, Ralph; Monteagudo, Edith; Muraglia, Ester; Nizi, Emanuela; Orvieto, Federica; Pace, Paola; Pescatore, Giovanna; Scarpelli, Rita; Stillmock, Kara; Witmer, Marc V.; Rowley, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5843-5855</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type-1 (HIV-1) integrase is one of the three virally encoded enzymes required for replication and therefore a rational target for chemotherapeutic intervention in the treatment of HIV-1 infection.  We report here the discovery of Raltegravir, the first HIV-integrase inhibitor approved by FDA for the treatment of HIV infection.  It derives from the evolution of 5,6-dihydroxypyrimidine-4-carboxamides and N-methyl-4-hydroxypyrimidinone-carboxamides, which exhibited potent inhibition of the HIV-integrase catalyzed strand transfer process.  Structural modifications on these mols. were made in order to maximize potency as HIV-integrase inhibitors against the wild type virus, a selection of mutants, and optimize the selectivity, pharmacokinetic, and metabolic profiles in preclin. species.  The good profile of Raltegravir has enabled its progression toward the end of phase III clin. trials for the treatment of HIV-1 infection and culminated with the FDA approval as the first HIV-integrase inhibitor for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYo6KKNjJRCrVg90H21EOLACvtfcHk0ljrbAeVmO9dLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM&md5=f90f994c7cd031a4063cbb3e91b4c3f0</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Raltegravir%252C%2520a%2520Potent%252C%2520Selective%2520Orally%2520Bioavailable%2520HIV-Integrase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520HIV-AIDS%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5843%26epage%3D5855%26doi%3D10.1021%2Fjm800245z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennis, J. E. J.</span>; <span class="NLM_string-name">Vandenberk, J.</span></span> <span> </span><span class="NLM_article-title">Novel 1,2-Benzisoxadol-3-yl and 1,2-Benzisothiazol-3-ylderivatives</span>. U.S. Patent <span class="NLM_patent">4,804,633</span>, <span class="NLM_year">1985</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&author=J.+E.+J.+Kennis&author=J.+Vandenberk&title=Novel+1%2C2-Benzisoxadol-3-yl+and+1%2C2-Benzisothiazol-3-ylderivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKennis%26aufirst%3DJ.%2BE.%2BJ.%26atitle%3DNovel%25201%252C2-Benzisoxadol-3-yl%2520and%25201%252C2-Benzisothiazol-3-ylderivatives%26date%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassel, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaldor, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwaltney, S. L.,  II</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Pyrimidinone and Pyrimidinedione Inhibitors of Dipeptidyl Peptidase IV</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1021/jm101016w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101016w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=510-524&author=Z.+Zhangauthor=M.+B.+Wallaceauthor=J.+Fengauthor=J.+A.+Staffordauthor=R.+J.+Skeneauthor=L.+Shiauthor=B.+Leeauthor=K.+Aertgeertsauthor=A.+Jenningsauthor=R.+Xuauthor=D.+B.+Kasselauthor=S.+W.+Kaldorauthor=M.+Navreauthor=D.+R.+Webbauthor=S.+L.+Gwaltney&title=Design+and+Synthesis+of+Pyrimidinone+and+Pyrimidinedione+Inhibitors+of+Dipeptidyl+Peptidase+IV&doi=10.1021%2Fjm101016w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV</span></div><div class="casAuthors">Zhang, Zhi-Yuan; Wallace, Michael B.; Feng, Jun; Stafford, Jeffrey A.; Skene, Robert J.; Shi, Li-Hong; Lee, Bum-Sup; Aertgeerts, Kathleen; Jennings, Andy; Xu, Rong-Da; Kassel, Daniel B.; Kaldor, Stephen W.; Navre, Marc; Webb, David R.; Gwaltney, Stephen L., II</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">510-524</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of two classes of heterocyclic dipeptidyl peptidase IV (DPP-4) inhibitors, pyrimidinones and pyrimidinediones, is described.  After a single oral dose, these potent, selective, and noncovalent inhibitors provide sustained redn. of plasma DPP-4 activity and lowering of blood glucose in animal models of diabetes.  Compds. I, II, and III were selected for development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxInStuMRjfbVg90H21EOLACvtfcHk0ljrbAeVmO9dLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtL7M&md5=7e3b66916acf243ad7943add0eaf6b1f</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Fjm101016w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101016w%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Pyrimidinone%2520and%2520Pyrimidinedione%2520Inhibitors%2520of%2520Dipeptidyl%2520Peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D510%26epage%3D524%26doi%3D10.1021%2Fjm101016w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Smith, T. D.</span>; <span class="NLM_string-name">Williams, S.</span>; <span class="NLM_string-name">Girlades, S.</span>; <span class="NLM_string-name">Toure, B.
B.</span>; <span class="NLM_string-name">Sendzik, M.</span></span> <span> </span><span class="NLM_article-title">N-azaspirocycloalkane Substituted N-Heteroaryl Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO <span class="NLM_patent">15107495</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+H.+Chen&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=R.+Karki&author=M.+Kato&author=M.+J.+LaMarche&author=L.+B.+Perez&author=T.+D.+Smith&author=S.+Williams&author=S.+Girlades&author=B.%0AB.+Toure&author=M.+Sendzik&title=N-azaspirocycloalkane+Substituted+N-Heteroaryl+Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DN-azaspirocycloalkane%2520Substituted%2520N-Heteroaryl%2520Compounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhalay, G.</span>; <span class="NLM_string-name">Culshaw, A. J.</span>; <span class="NLM_string-name">Dziadulewicz, E. K.</span>; <span class="NLM_string-name">Brain, C. T.</span>; <span class="NLM_string-name">Ritchie, T. J.</span>; <span class="NLM_string-name">Beattie, D.</span>; <span class="NLM_string-name">Bala, K.
J.</span>; <span class="NLM_string-name">Brewer, A.</span>; <span class="NLM_string-name">Hughes, G.</span></span> <span> </span><span class="NLM_article-title">Organic Compounds</span>. WO <span class="NLM_patent">2007/065662 A2</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+Bhalay&author=A.+J.+Culshaw&author=E.+K.+Dziadulewicz&author=C.+T.+Brain&author=T.+J.+Ritchie&author=D.+Beattie&author=K.%0AJ.+Bala&author=A.+Brewer&author=G.+Hughes&title=Organic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBhalay%26aufirst%3DG.%26atitle%3DOrganic%2520Compounds%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of Fluorine in Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+Fluorine+in+Medicinal+Chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lgfkebbov4lTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520Fluorine%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span> </span><span class="NLM_article-title">Dose Finding Study of TNO155 in Adult Patients
With Advanced Solid
Tumors</span>, <span class="NLM_publisher-name">ClinicalTrials.gov Identifier</span>: NCT03114319.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dose+Finding+Study+of+TNO155+in+Adult+Patients%0AWith+Advanced+Solid%0ATumors%2C+ClinicalTrials.gov+Identifier%3A+NCT03114319."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DDose%2520Finding%2520Study%2520of%2520TNO155%2520in%2520Adult%2520Patients%250AWith%2520Advanced%2520Solid%250ATumors%26pub%3DClinicalTrials.gov%2520Identifier" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/s0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2Fs0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgfkebbov4lTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2Fs0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P.</span>; <span class="NLM_string-name">Smart, O.
S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T. O.</span></span> <i>BUSTER</i>, version 2.8.0; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.%0AS.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development ofCoot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/s0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+ofCoot&doi=10.1107%2Fs0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lgfkebbov4lTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520ofCoot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2Fs0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kerstin Hiesinger, Dmitry Dar’in, Ewgenij Proschak, <span class="NLM_string-name hlFld-ContribAuthor">Mikhail Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 150-183. <a href="https://doi.org/10.1021/acs.jmedchem.0c01473" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01473%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BMedicinal%252BChemistry%26aulast%3DHiesinger%26aufirst%3DKerstin%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D24082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D150%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yelena Mostinski, Guus J. J. E. Heynen, Maria Pascual López-Alberca, Jerome Paul, Sandra Miksche, Silke Radetzki, David Schaller, Elena Shanina, Carola Seyffarth, Yuliya Kolomeets, Nandor Ziebart, Judith de Schryver, Sylvia Oestreich, Martin Neuenschwander, Yvette Roske, Udo Heinemann, Christoph Rademacher, Andrea Volkamer, Jens Peter von Kries, Walter Birchmeier, <span class="NLM_string-name hlFld-ContribAuthor">Marc Nazaré</span>. </span><span class="cited-content_cbyCitation_article-title">From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14780-14804. <a href="https://doi.org/10.1021/acs.jmedchem.0c01265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BPyrazolones%252Bto%252BAzaindoles%25253A%252BEvolution%252Bof%252BActive-Site%252BSHP2%252BInhibitors%252BBased%252Bon%252BScaffold%252BHopping%252Band%252BBioisosteric%252BReplacement%26aulast%3DMostinski%26aufirst%3DYelena%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D19112020%26volume%3D63%26issue%3D23%26spage%3D14780%26epage%3D14804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew J. LaMarche, Michael Acker, Andreea Argintaru, Daniel Bauer, Julie Boisclair, Homan Chan, Christine Hiu-Tung Chen, Ying-Nan Chen, Zhouliang Chen, Zhan Deng, Michael Dore, David Dunstan, Jianmei Fan, Peter Fekkes, Brant Firestone, Michelle Fodor, Jorge Garcia-Fortanet, Pascal D. Fortin, Cary Fridrich, John Giraldes, Meir Glick, Denise Grunenfelder, Huia-Xiang Hao, Martin Hentemann, Samuel Ho, Andriana Jouk, Zhao B. Kang, Rajesh Karki, Mitsunori Kato, Nick Keen, Robert Koenig, Laura R. LaBonte, Jay Larrow, Gang Liu, Shumei Liu, Dyuti Majumdar, Simon Mathieu, Matthew J. Meyer, Morvarid Mohseni, Rukundo Ntaganda, Mark Palermo, Lawrence Perez, Minying Pu, Timothy Ramsey, John Reilly, Patrick Sarver, William R. Sellers, Martin Sendzik, Michael D. Shultz, Joanna Slisz, Kelly Slocum, Troy Smith, Stanley Spence, Travis Stams, Christopher Straub, Victoriano Tamez, Jr., Bakary-Barry Toure, Christopher Towler, Ping Wang, Hongyun Wang, Sarah L. Williams, Fan Yang, Bing Yu, Ji-Hu Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Suzanne Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13578-13594. <a href="https://doi.org/10.1021/acs.jmedchem.0c01170" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01170%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BTNO155%25252C%252Ban%252BAllosteric%252BSHP2%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DLaMarche%26aufirst%3DMatthew%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D24092020%26date%3D10092020%26volume%3D63%26issue%3D22%26spage%3D13578%26epage%3D13594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinrui Yuan, Hong Bu, Jinpei Zhou, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Huibin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11368-11396. <a href="https://doi.org/10.1021/acs.jmedchem.0c00249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00249%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bof%252BSHP2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BCurrent%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D10062020%26date%3D27052020%26volume%3D63%26issue%3D20%26spage%3D11368%26epage%3D11396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bingsong Han, Francesco G. Salituro, <span class="NLM_string-name hlFld-ContribAuthor">Maria-Jesus Blanco</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1810-1819. <a href="https://doi.org/10.1021/acsmedchemlett.9b00655" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00655%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImpact%252Bof%252BAllosteric%252BModulation%252Bin%252BDrug%252BDiscovery%25253A%252BInnovation%252Bin%252BEmerging%252BChemical%252BModalities%26aulast%3DHan%26aufirst%3DBingsong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26122019%26date%3D10032020%26date%3D20032020%26date%3D10032020%26volume%3D11%26issue%3D10%26spage%3D1810%26epage%3D1819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingliang Wang, Jianfeng Lu, Mi Wang, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7510-7528. <a href="https://doi.org/10.1021/acs.jmedchem.0c00471" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00471%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSHP2-D26%252Bas%252Ba%252BFirst%25252C%252BPotent%25252C%252Band%252BEffective%252BPROTAC%252BDegrader%252Bof%252BSHP2%252BProtein%26aulast%3DWang%26aufirst%3DMingliang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20032020%26date%3D21052020%26volume%3D63%26issue%3D14%26spage%3D7510%26epage%3D7528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jeffrey
T. Bagdanoff, Zhouliang Chen, Michael Acker, Ying-Nan Chen, Homan Chan, Michael Dore, Brant Firestone, Michelle Fodor, Jorge Fortanet, Murphy Hentemann, Mitsunori Kato, Robert Koenig, Laura R. LaBonte, Shumei Liu, Movarid Mohseni, Rukundo Ntaganda, Patrick Sarver, Troy Smith, Martin Sendzik, Travis Stams, Stan Spence, Christopher Towler, Hongyun Wang, Ping Wang, Sarah L. Williams, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. LaMarche</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1781-1792. <a href="https://doi.org/10.1021/acs.jmedchem.8b01725" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01725%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BFused%252BBicyclic%252BAllosteric%252BSHP2%252BInhibitors%26aulast%3DBagdanoff%26aufirst%3DJeffrey%2BT.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D05112018%26date%3D08022019%26date%3D28012019%26volume%3D62%26issue%3D4%26spage%3D1781%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios  Chatzigoulas</span>, <span class="hlFld-ContribAuthor ">Zoe  Cournia</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of allosteric modulators: Challenges and successes. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2021,</strong> <em>17 </em><a href="https://doi.org/10.1002/wcms.1529" title="DOI URL">https://doi.org/10.1002/wcms.1529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1529%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DRational%252Bdesign%252Bof%252Ballosteric%252Bmodulators%25253A%252BChallenges%252Band%252Bsuccesses%26aulast%3DChatzigoulas%26aufirst%3DAlexios%26date%3D2021%26date%3D2021%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Guo</span>, <span class="hlFld-ContribAuthor ">Yaping  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (22)
                                     , 5504-5523. <a href="https://doi.org/10.1002/slct.202100186" title="DOI URL">https://doi.org/10.1002/slct.202100186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100186%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCross%252Bthe%252BUndruggable%252BBarrier%25252C%252Bthe%252BDevelopment%252Bof%252BSHP2%252BInhibitors%25253A%252BFrom%252BCatalytic%252BSite%252BInhibitors%252Bto%252BAllosteric%252BInhibitors%26aulast%3DGuo%26aufirst%3DYu%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D22%26spage%3D5504%26epage%3D5523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangbo  Yang</span>, <span class="hlFld-ContribAuthor ">Zhijia  Wang</span>, <span class="hlFld-ContribAuthor ">Yuan  Pei</span>, <span class="hlFld-ContribAuthor ">Ning  Song</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Bo  Feng</span>, <span class="hlFld-ContribAuthor ">Hanlin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaobei  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Qiu</span>, <span class="hlFld-ContribAuthor ">Huijin  Feng</span>, <span class="hlFld-ContribAuthor ">Yaxi  Yang</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113341. <a href="https://doi.org/10.1016/j.ejmech.2021.113341" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113341%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthalidomide-based%252BPROTAC%252Bsmall%252Bmolecules%252Bas%252Bthe%252Bhighly%252Befficient%252BSHP2%252Bdegraders%26aulast%3DYang%26aufirst%3DXiangbo%26date%3D2021%26volume%3D218%26spage%3D113341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. Lucas  Kerr</span>, <span class="hlFld-ContribAuthor ">Franziska  Haderk</span>, <span class="hlFld-ContribAuthor ">Trever G.  Bivona</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>62 </em>, 1-12. <a href="https://doi.org/10.1016/j.cbpa.2020.11.007" title="DOI URL">https://doi.org/10.1016/j.cbpa.2020.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2020.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2020.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DAllosteric%252BSHP2%252Binhibitors%252Bin%252Bcancer%25253A%252BTargeting%252Bthe%252Bintersection%252Bof%252BRAS%25252C%252Bresistance%25252C%252Band%252Bthe%252Bimmune%252Bmicroenvironment%26aulast%3DKerr%26aufirst%3DD.%2BLucas%26date%3D2021%26volume%3D62%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Nian</span>, <span class="hlFld-ContribAuthor ">Jinhao  Zeng</span>, <span class="hlFld-ContribAuthor ">Li  He</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Fernando  Rodrigues-Lima</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuanlin  Feng</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">A small molecule inhibitor targeting SHP2 mutations for the lung carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>32 </em>
                                    (5)
                                     , 1645-1652. <a href="https://doi.org/10.1016/j.cclet.2021.01.002" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DA%252Bsmall%252Bmolecule%252Binhibitor%252Btargeting%252BSHP2%252Bmutations%252Bfor%252Bthe%252Blung%252Bcarcinoma%26aulast%3DNian%26aufirst%3DQing%26date%3D2021%26volume%3D32%26issue%3D5%26spage%3D1645%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengzhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Canrong  Wu</span>, <span class="hlFld-ContribAuthor ">Kaiyin  Yang</span>, <span class="hlFld-ContribAuthor ">Qiqi  Wang</span>, <span class="hlFld-ContribAuthor ">Yirong  Zhou</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Novel PROTACs for degradation of SHP2 protein. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104788. <a href="https://doi.org/10.1016/j.bioorg.2021.104788" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104788%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252BPROTACs%252Bfor%252Bdegradation%252Bof%252BSHP2%252Bprotein%26aulast%3DZheng%26aufirst%3DMengzhu%26date%3D2021%26volume%3D110%26spage%3D104788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Dong</span>, <span class="hlFld-ContribAuthor ">Da  Han</span>, <span class="hlFld-ContribAuthor ">Xinyi  Meng</span>, <span class="hlFld-ContribAuthor ">Mengchuan  Xu</span>, <span class="hlFld-ContribAuthor ">Chuwen  Zheng</span>, <span class="hlFld-ContribAuthor ">Qin  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Activating Mutation of SHP2 Establishes a Tumorigenic Phonotype Through Cell-Autonomous and Non-Cell-Autonomous Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fcell.2021.630712" title="DOI URL">https://doi.org/10.3389/fcell.2021.630712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2021.630712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2021.630712%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DActivating%252BMutation%252Bof%252BSHP2%252BEstablishes%252Ba%252BTumorigenic%252BPhonotype%252BThrough%252BCell-Autonomous%252Band%252BNon-Cell-Autonomous%252BMechanisms%26aulast%3DDong%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingwei  Wu</span>, <span class="hlFld-ContribAuthor ">Weiya  Li</span>, <span class="hlFld-ContribAuthor ">Zhihui  Zheng</span>, <span class="hlFld-ContribAuthor ">Xinhua  Lu</span>, <span class="hlFld-ContribAuthor ">Huan  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Runling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation, common feature pharmacophore model and molecular dynamics simulation studies of ethyl 4-(phenoxymethyl)-2-phenylthiazole-5-carboxylate as Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (4)
                                     , 1174-1188. <a href="https://doi.org/10.1080/07391102.2020.1726817" title="DOI URL">https://doi.org/10.1080/07391102.2020.1726817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1726817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1726817%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Bcommon%252Bfeature%252Bpharmacophore%252Bmodel%252Band%252Bmolecular%252Bdynamics%252Bsimulation%252Bstudies%252Bof%252Bethyl%252B4-%252528phenoxymethyl%252529-2-phenylthiazole-5-carboxylate%252Bas%252BSrc%252Bhomology-2%252Bdomain%252Bcontaining%252Bprotein%252Btyrosine%252Bphosphatase-2%252B%252528SHP2%252529%252Binhibitors%26aulast%3DWu%26aufirst%3DJingwei%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D4%26spage%3D1174%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities – A comprehensive review. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (3)
                                     , 721-773. <a href="https://doi.org/10.1111/cbdd.13807" title="DOI URL">https://doi.org/10.1111/cbdd.13807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13807%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DEmerging%252Bchemical%252Bscaffolds%252Bwith%252Bpotential%252BSHP2%252Bphosphatase%252Binhibitory%252Bcapabilities%252B%2525E2%252580%252593%252BA%252Bcomprehensive%252Breview%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D3%26spage%3D721%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Liu</span>, <span class="hlFld-ContribAuthor ">Shan  Gao</span>, <span class="hlFld-ContribAuthor ">Reham M.  Elhassan</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to overcome drug resistance using SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>27 </em><a href="https://doi.org/10.1016/j.apsb.2021.03.037" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.037%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DStrategies%252Bto%252Bovercome%252Bdrug%252Bresistance%252Busing%252BSHP2%252Binhibitors%26aulast%3DLiu%26aufirst%3DMeng%26date%3D2021%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaohe  Yang</span>, <span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Yueying  Yang</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a therapeutic strategy for inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113264. <a href="https://doi.org/10.1016/j.ejmech.2021.113264" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113264%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252Binflammatory%252Bdiseases%26aulast%3DLiu%26aufirst%3DYang%26date%3D2021%26volume%3D214%26spage%3D113264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhendong  Song</span>, <span class="hlFld-ContribAuthor ">Meijing  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Ge</span>, <span class="hlFld-ContribAuthor ">Xue-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Ziyang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 13-29. <a href="https://doi.org/10.1016/j.apsb.2020.07.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.07.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.07.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Bin%252Btumor-targeted%252Btherapies%26aulast%3DSong%26aufirst%3DZhendong%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D13%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Liu</span>, <span class="hlFld-ContribAuthor ">Hengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Hongyun  Wang</span>, <span class="hlFld-ContribAuthor ">Alice  Loo</span>, <span class="hlFld-ContribAuthor ">Xiamei  Zhang</span>, <span class="hlFld-ContribAuthor ">Guizhi  Yang</span>, <span class="hlFld-ContribAuthor ">Colleen  Kowal</span>, <span class="hlFld-ContribAuthor ">Scott  Delach</span>, <span class="hlFld-ContribAuthor ">Ye  Wang</span>, <span class="hlFld-ContribAuthor ">Silvia  Goldoni</span>, <span class="hlFld-ContribAuthor ">William D.  Hastings</span>, <span class="hlFld-ContribAuthor ">Karrie  Wong</span>, <span class="hlFld-ContribAuthor ">Hui  Gao</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Meyer</span>, <span class="hlFld-ContribAuthor ">Susan E.  Moody</span>, <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>, <span class="hlFld-ContribAuthor ">Juliet A.  Williams</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>, <span class="hlFld-ContribAuthor ">Tinya J.  Abrams</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Giordano  Caponigro</span>, <span class="hlFld-ContribAuthor ">Huai-Xiang  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2021,</strong> <em>27 </em>
                                    (1)
                                     , 342-354. <a href="https://doi.org/10.1158/1078-0432.CCR-20-2718" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-20-2718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-20-2718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-20-2718%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DCombinations%252Bwith%252BAllosteric%252BSHP2%252BInhibitor%252BTNO155%252Bto%252BBlock%252BReceptor%252BTyrosine%252BKinase%252BSignaling%26aulast%3DLiu%26aufirst%3DChen%26date%3D2021%26date%3D2020%26volume%3D27%26issue%3D1%26spage%3D342%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">祥东  孟</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Evaluation of Aminobenzoic Acid Derivatives against SHP2. </span><span class="cited-content_cbyCitation_journal-name">Hans Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>09 </em>
                                    (02)
                                     , 87-93. <a href="https://doi.org/10.12677/HJMCe.2021.92011" title="DOI URL">https://doi.org/10.12677/HJMCe.2021.92011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/HJMCe.2021.92011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FHJMCe.2021.92011%26sid%3Dliteratum%253Aachs%26jtitle%3DHans%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiological%252BEvaluation%252Bof%252BAminobenzoic%252BAcid%252BDerivatives%252Bagainst%252BSHP2%26aulast%3D%25E5%25AD%259F%26aufirst%3D%25E7%25A5%25A5%25E4%25B8%259C%26date%3D2021%26volume%3D09%26issue%3D02%26spage%3D87%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arafa  Musa</span>, <span class="hlFld-ContribAuthor ">Abeer H  Elmaidomy</span>, <span class="hlFld-ContribAuthor ">Ahmed M  Sayed</span>, <span class="hlFld-ContribAuthor ">Sami I  Alzarea</span>, <span class="hlFld-ContribAuthor ">Mohammad M  Al-Sanea</span>, <span class="hlFld-ContribAuthor ">Ehab M  Mostafa</span>, <span class="hlFld-ContribAuthor ">Omina Magdy  Hendawy</span>, <span class="hlFld-ContribAuthor ">Mohamed A  Abdelgawad</span>, <span class="hlFld-ContribAuthor ">Khayrya A  Youssif</span>, <span class="hlFld-ContribAuthor ">Hesham  Refaat</span>, <span class="hlFld-ContribAuthor ">Eman  Alaaeldin</span>, <span class="hlFld-ContribAuthor ">Usama Ramadan  Abdelmohsen</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxic Potential, Metabolic Profiling, and Liposomes of Coscinoderma sp. Crude Extract Supported by in silico Analysis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Nanomedicine</span><span> <strong>2021,</strong> <em>Volume 16 </em>, 3861-3874. <a href="https://doi.org/10.2147/IJN.S310720" title="DOI URL">https://doi.org/10.2147/IJN.S310720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/IJN.S310720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FIJN.S310720%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Nanomedicine%26atitle%3DCytotoxic%252BPotential%25252C%252BMetabolic%252BProfiling%25252C%252Band%252BLiposomes%252Bof%252BCoscinoderma%252Bsp.%252BCrude%252BExtract%252BSupported%252Bby%252Bin%252Bsilico%252BAnalysis%26aulast%3DMusa%26aufirst%3DArafa%26date%3D2021%26date%3D2021%26volume%3DVolume%252016%26spage%3D3861%26epage%3D3874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Tang</span>, <span class="hlFld-ContribAuthor ">Yao-Nan  Jia</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112657. <a href="https://doi.org/10.1016/j.ejmech.2020.112657" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112657%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Band%252BPROTAC%252Bdegraders%26aulast%3DTang%26aufirst%3DKai%26date%3D2020%26volume%3D204%26spage%3D112657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dadong  Shen</span>, <span class="hlFld-ContribAuthor ">Wenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guofeng  Wu</span>, <span class="hlFld-ContribAuthor ">Runpu  Shen</span>, <span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of targeting SHP2 in human developmental disorders and cancers. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112117. <a href="https://doi.org/10.1016/j.ejmech.2020.112117" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112117%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bpotential%252Bof%252Btargeting%252BSHP2%252Bin%252Bhuman%252Bdevelopmental%252Bdisorders%252Band%252Bcancers%26aulast%3DShen%26aufirst%3DDadong%26date%3D2020%26volume%3D190%26spage%3D112117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianqian  Liu</span>, <span class="hlFld-ContribAuthor ">Jiao  Qu</span>, <span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a promising strategy for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>152 </em>, 104595. <a href="https://doi.org/10.1016/j.phrs.2019.104595" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104595%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Bpromising%252Bstrategy%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DLiu%26aufirst%3DQianqian%26date%3D2020%26volume%3D152%26spage%3D104595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Chen  Liu</span>, <span class="hlFld-ContribAuthor ">Hung  Huynh</span>, <span class="hlFld-ContribAuthor ">Thi Bich Uyen  Le</span>, <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>, <span class="hlFld-ContribAuthor ">Giordano  Caponigro</span>, <span class="hlFld-ContribAuthor ">Huai-Xiang  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 265-281. <a href="https://doi.org/10.18632/oncotarget.27435" title="DOI URL">https://doi.org/10.18632/oncotarget.27435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.27435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.27435%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DResistance%252Bto%252Ballosteric%252BSHP2%252Binhibition%252Bin%252BFGFR-driven%252Bcancers%252Bthrough%252Brapid%252Bfeedback%252Bactivation%252Bof%252BFGFR%26aulast%3DLu%26aufirst%3DHengyu%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D3%26spage%3D265%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bohee  Kim</span>, <span class="hlFld-ContribAuthor ">Seungjin  Jo</span>, <span class="hlFld-ContribAuthor ">Sung Bum  Park</span>, <span class="hlFld-ContribAuthor ">Chong Hak  Chae</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>, <span class="hlFld-ContribAuthor ">Byumseok  Koh</span>, <span class="hlFld-ContribAuthor ">Inji  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and structure-activity relationship study of SHP2 inhibitor containing 3,4,6-trihydroxy-5-oxo-5H-benzo[7]annulene. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (1)
                                     , 126756. <a href="https://doi.org/10.1016/j.bmcl.2019.126756" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126756%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Band%252Bstructure-activity%252Brelationship%252Bstudy%252Bof%252BSHP2%252Binhibitor%252Bcontaining%252B3%25252C4%25252C6-trihydroxy-5-oxo-5H-benzo%25255B7%25255Dannulene%26aulast%3DKim%26aufirst%3DBohee%26date%3D2020%26volume%3D30%26issue%3D1%26spage%3D126756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">勃  冯</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Evaluation of Benzo[c]heterocyclic Compounds against SHP2. </span><span class="cited-content_cbyCitation_journal-name">Hans Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>08 </em>
                                    (03)
                                     , 79-83. <a href="https://doi.org/10.12677/HJMCe.2020.83009" title="DOI URL">https://doi.org/10.12677/HJMCe.2020.83009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/HJMCe.2020.83009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FHJMCe.2020.83009%26sid%3Dliteratum%253Aachs%26jtitle%3DHans%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiological%252BEvaluation%252Bof%252BBenzo%25255Bc%25255Dheterocyclic%252BCompounds%252Bagainst%252BSHP2%26aulast%3D%25E5%2586%25AF%26aufirst%3D%25E5%258B%2583%26date%3D2020%26volume%3D08%26issue%3D03%26spage%3D79%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panagiotis  Parsonidis</span>, <span class="hlFld-ContribAuthor ">Mahammad  Shaik</span>, <span class="hlFld-ContribAuthor ">Athanasia Panagiota  Serafeim</span>, <span class="hlFld-ContribAuthor ">Ioanna  Vlachou</span>, <span class="hlFld-ContribAuthor ">Vasiliki  Daikopoulou</span>, <span class="hlFld-ContribAuthor ">Ioannis  Papasotiriou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Activity of Pyrazine Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (23)
                                     , 4389. <a href="https://doi.org/10.3390/molecules24234389" title="DOI URL">https://doi.org/10.3390/molecules24234389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24234389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24234389%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BActivity%252Bof%252BPyrazine%252BCompounds%26aulast%3DParsonidis%26aufirst%3DPanagiotis%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D23%26spage%3D4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Design of pyrimidinones <b>4</b> from pyrazine (<b>2</b>) and pyrazolo-pyrimidinone (<b>3</b>). (B) Overlay of X-ray of <b>2</b>-SHP2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>) and <b>3</b>-SHP2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a>) in the allosteric binding pocket of SHP2. (C) Amine region overlay: X-ray of <b>2</b>-SHP2 and <b>3</b>-SHP2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Thioether-azabenzimidazole HTS hit <b>5</b> and thioether-pyrimidinones <b>6</b> and <b>7</b>. (B) X-ray of <b>7</b> and SHP2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD7">6MD7</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PK-PD of <b>8</b> in KYSE520 tumor-implanted immunocompromised mice at 10, 30, and 100 mg/kg. (A) p-ERK modulation in the KYSE520 model. (B) DUSP6 modulation in the KYSE520 model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-Methylamino Pyrimidinone <b>1</b>: (a) Amine, BOP, DBU, DMF, RT, 3 Days, 59% Yield (b) Boc<sub>2</sub>O, DIPEA, DMF, RT, 1 h, (c) NIS, DMF, RT, 10 min, 39% Yield (2 Steps) (d) ArSH, CuI, TMEDA, K<sub>3</sub>PO<sub>4</sub>, 1,4-Dioxane, 100 °C, 1.5 h, and (e) TFA, DCM, 3 h, 51% Yield (2 Steps)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/medium/jm-2018-017268_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PK/PD and efficacy of <b>1</b> in the pharyngeal carcinoma Detroit-562 xenograft model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01726/20190221/images/large/jm-2018-017268_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01726&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehler, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Burgt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ion, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalidas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patton, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Mutations in <i>Ptpn11</i>, Encoding the Protein Tyrosine Phosphatase SHP-2, Cause Noonan syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">468</span>, <span class="refDoi"> DOI: 10.1038/ng772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-468&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+van+der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=M.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+Ptpn11%2C+Encoding+the+Protein+Tyrosine+Phosphatase+SHP-2%2C+Cause+Noonan+syndrome&doi=10.1038%2Fng772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0lhzoJPpFTMmXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DM.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520Ptpn11%252C%2520Encoding%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%252C%2520Cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D468%26doi%3D10.1038%2Fng772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemeyer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hählen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/ng1156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+H%C3%A4hlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+mutations+in+PTPN11+in+juvenile+myelomonocytic+leukemia%2C+myelodysplastic+syndromes+and+acute+myeloid+leukemia&doi=10.1038%2Fng1156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0lhzoJPpFTMmXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DH%25C3%25A4hlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520mutations%2520in%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%252C%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150%26doi%3D10.1038%2Fng1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mulero-Navarro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevilla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riess, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaniel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baccarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavé, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strullu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalcin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhandapany, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yongchao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahieg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flex, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemischka, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11 -Associated Juvenile Myelomonocytic Leukemia</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">515</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.celrep.2015.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=26456833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=504-515&author=S.+Mulero-Navarroauthor=A.+Sevillaauthor=A.+C.+Romanauthor=D.-F.+Leeauthor=S.+L.+D%E2%80%99Souzaauthor=S.+Pardoauthor=I.+Riessauthor=J.+Suauthor=N.+Cohenauthor=C.+Schanielauthor=N.+A.+Rodriguezauthor=A.+Baccariniauthor=B.+D.+Brownauthor=H.+Cav%C3%A9author=A.+Cayeauthor=M.+Strulluauthor=S.+Yalcinauthor=C.+Y.+Parkauthor=P.+S.+Dhandapanyauthor=G.+Yongchaoauthor=L.+Edelmannauthor=S.+Bahiegauthor=P.+Raynalauthor=E.+Flexauthor=M.+Tartagliaauthor=K.+A.+Mooreauthor=I.+R.+Lemischkaauthor=B.+D.+Gelb&title=Myeloid+Dysregulation+in+a+Human+Induced+Pluripotent+Stem+Cell+Model+of+PTPN11+-Associated+Juvenile+Myelomonocytic+Leukemia&doi=10.1016%2Fj.celrep.2015.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia</span></div><div class="casAuthors">Mulero-Navarro, Sonia; Sevilla, Ana; Roman, Angel C.; Lee, Dung-Fang; D'Souza, Sunita L.; Pardo, Sherly; Riess, Ilan; Su, Jie; Cohen, Ninette; Schaniel, Christoph; Rodriguez, Nelson A.; Baccarini, Alessia; Brown, Brian D.; Cave, Helene; Caye, Aurelie; Strullu, Marion; Yalcin, Safak; Park, Christopher Y.; Dhandapany, Perundurai S.; Yongchao, Ge; Edelmann, Lisa; Bahieg, Sawsan; Raynal, Patrick; Flex, Elisabetta; Tartaglia, Marco; Moore, Kateri A.; Lemischka, Ihor R.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">504-515</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Somatic PTPN11 mutations cause juvenile myelomonocytic leukemia (JMML).  Germline PTPN11 defects cause Noonan syndrome (NS), and specific inherited mutations cause NS/JMML.  Here, we report that hematopoietic cells differentiated from human induced pluripotent stem cells (hiPSCs) harboring NS/JMML-causing PTPN11 mutations recapitulated JMML features.  HiPSC-derived NS/JMML myeloid cells exhibited increased signaling through STAT5 and upregulation of miR-223 and miR-15a.  Similarly, miR-223 and miR-15a were upregulated in 11/19 JMML bone marrow mononuclear cells harboring PTPN11 mutations, but not those without PTPN11 defects.  Reducing miR-223's function in NS/JMML hiPSCs normalized myelogenesis.  MicroRNA target gene expression levels were reduced in hiPSC-derived myeloid cells as well as in JMML cells with PTPN11 mutations.  Thus, studying an inherited human cancer syndrome with hiPSCs illuminated early oncogenesis prior to the accumulation of secondary genomic alterations, enabling us to discover microRNA dysregulation, establishing a genotype-phenotype assocn. for JMML and providing therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY4KSRRWwnr7Vg90H21EOLACvtfcHk0li0P412CUF-MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjM&md5=a572b0d257818fc6510cdf2f81297834</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DMulero-Navarro%26aufirst%3DS.%26aulast%3DSevilla%26aufirst%3DA.%26aulast%3DRoman%26aufirst%3DA.%2BC.%26aulast%3DLee%26aufirst%3DD.-F.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DS.%2BL.%26aulast%3DPardo%26aufirst%3DS.%26aulast%3DRiess%26aufirst%3DI.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DN.%26aulast%3DSchaniel%26aufirst%3DC.%26aulast%3DRodriguez%26aufirst%3DN.%2BA.%26aulast%3DBaccarini%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DB.%2BD.%26aulast%3DCav%25C3%25A9%26aufirst%3DH.%26aulast%3DCaye%26aufirst%3DA.%26aulast%3DStrullu%26aufirst%3DM.%26aulast%3DYalcin%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DC.%2BY.%26aulast%3DDhandapany%26aufirst%3DP.%2BS.%26aulast%3DYongchao%26aufirst%3DG.%26aulast%3DEdelmann%26aufirst%3DL.%26aulast%3DBahieg%26aufirst%3DS.%26aulast%3DRaynal%26aufirst%3DP.%26aulast%3DFlex%26aufirst%3DE.%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DK.%2BA.%26aulast%3DLemischka%26aufirst%3DI.%2BR.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMyeloid%2520Dysregulation%2520in%2520a%2520Human%2520Induced%2520Pluripotent%2520Stem%2520Cell%2520Model%2520of%2520PTPN11%2520-Associated%2520Juvenile%2520Myelomonocytic%2520Leukemia%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D13%26spage%3D504%26epage%3D515%26doi%3D10.1016%2Fj.celrep.2015.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bentires-Alj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paez, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilhack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maris, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugarbaker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Activating Mutations of the Noonan Syndrome-AssociatedSHP2/PTPN11Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">8816</span>– <span class="NLM_lpage">8820</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-04-1923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1158%2F0008-5472.can-04-1923" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-8820&author=M.+Bentires-Aljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbakerauthor=W.+G.+Richardsauthor=J.+Duauthor=L.+Girardauthor=J.+D.+Minnaauthor=M.+L.+Lohauthor=D.+E.+Fisherauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=M.+Meyersonauthor=W.+R.+Sellersauthor=B.+G.+Neel&title=Activating+Mutations+of+the+Noonan+Syndrome-AssociatedSHP2%2FPTPN11Gene+in+Human+Solid+Tumors+and+Adult+Acute+Myelogenous+Leukemia&doi=10.1158%2F0008-5472.can-04-1923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DActivating%2520Mutations%2520of%2520the%2520Noonan%2520Syndrome-AssociatedSHP2%252FPTPN11Gene%2520in%2520Human%2520Solid%2520Tumors%2520and%2520Adult%2520Acute%2520Myelogenous%2520Leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D8820%26doi%3D10.1158%2F0008-5472.can-04-1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaitzidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+tyrosine+phosphatase+Shp2+%28PTPN11%29+in+cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0ljbOZlWlZ2oBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520tyrosine%2520phosphatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yomogita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatakeyama, M.</span></span> <span> </span><span class="NLM_article-title">Isolation of a Distinct Class of Gain-of-Function SHP-2 mutants with Oncogenic RAS-like Transforming Activity From Solid Tumors</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3508</span>– <span class="NLM_lpage">3515</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1211019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+Distinct+Class+of+Gain-of-Function+SHP-2+mutants+with+Oncogenic+RAS-like+Transforming+Activity+From+Solid+Tumors&doi=10.1038%2Fsj.onc.1211019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0ljbOZlWlZ2oBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520Distinct%2520Class%2520of%2520Gain-of-Function%2520SHP-2%2520mutants%2520with%2520Oncogenic%2520RAS-like%2520Transforming%2520Activity%2520From%2520Solid%2520Tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515%26doi%3D10.1038%2Fsj.onc.1211019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, L.</span></span> <span> </span><span class="NLM_article-title">The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/s0968-0004(03)00091-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fs0968-0004%2803%2900091-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%98Shp%E2%80%99ing+news%3A+SH2+domain-containing+tyrosine+phosphatases+in+cell+signaling&doi=10.1016%2Fs0968-0004%2803%2900091-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fs0968-0004%2803%2900091-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0968-0004%252803%252900091-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2598Shp%25E2%2580%2599ing%2520news%253A%2520SH2%2520domain-containing%2520tyrosine%2520phosphatases%2520in%2520cell%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293%26doi%3D10.1016%2Fs0968-0004%2803%2900091-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, G. S.</span></span> <span> </span><span class="NLM_article-title">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">867</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-07-028829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1182%2Fblood-2006-07-028829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=17053061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+first+identified+proto-oncogene+that+encodes+a+tyrosine+phosphatase&doi=10.1182%2Fblood-2006-07-028829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span></div><div class="casAuthors">Chan, Rebecca J.; Feng, Gen-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-867</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Elucidation of the mol. mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes.  One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homol. 2 (SH2) domains (Shp2).  This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis.  More recently, somatic missense PTPN11 gain-of-function mutations were detected in leukemias and rarely in solid tumors, and were found to induce aberrant hyperactivation of the Ras-Erk pathway.  This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the mol. mechanisms underlying cell transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqsuOora-d37Vg90H21EOLACvtfcHk0li9UYs4tys4Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D&md5=8c5760a6ac385635f9794acbf5b64a03</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-028829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-028829%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520first%2520identified%2520proto-oncogene%2520that%2520encodes%2520a%2520tyrosine%2520phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867%26doi%3D10.1182%2Fblood-2006-07-028829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tiganis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, A. M.</span></span> <span> </span><span class="NLM_article-title">Protein tyrosine phosphatase function: the substrate perspective</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1042/bj20061548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1042%2Fbj20061548" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2007&pages=1-15&author=T.+Tiganisauthor=A.+M.+Bennett&title=Protein+tyrosine+phosphatase+function%3A+the+substrate+perspective&doi=10.1042%2Fbj20061548"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1042%2Fbj20061548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20061548%26sid%3Dliteratum%253Aachs%26aulast%3DTiganis%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DA.%2BM.%26atitle%3DProtein%2520tyrosine%2520phosphatase%2520function%253A%2520the%2520substrate%2520perspective%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D402%26spage%3D1%26epage%3D15%26doi%3D10.1042%2Fbj20061548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jie, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildener-Leapman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R. L.</span></span> <span> </span><span class="NLM_article-title">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-14-1215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1158%2F0008-5472.can-14-1215" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=508-518&author=J.+Liauthor=H.-B.+Jieauthor=Y.+Leiauthor=N.+Gildener-Leapmanauthor=S.+Trivediauthor=T.+Greenauthor=L.+P.+Kaneauthor=R.+L.+Ferris&title=PD-1%2FSHP-2+Inhibits+Tc1%2FTh1+Phenotypic+Responses+and+the+Activation+of+T+Cells+in+the+Tumor+Microenvironment&doi=10.1158%2F0008-5472.can-14-1215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-14-1215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-14-1215%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJie%26aufirst%3DH.-B.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DGildener-Leapman%26aufirst%3DN.%26aulast%3DTrivedi%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DT.%26aulast%3DKane%26aufirst%3DL.%2BP.%26aulast%3DFerris%26aufirst%3DR.%2BL.%26atitle%3DPD-1%252FSHP-2%2520Inhibits%2520Tc1%252FTh1%2520Phenotypic%2520Responses%2520and%2520the%2520Activation%2520of%2520T%2520Cells%2520in%2520the%2520Tumor%2520Microenvironment%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D75%26spage%3D508%26epage%3D518%26doi%3D10.1158%2F0008-5472.can-14-1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasmal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vale, R. D.</span></span> <span> </span><span class="NLM_article-title">T Cell Costimulatory Receptor CD28 is a Primary Target for PD-1-Mediated Inhibition</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1428</span>– <span class="NLM_lpage">1433</span>, <span class="refDoi"> DOI: 10.1126/science.aafl29210.1126/science.aaf1292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1126%2Fscience.aafl29210.1126%2Fscience.aaf1292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=28280247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVWhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2017&pages=1428-1433&author=E.+Huiauthor=J.+Cheungauthor=J.+Zhuauthor=X.+Suauthor=M.+J.+Taylorauthor=H.+A.+Wallweberauthor=D.+K.+Sasmalauthor=J.+Huangauthor=J.+M.+Kimauthor=I.+Mellmanauthor=R.+D.+Vale&title=T+Cell+Costimulatory+Receptor+CD28+is+a+Primary+Target+for+PD-1-Mediated+Inhibition&doi=10.1126%2Fscience.aafl29210.1126%2Fscience.aaf1292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition</span></div><div class="casAuthors">Hui, Enfu; Cheung, Jeanne; Zhu, Jing; Su, Xiaolei; Taylor, Marcus J.; Wallweber, Heidi A.; Sasmal, Dibyendu K.; Huang, Jun; Kim, Jeong M.; Mellman, Ira; Vale, Ronald D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6332</span>),
    <span class="NLM_cas:pages">1428-1433</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">PD-1-targeted therapies have been a breakthrough for treating certain tumors and can rejuvenate T cells to unleash the anticancer immune response (see the Perspective by Clouthier and Ohashi).  It is widely believed that PD-1 suppresses signaling through the T cell receptor (TCR).  However, Hui et al. find instead that the TCR costimulatory receptor, CD28, is the primary target of PD-1 signaling.  Independently, Kamphorst et al. show that CD28 is required for PD-1 therapies to kill cancer cells efficiently and eliminate chronic viral infections in mice.  Lung cancer patients that responded to PD-1 therapy had more CD28+ T cells, which suggests that CD28 may predict treatment response.  Science, ibid p. 1428, p. 1423; see also p. 1373.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM_s4cf1lkxrVg90H21EOLACvtfcHk0li9UYs4tys4Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVWhu7g%253D&md5=69750b99b68316ee035a0b7eeddfb9fa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.aafl29210.1126%2Fscience.aaf1292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aafl29210.1126%252Fscience.aaf1292%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DE.%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DSasmal%26aufirst%3DD.%2BK.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DVale%26aufirst%3DR.%2BD.%26atitle%3DT%2520Cell%2520Costimulatory%2520Receptor%2520CD28%2520is%2520a%2520Primary%2520Target%2520for%2520PD-1-Mediated%2520Inhibition%26jtitle%3DScience%26date%3D2017%26volume%3D355%26spage%3D1428%26epage%3D1433%26doi%3D10.1126%2Fscience.aafl29210.1126%2Fscience.aaf1292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overduin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatase SHP2 for Therapeutic Intervention</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1423</span>– <span class="NLM_lpage">1437</span>, <span class="refDoi"> DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+Protein+Tyrosine+Phosphatase+SHP2+for+Therapeutic+Intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0lh2SRSIp5gP2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520for%2520Therapeutic%2520Intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, M. L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1124/mol.106.025536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1124%2Fmol.106.025536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=16717135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=562-570&author=L.+Chenauthor=S.-S.+Sungauthor=M.+L.+R.+Yipauthor=H.+R.+Lawrenceauthor=Y.+Renauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Discovery+of+a+Novel+Shp2+Protein+Tyrosine+Phosphatase+Inhibitor&doi=10.1124%2Fmol.106.025536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor</span></div><div class="casAuthors">Chen, Liwei; Sung, Shen-Shu; Yip, M. L. Richard; Lawrence, Harshani R.; Ren, Yuan; Guida, Wayne C.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">562-570</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Shp2 is a non-receptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene.  It is involved in growth factor-induced activation of mitogen-activated protein (MAP) kinases Erk1 and Erk2 (Erk1/2) and has been implicated in the pathogenicity of the oncogenic bacterium Helicobacter pylori.  Moreover, gain-of-function Shp2 mutations have been found in childhood leukemias and Noonan syndrome.  Thus, small mol. Shp2 PTP inhibitors are much needed reagents for evaluation of Shp2 as a therapeutic target and for chem. biol. studies of Shp2 function.  By screening the National Cancer Institute (NCI) Diversity Set chem. library, we identified 8-hydroxy-7-(6-sulfonaphthalen-2-yl)diazenyl-quinoline-5-sulfonic acid (NSC-87877) as a potent Shp2 PTP inhibitor.  Mol. modeling and site-directed mutagenesis studies suggested that NSC-87877 binds to the catalytic cleft of Shp2 PTP.  NSC-87877 cross-inhibited Shp1 in vitro, but it was selective for Shp2 over other PTPs (PTP1B, HePTP, DEP1, CD45, and LAR).  It is noteworthy that NSC-87877 inhibited epidermal growth factor (EGF)-induced activation of Shp2 PTP, Ras, and Erk1/2 in cell cultures but did not block EGF-induced Gab1 tyrosine phosphorylation or Gab1-Shp2 assocn.  Furthermore, NSC-87877 inhibited Erk1/2 activation by a Gab1-Shp2 chimera but did not affect the Shp2-independent Erk1/2 activation by phorbol 12-myristate 13-acetate.  These results identified NSC-87877 as the first PTP inhibitor capable of inhibiting Shp2 PTP in cell cultures without a detectable off-target effect.  Our study also provides the first pharmacol. evidence that Shp2 mediates EGF-induced Erk1/2 MAP kinase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4XVGUjw3W7Vg90H21EOLACvtfcHk0lh2SRSIp5gP2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D&md5=a2ce03150ecbe6937876bb292ced30dc</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025536%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSung%26aufirst%3DS.-S.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Shp2%2520Protein%2520Tyrosine%2520Phosphatase%2520Inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D562%26epage%3D570%26doi%3D10.1124%2Fmol.106.025536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">17626</span>, <span class="refDoi"> DOI: 10.1038/srep17626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fsrep17626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=26626996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=17626&author=C.+Chenauthor=M.+Caoauthor=S.+Zhuauthor=C.+Wangauthor=F.+Liangauthor=L.+Yanauthor=D.+Luo&title=Discovery+of+a+Novel+Inhibitor+of+the+Protein+Tyrosine+Phosphatase+Shp2&doi=10.1038%2Fsrep17626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2</span></div><div class="casAuthors">Chen, Chuan; Cao, Mengmeng; Zhu, Siyu; Wang, Cuicui; Liang, Fan; Yan, Leilei; Luo, Duqiang</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17626</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Shp2 is a ubiquitously expressed protein tyrosine phosphatase (PTP) related to adult acute myelogenous leukemia and human solid tumors.  In this report, we describe identification of a potent Shp2 inhibitor, Fumosorinone (Fumos) from entomogenous fungi, which shows selective inhibition of Shp2 over other tested PTPs.  Using a surface plasmon resonance anal., we further confirmed the phys. interaction between Shp2 and Fumos.  Fumos inhibits Shp2-dependent activation of the Ras/ERK signal pathway downstream of EGFR, and interrupts EGF-induced Gab1-Shp2 assocn.  As expected, Fumos shows little effects on the Shp2-independent ERK1/2 activation induced by PMA or oncogenic Ras.  Furthermore, Fumos down-regulates Src activation, inhibits phosphorylation of Paxillin and prevents tumor cell invasion.  These results suggest that Fumos can inhibit Shp2-dependent cell signaling in human cells and has a potential for treatment of Shp2-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoswqt5Y98UCrVg90H21EOLACvtfcHk0lh2SRSIp5gP2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bN&md5=ae7d1a3adf914820e57a2862ade65cf7</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fsrep17626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep17626%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Inhibitor%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520Shp2%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D17626%26doi%3D10.1038%2Fsrep17626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, D.</span></span> <span> </span><span class="NLM_article-title">Identification of demethylincisterol A 3 as a selective inhibitor of protein tyrosine phosphatase Shp2</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>795</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2016.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.ejphar.2016.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=27939989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyitrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=795&publication_year=2017&pages=124-133&author=C.+Chenauthor=F.+Liangauthor=B.+Chenauthor=Z.+Sunauthor=T.+Xueauthor=R.+Yangauthor=D.+Luo&title=Identification+of+demethylincisterol+A+3+as+a+selective+inhibitor+of+protein+tyrosine+phosphatase+Shp2&doi=10.1016%2Fj.ejphar.2016.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of demethylincisterol A3 as a selective inhibitor of protein tyrosine phosphatase Shp2</span></div><div class="casAuthors">Chen, Chuan; Liang, Fan; Chen, Bo; Sun, Zhongyi; Xue, Tongdan; Yang, Runlei; Luo, Duqiang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">795</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124-133</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Shp2 is a classical non-receptor protein tyrosine phosphatase (PTP) involved in many human diseases such as Noonan syndrome and tumors, and identified as a potential therapeutic target.  In order to find a potent and selective Shp2 inhibitor, we screened a diverse collection of the secondary metabolites from endophyte fungi using an in vitro enzyme assay, and finally identified a potent Shp2 inhibitor, HLP46 (demethylincisterol A3) from Pestalotiopsis sp.  HLP46 was reported to have anti-tumor and anti-inflammation activity previously.  We provide the first evidence that HLP46 is an inhibitor of the Shp2.  HLP46 shows high selective inhibition of Shp2 over Shp1, PTP1B, Lyp, STEP, PTPRA and Cdc25b.  Enzymic kinetic analyses showed that HLP46 is a non-competitive inhibitor of Shp2.  HLP46 interrupts Gab1-Shp2 assocn. and blocked Shp2-dependent activation of the Ras/ERK signal pathway induced by EGF.  Furthermore, HLP46 decreased Src activation and inhibit tumor cell migration and invasion.  As expected, HLP46 has no effect on the Shp2-independent activation of ERK induced by PMA or on the activation of the PI3K/Akt pathway.  We testified therapeutic efficacy targeting both Shp2 and PI3K in MCF7 cells.  HLP46 does not show any synergistic inhibition with PI3K inhibitor in suppressing cell growth.  Collectively, these results suggest that HLP46 is a selective Shp2 inhibitor and could inhibit Shp2-dependent cell signaling in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof4M-8QCExP7Vg90H21EOLACvtfcHk0lj0vrkufnPtiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyitrjM&md5=433ef816f666648e69bd672b8c75554a</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520demethylincisterol%2520A%25203%2520as%2520a%2520selective%2520inhibitor%2520of%2520protein%2520tyrosine%2520phosphatase%2520Shp2%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D795%26spage%3D124%26epage%3D133%26doi%3D10.1016%2Fj.ejphar.2016.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Grosskopf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radetzki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibitors of the Protein Tyrosine Phosphatase SHP2 Block Cellular Motility and Growth of Cancer Cells in vitro and in vivo</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1002%2Fcmdc.201500015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=25877780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFers7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=815-826&author=S.+Grosskopfauthor=C.+Eckertauthor=C.+Arkonaauthor=S.+Radetzkiauthor=K.+B%C3%B6hmauthor=U.+Heinemannauthor=G.+Wolberauthor=J.-P.+von+Kriesauthor=W.+Birchmeierauthor=J.+Rademann&title=Selective+Inhibitors+of+the+Protein+Tyrosine+Phosphatase+SHP2+Block+Cellular+Motility+and+Growth+of+Cancer+Cells+in+vitro+and+in+vivo&doi=10.1002%2Fcmdc.201500015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibitors of the Protein Tyrosine Phosphatase SHP2 Block Cellular Motility and Growth of Cancer Cells in vitro and in vivo</span></div><div class="casAuthors">Grosskopf, Stefanie; Eckert, Chris; Arkona, Christoph; Radetzki, Silke; Boehm, Kerstin; Heinemann, Udo; Wolber, Gerhard; von Kries, Jens-Peter; Birchmeier, Walter; Rademann, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">815-826</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective inhibitors of the protein tyrosine phosphatase SHP2 (src homol. region 2 domain phosphatase; PTPN11), an enzyme that is deregulated in numerous human tumors, were generated through a combination of chem. synthesis and structure-based rational design.  Seventy pyridazolon-4-ylidenehydrazinyl benzenesulfonates were prepd. and evaluated in enzyme assays.  The binding modes of active inhibitors were simulated in silico using a newly generated crystal structure of SHP2.  The most powerful compd. I inhibited SHP2 with an IC50 value of 71±15 nM in the enzyme assay and was 29- and 45-fold more active toward SHP2 than against related SHP1 and PTP1B.  In cell culture expts. compd. I was found to block hepatocyte growth factor (HGF)-stimulated epithelial-mesenchymal transition of human pancreatic adenocarcinoma (HPAF) cells, as indicated by a decrease in the min. neighbor distances of cells.  Moreover, I inhibited cell colony formation in the nonsmall-cell lung cancer cell line LXFA 526 L in soft agar.  Finally, I was obsd. to inhibit tumor growth in a murine xenograft model.  Therefore, the novel specific compd. I strengthens the hypothesis that SHP2 is a relevant protein target for the inhibition of mobility and invasiveness of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovDT-98edFurVg90H21EOLACvtfcHk0lj0vrkufnPtiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFers7g%253D&md5=72fa2915b67c514076144b3005441b17</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500015%26sid%3Dliteratum%253Aachs%26aulast%3DGrosskopf%26aufirst%3DS.%26aulast%3DEckert%26aufirst%3DC.%26aulast%3DArkona%26aufirst%3DC.%26aulast%3DRadetzki%26aufirst%3DS.%26aulast%3DB%25C3%25B6hm%26aufirst%3DK.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DWolber%26aufirst%3DG.%26aulast%3Dvon%2BKries%26aufirst%3DJ.-P.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DRademann%26aufirst%3DJ.%26atitle%3DSelective%2520Inhibitors%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520Block%2520Cellular%2520Motility%2520and%2520Growth%2520of%2520Cancer%2520Cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D815%26epage%3D826%26doi%3D10.1002%2Fcmdc.201500015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bialy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Protein Tyrosine Phosphatases: Next Generation Drugs?</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3813</span>– <span class="NLM_lpage">3839</span>, <span class="refDoi"> DOI: 10.1002/anie.200461517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1002%2Fanie.200461517" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=3813-3839&author=L.+Bialyauthor=H.+Waldmann&title=Inhibitors+of+Protein+Tyrosine+Phosphatases%3A+Next+Generation+Drugs%3F&doi=10.1002%2Fanie.200461517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2Fanie.200461517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200461517%26sid%3Dliteratum%253Aachs%26aulast%3DBialy%26aufirst%3DL.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DInhibitors%2520of%2520Protein%2520Tyrosine%2520Phosphatases%253A%2520Next%2520Generation%2520Drugs%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D3813%26epage%3D3839%26doi%3D10.1002%2Fanie.200461517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Targeting protein tyrosine phosphatases for anticancer drug discovery</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1862</span>, <span class="refDoi"> DOI: 10.2174/138161210791209027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.2174%2F138161210791209027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=20337577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1ClsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1843-1862&author=L.+M.+Scottauthor=H.+R.+Lawrenceauthor=N.+J.+Sebtiauthor=J.+Lawrenceauthor=J.+Wu&title=Targeting+protein+tyrosine+phosphatases+for+anticancer+drug+discovery&doi=10.2174%2F138161210791209027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatases for anticancer drug discovery</span></div><div class="casAuthors">Scott, Latanya M.; Lawrence, Harshani R.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1843-1862</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases (PTPs) are a diverse family of enzymes encoded by 107 genes in the human genome.  Together with protein tyrosine kinases (PTKs), PTPs regulate various cellular activities essential for the initiation and maintenance of malignant phenotypes.  While PTK inhibitors are now used routinely for cancer treatment, the PTP inhibitor development field is still in the discovery phase.  In this article, the suitability of targeting PTPs for novel anticancer drug discovery is discussed.  Examples are presented for PTPs that have been targeted for anticancer drug discovery as well as potential new PTP targets for novel anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHuBrNeSP0n7Vg90H21EOLACvtfcHk0lj0vrkufnPtiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1ClsLY%253D&md5=17813d1fba0225fd5e54692b1159bc4a</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.2174%2F138161210791209027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210791209027%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BM.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DSebti%26aufirst%3DN.%2BJ.%26aulast%3DLawrence%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTargeting%2520protein%2520tyrosine%2520phosphatases%2520for%2520anticancer%2520drug%2520discovery%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D1843%26epage%3D1862%26doi%3D10.2174%2F138161210791209027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmartin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faitg, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seefeld, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minthorn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinnamon, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heerding, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span> <span> </span><span class="NLM_article-title">Allosteric WIP1 Phosphatase Inhibition Through Flap-Subdomain Interaction</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fnchembio.1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=24390428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=181-187&author=A.+G.+Gilmartinauthor=T.+H.+Faitgauthor=M.+Richterauthor=A.+Groyauthor=M.+A.+Seefeldauthor=M.+G.+Darcyauthor=X.+Pengauthor=K.+Federowiczauthor=J.+Yangauthor=S.-Y.+Zhangauthor=E.+Minthornauthor=J.-P.+Jaworskiauthor=M.+Schaberauthor=S.+Martensauthor=D.+E.+McNultyauthor=R.+H.+Sinnamonauthor=H.+Zhangauthor=R.+B.+Kirkpatrickauthor=N.+Nevinsauthor=G.+Cuiauthor=B.+Pietrakauthor=E.+Diazauthor=A.+Jonesauthor=M.+Brandtauthor=B.+Schwartzauthor=D.+A.+Heerdingauthor=R.+Kumar&title=Allosteric+WIP1+Phosphatase+Inhibition+Through+Flap-Subdomain+Interaction&doi=10.1038%2Fnchembio.1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction</span></div><div class="casAuthors">Gilmartin, Aidan G.; Faitg, Thomas H.; Richter, Mark; Groy, Arthur; Seefeld, Mark A.; Darcy, Michael G.; Peng, Xin; Federowicz, Kelly; Yang, Jingsong; Zhang, Shu-Yun; Minthorn, Elisabeth; Jaworski, Jon-Paul; Schaber, Michael; Martens, Stan; McNulty, Dean E.; Sinnamon, Robert H.; Zhang, Hong; Kirkpatrick, Robert B.; Nevins, Neysa; Cui, Guanglei; Pietrak, Beth; Diaz, Elsie; Jones, Amber; Brandt, Martin; Schwartz, Benjamin; Heerding, Dirk A.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-187</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although therapeutic interventions of signal-transduction cascades with targeted kinase inhibitors are a well-established strategy, drug-discovery efforts to identify targeted phosphatase inhibitors have proven challenging.  Herein we report a series of allosteric, small-mol. inhibitors of wild-type p53-induced phosphatase (Wip1), an oncogenic phosphatase common to multiple cancers.  Compd. binding to Wip1 is dependent on a 'flap' subdomain located near the Wip1 catalytic site that renders Wip1 structurally divergent from other members of the protein phosphatase 2C (PP2C) family and that thereby confers selectivity for Wip1 over other phosphatases.  Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of Wip1 substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53.  Oral administration of Wip1 inhibitors in mice results in expected pharmacodynamic effects and causes inhibition of lymphoma xenograft growth.  To our knowledge, GSK2830371 is the first orally active, allosteric inhibitor of Wip1 phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jXZXKTKTL7Vg90H21EOLACvtfcHk0lgnAjiM_YNlCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D&md5=47524caa70df233fb152a2d683417e7d</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1427%26sid%3Dliteratum%253Aachs%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DFaitg%26aufirst%3DT.%2BH.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DSeefeld%26aufirst%3DM.%2BA.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFederowicz%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DS.-Y.%26aulast%3DMinthorn%26aufirst%3DE.%26aulast%3DJaworski%26aufirst%3DJ.-P.%26aulast%3DSchaber%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DSinnamon%26aufirst%3DR.%2BH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DAllosteric%2520WIP1%2520Phosphatase%2520Inhibition%2520Through%2520Flap-Subdomain%2520Interaction%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D181%26epage%3D187%26doi%3D10.1038%2Fnchembio.1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. C.</span></span> <span> </span><span class="NLM_article-title">Rational Design of Allosteric-Inhibition Sites in Classical Protein Tyrosine Phosphatases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2828</span>– <span class="NLM_lpage">2838</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.bmc.2015.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=25828055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVWhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2828-2838&author=C.+M.+Chioauthor=X.+Yuauthor=A.+C.+Bishop&title=Rational+Design+of+Allosteric-Inhibition+Sites+in+Classical+Protein+Tyrosine+Phosphatases&doi=10.1016%2Fj.bmc.2015.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases</span></div><div class="casAuthors">Chio, Cynthia M.; Yu, Xiaoling; Bishop, Anthony C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2828-2838</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs), which catalyze the dephosphorylation of phosphotyrosine in protein substrates, are crit. regulators of metazoan cell signaling and have emerged as potential drug targets for a range of human diseases.  Strategies for chem. targeting the function of individual PTPs selectively could serve to elucidate the signaling roles of these enzymes and would potentially expedite validation of the therapeutic promise of PTP inhibitors.  Here we report a novel strategy for the design of non-natural allosteric-inhibition sites in PTPs; these sites, which can be introduced into target PTPs through protein engineering, serve to sensitize target PTPs to potent and selective inhibition by a biarsenical small mol.  Building on the recent discovery of a naturally occurring cryptic allosteric site in wild-type Src-homol.-2 domain contg. PTP (Shp2) that can be targeted by biarsenical compds., we hypothesized that Shp2's unusual sensitivity to biarsenicals could be strengthened through rational design and that the Shp2-specific site could serve as a blueprint for the introduction of non-natural inhibitor sensitivity in other PTPs.  Indeed, we show here that the strategic introduction of a cysteine residue at a position removed from the Shp2 active site can serve to increase the potency and selectivity of the interaction between Shp2's allosteric site and the biarsenical inhibitor.  Moreover, we find that 'Shp2-like' allosteric sites can be installed de novo in PTP enzymes that do not possess naturally occurring sensitivity to biarsenical compds.  Using primary-sequence alignments to guide our enzyme engineering, we have successfully introduced allosteric-inhibition sites in four classical PTPs-PTP1B, PTPH-1, FAP-1, and HePTP-from four different PTP subfamilies, suggesting that our sensitization approach can likely be applied widely across the classical PTP family to generate biarsenical-responsive PTPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwDXbkv2RdC7Vg90H21EOLACvtfcHk0lgnAjiM_YNlCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVWhs7s%253D&md5=14a48e70c722a586a2e3ccb3fa9006ae</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DC.%2BM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DBishop%26aufirst%3DA.%2BC.%26atitle%3DRational%2520Design%2520of%2520Allosteric-Inhibition%2520Sites%2520in%2520Classical%2520Protein%2520Tyrosine%2520Phosphatases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2828%26epage%3D2838%26doi%3D10.1016%2Fj.bmc.2015.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beumer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simard, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grütter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span> <span> </span><span class="NLM_article-title">Selective Detection of Allosteric Phosphatase Inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">6838</span>– <span class="NLM_lpage">6841</span>, <span class="refDoi"> DOI: 10.1021/ja4030484</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4030484" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlWhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=6838-6841&author=R.+Schneiderauthor=C.+Beumerauthor=J.+R.+Simardauthor=C.+Gr%C3%BCtterauthor=D.+Rauh&title=Selective+Detection+of+Allosteric+Phosphatase+Inhibitors&doi=10.1021%2Fja4030484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Detection of Allosteric Phosphatase Inhibitors</span></div><div class="casAuthors">Schneider, Ralf; Beumer, Claudia; Simard, Jeffrey R.; Gruetter, Christian; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6838-6841</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Normal cellular function, such as signal transduction, is largely controlled by the reversible phosphorylation of cellular proteins catalyzed by two major classes of enzymes, kinases and phosphatases.  A misbalance in this complex and dynamic interplay leads to a variety of severe diseases, such as cancer, inflammation, or autoimmune diseases.  This makes kinases as well as phosphatases equally attractive targets for therapeutic manipulation by small mols.  While the development of kinase inhibitors has resulted in several blockbuster drugs, such as imatinib, with remarkable success in the clinic and sales of many billions of U.S. dollars per yr, not a single phosphatase inhibitor has yet been approved for clin. use.  Similar to the kinase world, substrate-competitive phosphatase inhibitors have been developed but were not suitable for further development into clin. candidates due to their charge and limited selectivity.  Research efforts, therefore, have shifted to the exploitation of allosteric sites that can regulate phosphatase activity and may enable the discovery of novel modulators of phosphatase activity with much improved pharmacol. properties.  However, assay systems, which enable the straightforward discovery of these inhibitor types, are missing.  Here, we present a novel binding assay capable of detecting ligands of an allosteric pocket of the protein tyrosine phosphatase 1B.  This assay is suitable for high-throughput screening and selectively detects ligands which bind to this unique site with a clear discrimination from substrate-competitive ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMMpcm8RfGWrVg90H21EOLACvtfcHk0lgTVwqDhg5-eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlWhtbk%253D&md5=49a980ad7f749718803f1afe1d8d1a04</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Fja4030484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4030484%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DBeumer%26aufirst%3DC.%26aulast%3DSimard%26aufirst%3DJ.%2BR.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DC.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DSelective%2520Detection%2520of%2520Allosteric%2520Phosphatase%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D6838%26epage%3D6841%26doi%3D10.1021%2Fja4030484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonakos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slisz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span> <span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-152&author=Y.-N.+P.+Chenauthor=M.+J.+LaMarcheauthor=H.+M.+Chanauthor=P.+Fekkesauthor=J.+Garcia-Fortanetauthor=M.+G.+Ackerauthor=B.+Antonakosauthor=C.+H.-T.+Chenauthor=Z.+Chenauthor=V.+G.+Cookeauthor=J.+R.+Dobsonauthor=Z.+Dengauthor=F.+Feiauthor=B.+Firestoneauthor=M.+Fodorauthor=C.+Fridrichauthor=H.+Gaoauthor=D.+Grunenfelderauthor=H.-X.+Haoauthor=J.+Jacobauthor=S.+Hoauthor=K.+Hsiaoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=J.+Larrowauthor=L.+R.+La+Bonteauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=E.+Priceauthor=C.+Quinnauthor=S.+Shakyaauthor=M.+D.+Shultzauthor=J.+Sliszauthor=K.+Venkatesanauthor=P.+Wangauthor=M.+Warmuthauthor=S.+Williamsauthor=G.+Yangauthor=J.+Yuanauthor=J.-H.+Zhangauthor=P.+Zhuauthor=T.+Ramseyauthor=N.+J.+Keenauthor=W.+R.+Sellersauthor=T.+Stamsauthor=P.+D.+Fortin&title=Allosteric+inhibition+of+SHP2+phosphatase+inhibits+cancers+driven+by+receptor+tyrosine+kinases&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 μM), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0lgTVwqDhg5-eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.-N.%2BP.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DH.%2BM.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarcia-Fortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DAntonakos%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCooke%26aufirst%3DV.%2BG.%26aulast%3DDobson%26aufirst%3DJ.%2BR.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DF.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DH.-X.%26aulast%3DJacob%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DQuinn%26aufirst%3DC.%26aulast%3DShakya%26aufirst%3DS.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DVenkatesan%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%2520phosphatase%2520inhibits%2520cancers%2520driven%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D152%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">0046ortanet, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7773</span>– <span class="NLM_lpage">7782</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00680</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00680" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7773-7782&author=J.+G.+0046ortanetauthor=C.+H.-T.+Chenauthor=Y.-N.+P.+Chenauthor=Z.+Chenauthor=Z.+Dengauthor=B.+Firestoneauthor=P.+Fekkesauthor=M.+Fodorauthor=P.+D.+Fortinauthor=C.+Fridrichauthor=D.+Grunenfelderauthor=S.+Hoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=N.+Keenauthor=L.+R.+LaBonteauthor=J.+Larrowauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=F.+Lombardoauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=T.+Ramseyauthor=W.+R.+Sellersauthor=M.+D.+Shultzauthor=T.+Stamsauthor=C.+Towlerauthor=P.+Wangauthor=S.+L.+Williamsauthor=J.-H.+Zhangauthor=M.+J.+LaMarche&title=Allosteric+Inhibition+of+SHP2%3A+Identification+of+a+Potent%2C+Selective%2C+and+Orally+Efficacious+Phosphatase+Inhibitor&doi=10.1021%2Facs.jmedchem.6b00680"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26aulast%3D0046ortanet%26aufirst%3DJ.%2BG.%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26aulast%3DChen%26aufirst%3DY.-N.%2BP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLaBonte%26aufirst%3DL.%2BR.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DAllosteric%2520Inhibition%2520of%2520SHP2%253A%2520Identification%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520Phosphatase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7773%26epage%3D7782%26doi%3D10.1021%2Facs.jmedchem.6b00680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Tyrosine Phosphatase SHP-2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1016/s0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fs0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+Structure+of+the+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2Fs0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0liAxbxWxhpWgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fs0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450%26doi%3D10.1016%2Fs0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Revealing Mechanisms for SH2 Domain Mediated Regulation of the Protein Tyrosine Phosphatase SHP-2</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/s0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fs0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+Mechanisms+for+SH2+Domain+Mediated+Regulation+of+the+Protein+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2Fs0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0liAxbxWxhpWgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fs0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520Mechanisms%2520for%2520SH2%2520Domain%2520Mediated%2520Regulation%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254%26doi%3D10.1016%2Fs0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durzynska, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2269</span>– <span class="NLM_lpage">2277</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.5b01287</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVagtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2269-2277&author=J.+R.+LaRochelleauthor=M.+Fodorauthor=X.+Xuauthor=I.+Durzynskaauthor=L.+Fanauthor=T.+Stamsauthor=H.+M.+Chanauthor=M.+J.+LaMarcheauthor=R.+Chopraauthor=P.+Wangauthor=P.+D.+Fortinauthor=M.+G.+Ackerauthor=S.+C.+Blacklow&title=Structural+and+Functional+Consequences+of+Three+Cancer-Associated+Mutations+of+the+Oncogenic+Phosphatase+SHP2&doi=10.1021%2Facs.biochem.5b01287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2</span></div><div class="casAuthors">LaRochelle, Jonathan R.; Fodor, Michelle; Xu, Xiang; Durzynska, Izabela; Fan, Lixin; Stams, Travis; Chan, Ho Man; LaMarche, Matthew J.; Chopra, Rajiv; Wang, Ping; Fortin, Pascal D.; Acker, Michael G.; Blacklow, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2269-2277</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The proto-oncogene PTPN11 encodes a cytoplasmic protein tyrosine phosphatase, SHP2, which is required for normal development and sustained activation of the Ras-MAPK signaling pathway.  Germline mutations in SHP2 cause developmental disorders, and somatic mutations have been identified in childhood and adult cancers and drive leukemia in mice.  Despite our knowledge of the PTPN11 variations assocd. with pathol., the structural and functional consequences of many disease-assocd. mutants remain poorly understood.  Here, we combine X-ray crystallog., small-angle X-ray scattering, and biochem. to elucidate structural and mechanistic features of three cancer-assocd. SHP2 variants harboring single point mutations within the N-SH2:PTP interdomain autoinhibitory interface.  Our findings directly compare the impact of each mutation on autoinhibition of the phosphatase and advance the development of structure-guided and mutation-specific SHP2 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdIaFVGm5lArVg90H21EOLACvtfcHk0ljn2pmA-kXUNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVagtLw%253D&md5=720b3dd9b18edde2c443d488cfb90dfc</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01287%26sid%3Dliteratum%253Aachs%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DDurzynska%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DH.%2BM.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26atitle%3DStructural%2520and%2520Functional%2520Consequences%2520of%2520Three%2520Cancer-Associated%2520Mutations%2520of%2520the%2520Oncogenic%2520Phosphatase%2520SHP2%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D2269%26epage%3D2277%26doi%3D10.1021%2Facs.biochem.5b01287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellegast, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemulapalli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmaier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span> <span> </span><span class="NLM_article-title">Identification of an Allosteric Benzothiazolopyrimidone Inhibitor of the Oncogenic Protein Tyrosine Phosphatase SHP2</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">6479</span>– <span class="NLM_lpage">6485</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.bmc.2017.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=29089257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A280%3ADC%252BC1M7mtlOksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=6479-6485&author=J.+R.+LaRochelleauthor=M.+Fodorauthor=J.+M.+Ellegastauthor=X.+Liuauthor=V.+Vemulapalliauthor=M.+Mohseniauthor=T.+Stamsauthor=S.+J.+Buhrlageauthor=K.+Stegmaierauthor=M.+J.+LaMarcheauthor=M.+G.+Ackerauthor=S.+C.+Blacklow&title=Identification+of+an+Allosteric+Benzothiazolopyrimidone+Inhibitor+of+the+Oncogenic+Protein+Tyrosine+Phosphatase+SHP2&doi=10.1016%2Fj.bmc.2017.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2</span></div><div class="casAuthors">LaRochelle Jonathan R; Liu Xiaoxi; Vemulapalli Vidyasiri; Buhrlage Sara J; Fodor Michelle; Stams Travis; Ellegast Jana M; Mohseni Morvarid; Acker Michael G; Stegmaier Kimberly; LaMarche Matthew J; Blacklow Stephen C</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6479-6485</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The PTPN11 oncogene encodes the cytoplasmic protein tyrosine phosphatase SHP2, which, through its role in multiple signaling pathways, promotes the progression of hematological malignancies and other cancers.  Here, we employ high-throughput screening to discover a lead chemical scaffold, the benzothiazolopyrimidones, that allosterically inhibits this oncogenic phosphatase by simultaneously engaging the C-SH2 and PTP domains.  We improved our lead to generate an analogue that better suppresses SHP2 activity in vitro.  Suppression of Erk phopsphorylation by the lead compound is also consistent with SHP2 inhibition in AML cells.  Our findings provide an alternative starting point for therapeutic intervention and will catalyze investigations into the relationship between SHP2 conformational regulation, activity, and disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQovWlxLHSQ4MRAV4D_Ins_fW6udTcc2eY_yCYnPkkr87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7mtlOksA%253D%253D&md5=4425bb1a20f079aa02986fb0b8a082e7</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DEllegast%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVemulapalli%26aufirst%3DV.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DStegmaier%26aufirst%3DK.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26atitle%3DIdentification%2520of%2520an%2520Allosteric%2520Benzothiazolopyrimidone%2520Inhibitor%2520of%2520the%2520Oncogenic%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D6479%26epage%3D6485%26doi%3D10.1016%2Fj.bmc.2017.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span> <span> </span><span class="NLM_article-title">Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10205</span>– <span class="NLM_lpage">10219</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01520</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01520" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCks7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10205-10219&author=J.+Xieauthor=X.+Siauthor=S.+Guauthor=M.+Wangauthor=J.+Shenauthor=H.+Liauthor=J.+Shenauthor=D.+Liauthor=Y.+Fangauthor=C.+Liuauthor=J.+Zhu&title=Allosteric+Inhibitors+of+SHP2+with+Therapeutic+Potential+for+Cancer+Treatment&doi=10.1021%2Facs.jmedchem.7b01520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment</span></div><div class="casAuthors">Xie, Jingjing; Si, Xiaojia; Gu, Shoulai; Wang, Mingliang; Shen, Jian; Li, Haoyan; Li, Dan; Fang, Yanjia; Liu, Cong; Zhu, Jidong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10205-10219</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2, a cytoplasmic protein tyrosine phosphatase encoded by the PTPN11 gene, is involved in multiple cell signaling processes including Ras/MAPK and Hippo/YAP pathways.  SHP2 has been shown to contribute to the progression of a no. of cancer types including leukemia, gastric, and breast cancers.  It also regulates T-cell activation by interacting with inhibitory immune checkpoint receptors such as the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA).  Thus, SHP2 inhibitors have drawn great attention by both inhibiting tumor cell proliferation and activating T cell immune responses toward cancer cells.  In this study, the authors report the identification of an allosteric SHP2 inhibitor I that locks SHP2 in a closed conformation by binding to the interface of the N-terminal SH2, C-terminal SH2, and phosphatase domains.  Compd. I suppresses MAPK signaling pathway and YAP transcriptional activity and shows antitumor activity in vivo.  The results indicate that allosteric inhibition of SHP2 could be a feasible approach for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWHA25LKpH7Vg90H21EOLACvtfcHk0ljn2pmA-kXUNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCks7%252FM&md5=4aaabafae3250476b7bf3687d83cffd3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01520%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DSi%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DAllosteric%2520Inhibitors%2520of%2520SHP2%2520with%2520Therapeutic%2520Potential%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10205%26epage%3D10219%26doi%3D10.1021%2Facs.jmedchem.7b01520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argintaru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Dual Allosteric Inhibition of SHP2 Phosphatase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00980</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00980" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=647-656&author=M.+Fodorauthor=E.+Priceauthor=P.+Wangauthor=H.+Luauthor=A.+Argintaruauthor=Z.+Chenauthor=M.+Glickauthor=H.-X.+Haoauthor=M.+Katoauthor=R.+Koenigauthor=J.+R.+LaRochelleauthor=G.+Liuauthor=E.+McNeillauthor=D.+Majumdarauthor=G.+A.+Nishiguchiauthor=L.+B.+Perezauthor=G.+Parisauthor=C.+M.+Quinnauthor=T.+Ramseyauthor=M.+Sendzikauthor=M.+D.+Shultzauthor=S.+L.+Williamsauthor=T.+Stamsauthor=S.+C.+Blacklowauthor=M.+G.+Ackerauthor=M.+J.+LaMarche&title=Dual+Allosteric+Inhibition+of+SHP2+Phosphatase&doi=10.1021%2Facschembio.7b00980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dual allosteric inhibition of SHP2 phosphatase</span></div><div class="casAuthors">Fodor, Michelle; Price, Edmund; Wang, Ping; Lu, Hengyu; Argintaru, Andreea; Chen, Zhouliang; Glick, Meir; Hao, Huai-Xiang; Kato, Mitsunori; Koenig, Robert; La Rochelle, Jonathan R.; Liu, Gang; McNeill, Eric; Majumdar, Dyuti; Nishiguchi, Gisele A.; Perez, Lawrence B.; Paris, Gregory; Quinn, Christopher M.; Ramsey, Timothy; Sendzik, Martin; Shultz, Michael David; Williams, Sarah L.; Stams, Travis; Blacklow, Stephen C.; Acker, Michael G.; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">647-656</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a cytoplasmic protein tyrosine phosphatase encoded by the PTPN11 gene and is involved in cell proliferation, differentiation, and survival.  Recently, we reported an allosteric mechanism of inhibition that stabilizes the auto-inhibited conformation of SHP2.  SHP099 (1) was identified and characterized as a moderately potent, orally bioavailable, allosteric small mol. inhibitor, which binds to a tunnel-like pocket formed by the confluence of three domains of SHP2.  In this report, we describe further screening strategies that enabled the identification of a second, distinct small mol. allosteric site.  SHP244 (2) was identified as a weak inhibitor of SHP2 with modest thermal stabilization of the enzyme.  X-ray crystallog. revealed that 2 binds and stabilizes the inactive, closed conformation of SHP2, at a distinct, previously unexplored binding site-a cleft formed at the interface of the N-terminal SH2 and PTP domains.  Derivatization of 2 using structure-based design resulted in an increase in SHP2 thermal stabilization, biochem. inhibition, and subsequent MAPK pathway modulation.  Downregulation of DUSP6 mRNA, a downstream MAPK pathway marker, was obsd. in KYSE-520 cancer cells.  Remarkably, simultaneous occupation of both allosteric sites by 1 and 2 was possible, as characterized by cooperative biochem. inhibition expts. and X-ray crystallog.  Combining an allosteric site 1 inhibitor with an allosteric site 2 inhibitor led to enhanced pharmacol. pathway inhibition in cells.  This work illustrates a rare example of dual allosteric targeted protein inhibition, demonstrates screening methodol. and tactics to identify allosteric inhibitors, and enables further interrogation of SHP2 in cancer and related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdw7pTS6sOLVg90H21EOLACvtfcHk0lja7LFgk7HcXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D&md5=8e4de4c353b9fc196c81e1cb51e367df</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00980%26sid%3Dliteratum%253Aachs%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DArgintaru%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGlick%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DH.-X.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DR.%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMcNeill%26aufirst%3DE.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26aulast%3DParis%26aufirst%3DG.%26aulast%3DQuinn%26aufirst%3DC.%2BM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DDual%2520Allosteric%2520Inhibition%2520of%2520SHP2%2520Phosphatase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D647%26epage%3D656%26doi%3D10.1021%2Facschembio.7b00980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Acker, M.</span>; <span class="NLM_string-name">Chen, Y. N.</span>; <span class="NLM_string-name">Chan, H.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Firestone, B.</span>; <span class="NLM_string-name">Fodor, M.</span>; <span class="NLM_string-name">Garcia-Fortanet, J.</span>; <span class="NLM_string-name">Hentemann, M.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">Koenig, R.</span>; <span class="NLM_string-name">LaBonte, L. R.</span>; <span class="NLM_string-name">Liu, S.</span>; <span class="NLM_string-name">Mohseni, M.</span>; <span class="NLM_string-name">Ntaganda, R.</span>; <span class="NLM_string-name">Sarver, P.</span>; <span class="NLM_string-name">Smith, T.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Stams, T.</span>; <span class="NLM_string-name">Spence, S.</span>; <span class="NLM_string-name">Towler, C.</span>; <span class="NLM_string-name">Wang, H.</span>; <span class="NLM_string-name">Wang, P.</span>; <span class="NLM_string-name">Williams, S. L.</span>; <span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of Fused-Bicyclic Allosteric SHP2 Inhibitors</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>.<span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01725</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01725" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+T.+Bagdanoff&author=Z.+Chen&author=M.+Acker&author=Y.+N.+Chen&author=H.+Chan&author=M.+Dore&author=B.+Firestone&author=M.+Fodor&author=J.+Garcia-Fortanet&author=M.+Hentemann&author=M.+Kato&author=R.+Koenig&author=L.+R.+LaBonte&author=S.+Liu&author=M.+Mohseni&author=R.+Ntaganda&author=P.+Sarver&author=T.+Smith&author=M.+Sendzik&author=T.+Stams&author=S.+Spence&author=C.+Towler&author=H.+Wang&author=P.+Wang&author=S.+L.+Williams&author=M.+J.+LaMarche&title=Optimization+of+Fused-Bicyclic+Allosteric+SHP2+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01725"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01725%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26atitle%3DOptimization%2520of%2520Fused-Bicyclic%2520Allosteric%2520SHP2%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.8b01725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gee, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalgat, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upson, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaubert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugland, R. P.</span></span> <span> </span><span class="NLM_article-title">Fluorogenic Substrates Based on Fluorinated Umbelliferones for Continuous Assays of Phosphatases and β-Galactosidases</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1006/abio.1999.4202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1006%2Fabio.1999.4202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1999&pages=41-48&author=K.+R.+Geeauthor=W.-C.+Sunauthor=M.+K.+Bhalgatauthor=R.+H.+Upsonauthor=D.+H.+Klaubertauthor=K.+A.+Lathamauthor=R.+P.+Haugland&title=Fluorogenic+Substrates+Based+on+Fluorinated+Umbelliferones+for+Continuous+Assays+of+Phosphatases+and+%CE%B2-Galactosidases&doi=10.1006%2Fabio.1999.4202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4202%26sid%3Dliteratum%253Aachs%26aulast%3DGee%26aufirst%3DK.%2BR.%26aulast%3DSun%26aufirst%3DW.-C.%26aulast%3DBhalgat%26aufirst%3DM.%2BK.%26aulast%3DUpson%26aufirst%3DR.%2BH.%26aulast%3DKlaubert%26aufirst%3DD.%2BH.%26aulast%3DLatham%26aufirst%3DK.%2BA.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26atitle%3DFluorogenic%2520Substrates%2520Based%2520on%2520Fluorinated%2520Umbelliferones%2520for%2520Continuous%2520Assays%2520of%2520Phosphatases%2520and%2520%25CE%25B2-Galactosidases%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D273%26spage%3D41%26epage%3D48%26doi%3D10.1006%2Fabio.1999.4202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wenlock, M.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1250</span>– <span class="NLM_lpage">1256</span>, <span class="refDoi"> DOI: 10.1021/jm021053p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021053p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1250-1256&author=M.%0AC.+Wenlockauthor=R.+P.+Austinauthor=P.+Bartonauthor=A.+M.+Davisauthor=P.+D.+Leeson&title=A+Comparison+of+Physiochemical+Property+Profiles+of+Development+and+Marketed+Oral+Drugs&doi=10.1021%2Fjm021053p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span></div><div class="casAuthors">Wenlock, Mark C.; Austin, Rupert P.; Barton, Patrick; Davis, Andrew M.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The process of drug discovery applies rigorous selection pressures.  Marketed oral drugs will generally possess favorable physiochem. properties with respect to absorption, metab., distribution, and clearance.  This paper describes a study in which the distributions of physiochem. properties of oral drugs in different phases of clin. development are compared to those already marketed.  The aim is to identify the trends in physiochem. properties that favor a drug's successful passage through clin. development and on to the market.  Two libraries were created, one of current development oral drugs and one of marketed oral drugs.  Statistical anal. of the two showed that the mean mol. wt. of orally administered drugs in development decreases on passing through each of the different clin. phases and gradually converges toward the mean mol. wt. of marketed oral drugs.  It is also clear that the most lipophilic compds. are being discontinued from development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0PksUFJq0bVg90H21EOLACvtfcHk0ljL2eocHWWUpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D&md5=b9809c803a61ec99a1b4171e97952452</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm021053p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021053p%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DA%2520Comparison%2520of%2520Physiochemical%2520Property%2520Profiles%2520of%2520Development%2520and%2520Marketed%2520Oral%2520Drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1250%26epage%3D1256%26doi%3D10.1021%2Fjm021053p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry</span>. <i>Nat. Rev. Drug. Disc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-Like+Concepts+on+Decision-Making+in+Medicinal+Chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljL2eocHWWUpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-Like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Disc.%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Setting Expectations in Molecular Optimizations: Strengths and Limitations of Commonly Used Composite Parameters</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5980</span>– <span class="NLM_lpage">5991</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1016%2Fj.bmcl.2013.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=24018190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5980-5991&author=M.+D.+Shultz&title=Setting+Expectations+in+Molecular+Optimizations%3A+Strengths+and+Limitations+of+Commonly+Used+Composite+Parameters&doi=10.1016%2Fj.bmcl.2013.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5980-5991</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Over the past 15 years there have been extensive efforts to understand and reduce the high attrition rates of drug candidates with an increased focus on physicochem. properties.  The fruits of this labor have been the generation of numerous efficiency indexes, metric-based rules and visualization tools to help guide medicinal chemists in the design of new compds. with more favorable properties.  This deluge of information may have had the unintended consequence of further obfuscating mol. optimizations by the inability of these scoring functions, rules and guides to reach a consensus on when a particular transformation is identified as beneficial.  In this manuscript, several composite parameters, or efficiency indexes, are examd. utilizing theor. and exptl. matched mol. pair analyses in order to understand the basis for how each will perform under varying scenarios of mol. optimizations.  In contrast to empirically derived composite parameters based on heavy atom count, lipophilic efficiency (LipE) sets consistent expectations regardless of mol. wt. or relative potency and can be used to generate consistent expectations for any matched mol. pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJeTISXSJyLbVg90H21EOLACvtfcHk0lgQx-gzhsmBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI&md5=3b766e26254f482b75b8973888c13aec</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DSetting%2520Expectations%2520in%2520Molecular%2520Optimizations%253A%2520Strengths%2520and%2520Limitations%2520of%2520Commonly%2520Used%2520Composite%2520Parameters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5980%26epage%3D5991%26doi%3D10.1016%2Fj.bmcl.2013.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavelin, S.</span></span> <span> </span><span class="NLM_article-title">Caco-2 and Emerging Alternatives for Prediction of Intestinal Drug Transport: A General Overview</span>. <i>Methods Princ. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1002/3527601473.ch4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1002%2F3527601473.ch4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=72-89&author=P.+Arturssonauthor=S.+Tavelin&title=Caco-2+and+Emerging+Alternatives+for+Prediction+of+Intestinal+Drug+Transport%3A+A+General+Overview&doi=10.1002%2F3527601473.ch4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2F3527601473.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F3527601473.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DTavelin%26aufirst%3DS.%26atitle%3DCaco-2%2520and%2520Emerging%2520Alternatives%2520for%2520Prediction%2520of%2520Intestinal%2520Drug%2520Transport%253A%2520A%2520General%2520Overview%26jtitle%3DMethods%2520Princ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D18%26spage%3D72%26epage%3D89%26doi%3D10.1002%2F3527601473.ch4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Paz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvieto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescatore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5843</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1021/jm800245z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+Raltegravir%2C+a+Potent%2C+Selective+Orally+Bioavailable+HIV-Integrase+Inhibitor+for+the+Treatment+of+HIV-AIDS+Infection&doi=10.1021%2Fjm800245z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection</span></div><div class="casAuthors">Summa, Vincenzo; Petrocchi, Alessia; Bonelli, Fabio; Crescenzi, Benedetta; Donghi, Monica; Ferrara, Marco; Fiore, Fabrizio; Gardelli, Cristina; Gonzalez Paz, Odalys; Hazuda, Daria J.; Jones, Philip; Kinzel, Olaf; Laufer, Ralph; Monteagudo, Edith; Muraglia, Ester; Nizi, Emanuela; Orvieto, Federica; Pace, Paola; Pescatore, Giovanna; Scarpelli, Rita; Stillmock, Kara; Witmer, Marc V.; Rowley, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5843-5855</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type-1 (HIV-1) integrase is one of the three virally encoded enzymes required for replication and therefore a rational target for chemotherapeutic intervention in the treatment of HIV-1 infection.  We report here the discovery of Raltegravir, the first HIV-integrase inhibitor approved by FDA for the treatment of HIV infection.  It derives from the evolution of 5,6-dihydroxypyrimidine-4-carboxamides and N-methyl-4-hydroxypyrimidinone-carboxamides, which exhibited potent inhibition of the HIV-integrase catalyzed strand transfer process.  Structural modifications on these mols. were made in order to maximize potency as HIV-integrase inhibitors against the wild type virus, a selection of mutants, and optimize the selectivity, pharmacokinetic, and metabolic profiles in preclin. species.  The good profile of Raltegravir has enabled its progression toward the end of phase III clin. trials for the treatment of HIV-1 infection and culminated with the FDA approval as the first HIV-integrase inhibitor for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYo6KKNjJRCrVg90H21EOLACvtfcHk0lgQx-gzhsmBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM&md5=f90f994c7cd031a4063cbb3e91b4c3f0</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Raltegravir%252C%2520a%2520Potent%252C%2520Selective%2520Orally%2520Bioavailable%2520HIV-Integrase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520HIV-AIDS%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5843%26epage%3D5855%26doi%3D10.1021%2Fjm800245z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennis, J. E. J.</span>; <span class="NLM_string-name">Vandenberk, J.</span></span> <span> </span><span class="NLM_article-title">Novel 1,2-Benzisoxadol-3-yl and 1,2-Benzisothiazol-3-ylderivatives</span>. U.S. Patent <span class="NLM_patent">4,804,633</span>, <span class="NLM_year">1985</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&author=J.+E.+J.+Kennis&author=J.+Vandenberk&title=Novel+1%2C2-Benzisoxadol-3-yl+and+1%2C2-Benzisothiazol-3-ylderivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKennis%26aufirst%3DJ.%2BE.%2BJ.%26atitle%3DNovel%25201%252C2-Benzisoxadol-3-yl%2520and%25201%252C2-Benzisothiazol-3-ylderivatives%26date%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassel, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaldor, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwaltney, S. L.,  II</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Pyrimidinone and Pyrimidinedione Inhibitors of Dipeptidyl Peptidase IV</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1021/jm101016w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101016w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=510-524&author=Z.+Zhangauthor=M.+B.+Wallaceauthor=J.+Fengauthor=J.+A.+Staffordauthor=R.+J.+Skeneauthor=L.+Shiauthor=B.+Leeauthor=K.+Aertgeertsauthor=A.+Jenningsauthor=R.+Xuauthor=D.+B.+Kasselauthor=S.+W.+Kaldorauthor=M.+Navreauthor=D.+R.+Webbauthor=S.+L.+Gwaltney&title=Design+and+Synthesis+of+Pyrimidinone+and+Pyrimidinedione+Inhibitors+of+Dipeptidyl+Peptidase+IV&doi=10.1021%2Fjm101016w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV</span></div><div class="casAuthors">Zhang, Zhi-Yuan; Wallace, Michael B.; Feng, Jun; Stafford, Jeffrey A.; Skene, Robert J.; Shi, Li-Hong; Lee, Bum-Sup; Aertgeerts, Kathleen; Jennings, Andy; Xu, Rong-Da; Kassel, Daniel B.; Kaldor, Stephen W.; Navre, Marc; Webb, David R.; Gwaltney, Stephen L., II</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">510-524</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of two classes of heterocyclic dipeptidyl peptidase IV (DPP-4) inhibitors, pyrimidinones and pyrimidinediones, is described.  After a single oral dose, these potent, selective, and noncovalent inhibitors provide sustained redn. of plasma DPP-4 activity and lowering of blood glucose in animal models of diabetes.  Compds. I, II, and III were selected for development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxInStuMRjfbVg90H21EOLACvtfcHk0lgQx-gzhsmBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtL7M&md5=7e3b66916acf243ad7943add0eaf6b1f</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Fjm101016w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101016w%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Pyrimidinone%2520and%2520Pyrimidinedione%2520Inhibitors%2520of%2520Dipeptidyl%2520Peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D510%26epage%3D524%26doi%3D10.1021%2Fjm101016w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Smith, T. D.</span>; <span class="NLM_string-name">Williams, S.</span>; <span class="NLM_string-name">Girlades, S.</span>; <span class="NLM_string-name">Toure, B.
B.</span>; <span class="NLM_string-name">Sendzik, M.</span></span> <span> </span><span class="NLM_article-title">N-azaspirocycloalkane Substituted N-Heteroaryl Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO <span class="NLM_patent">15107495</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+H.+Chen&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=R.+Karki&author=M.+Kato&author=M.+J.+LaMarche&author=L.+B.+Perez&author=T.+D.+Smith&author=S.+Williams&author=S.+Girlades&author=B.%0AB.+Toure&author=M.+Sendzik&title=N-azaspirocycloalkane+Substituted+N-Heteroaryl+Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DN-azaspirocycloalkane%2520Substituted%2520N-Heteroaryl%2520Compounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhalay, G.</span>; <span class="NLM_string-name">Culshaw, A. J.</span>; <span class="NLM_string-name">Dziadulewicz, E. K.</span>; <span class="NLM_string-name">Brain, C. T.</span>; <span class="NLM_string-name">Ritchie, T. J.</span>; <span class="NLM_string-name">Beattie, D.</span>; <span class="NLM_string-name">Bala, K.
J.</span>; <span class="NLM_string-name">Brewer, A.</span>; <span class="NLM_string-name">Hughes, G.</span></span> <span> </span><span class="NLM_article-title">Organic Compounds</span>. WO <span class="NLM_patent">2007/065662 A2</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+Bhalay&author=A.+J.+Culshaw&author=E.+K.+Dziadulewicz&author=C.+T.+Brain&author=T.+J.+Ritchie&author=D.+Beattie&author=K.%0AJ.+Bala&author=A.+Brewer&author=G.+Hughes&title=Organic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBhalay%26aufirst%3DG.%26atitle%3DOrganic%2520Compounds%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of Fluorine in Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+Fluorine+in+Medicinal+Chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lgPfgdkHaWcRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520Fluorine%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span> </span><span class="NLM_article-title">Dose Finding Study of TNO155 in Adult Patients
With Advanced Solid
Tumors</span>, <span class="NLM_publisher-name">ClinicalTrials.gov Identifier</span>: NCT03114319.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dose+Finding+Study+of+TNO155+in+Adult+Patients%0AWith+Advanced+Solid%0ATumors%2C+ClinicalTrials.gov+Identifier%3A+NCT03114319."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DDose%2520Finding%2520Study%2520of%2520TNO155%2520in%2520Adult%2520Patients%250AWith%2520Advanced%2520Solid%250ATumors%26pub%3DClinicalTrials.gov%2520Identifier" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/s0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2Fs0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgPfgdkHaWcRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2Fs0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P.</span>; <span class="NLM_string-name">Smart, O.
S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T. O.</span></span> <i>BUSTER</i>, version 2.8.0; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.%0AS.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development ofCoot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/s0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+ofCoot&doi=10.1107%2Fs0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lgdbTiJJUOqFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520ofCoot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2Fs0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP','PDB','2SHP'); return false;">PDB: 2SHP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR','PDB','5EHR'); return false;">PDB: 5EHR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB','PDB','6MDB'); return false;">PDB: 6MDB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD7','PDB','6MD7'); return false;">PDB: 6MD7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01726">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_75801"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01726">10.1021/acs.jmedchem.8b01726</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01726/suppl_file/jm8b01726_si_001.csv">CSV</a>)</p></li><li><p class="inline">X-ray data table and additional synthetic procedures (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01726/suppl_file/jm8b01726_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01726/suppl_file/jm8b01726_si_001.csv">jm8b01726_si_001.csv (1.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01726/suppl_file/jm8b01726_si_002.pdf">jm8b01726_si_002.pdf (325.09 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD7">6MD7</a> for SHP2 in complex with compound <b>7</b>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01726%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-4%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01726" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66798444685823e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
